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Abstract 
 
The formation or cleavage of carbon-carbon bonds is often thermodynamically 
unfavourable and, using abiotic catalysts, only achieved under harsh reaction 
conditions. As an alternative, numerous enzymes are able to catalyse equivalent 
reactions and constitute versatile biocatalytic tools for the production of high value 
chemical building blocks. Three such catalysts have now been analysed with respect 
to their structure, function, reaction mechanism and/or substrate specificity.  
 
The Bacillus subtilis phenolic acid decarboxylase (BsPAD) is a carbon-carbon bond 
lyase. Despite the availability of an apo-structure, the enzyme’s reaction mechanism 
remained speculative. Within this work, an active site mutant library was prepared 
and analysed and the structure of one of the variants could be determined in complex 
with its phenolic acid substrate. Using combined structural and kinetic data, a 
catalytic mechanism was proposed and confirmed previous modelling approaches. 
In addition, the codon optimised genes of two carbon-carbon bond hydrolases were 
subcloned for recombinant protein production. Phloretin hydrolase (Phy), a retro-
Friedel Crafts hydrolase from Eubacterium ramulus, was purified and crystallised. 
Although the crystals’ diffraction quality was too poor for structure determination, a 
fluorescence spectrum revealed Phy to bind zinc. Together with a substrate screen 
and kinetic data from an active site mutant library, these findings gave novel insights 
into a unique metal dependent hydrolase. 
As a member of the !-diketone cleaving family of enzymes, the oxidised polyvinyl 
alcohol hydrolase (OPH) from Pseudomonas sp. VM15C was analysed. After 
extensive solubility screening and construct optimisation, OPH could, for the first 
time, be purified as a soluble fusion construct with an N-terminal GST tag. The fused 
protein crystallised and now awaits further structural and mechanistic analysis.  
 
It is hoped that the data obtained as part of this project will now advance the 
understanding of the characterised biocatalysts and create a basis for their 
optimisation and use in industrial applications.  
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Chapter 1: Introduction 
 
1. Biocatalysis  
 
The chemical synthesis and degradation of many organic compounds can be complex 
and challenging. Expensive starting materials, harsh reaction conditions and multiple 
bottlenecks can make processes unfeasible. Furthermore, unfavourable equilibria and 
poor regio- and/or enantioselectivity of the catalysts may lead to low overall yields. 
To overcome this problem, the catalysts’ biological counterparts - from isolated 
enzymes to whole live cells - may replace one or several components of a reaction 
and a purely abiotic reaction turns into what is known as “Biocatalysis”. These 
biological components will not only be able to catalyse the desired reaction but have 
several advantages with respect to reaction conditions and overall productivity. 
Enzymes, being the active reagent in all forms of biocatalysis, are often most active 
at moderate temperatures and pressure as well as physiological pH values. They 
show high substrate specificity and can differentiate between different stereoisomers.  
Enzymes have a further advantage in their use as catalytic tools as they can, within 
limits, be optimised and shaped into desired functionalities. Alteration of the primary 
amino acid sequence and subsequently smaller or larger changes to secondary and 
tertiary structure can allow for alterations in the substrate scope, activity and 
selectivity. Still, no matter what reaction will be catalysed eventually, biocatalysis 
can conform to the Principles of Green Chemistry, which promote processes which 
are efficient, yet safe and sustainable (1,2).  
 
1.2 Enzymatic C-C bond formation and cleavage in biocatalysis 
 
Carbon-carbon bonds form the backbone of most organic compounds, many of 
which are important in biotechnological applications. Their formation and cleavage 
is essential to the synthesis and degradation of such molecules but form bottlenecks 
in chemical processes. Especially for the formation of C-C bonds, equilibria are often 
unfavourable and reaction conditions too harsh for large scale applications. Unlike 
carbon-heteroatom bonds, the linkage between two carbon atoms is not polar and, 
especially for the sp3 hybridised C-C single bonds, very strong. As a consequence, 
the use of enzymes in the formation and cleavage of carbon-carbon bonds has 
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become an attractive alternative, allowing for the production (or degradation) of 
complex organic molecules on a large scale (3,4).  
A number of enzymes have been characterised with respect to their ability to cleave 
and/or form carbon-carbon bonds. The majority are C-C lyases and C-C hydrolases, 
belonging to enzyme classes EC 4.1 and EC 3.7 respectively, in addition to a smaller 
number of oxidoreductases and transferases.  Members of the two main classes 
commonly cleave carbon-carbon bonds in nature but differ in structure, function, 
reaction mechanisms and cofactor requirements. In vitro, a small number of these 
enzymes have been shown to also catalyse the reverse reaction and form C-C bonds 
rather than cleave them. This reaction is, however, still unexploited for many 
biocatalysts, especially the hydrolases, and is an area of potential interest for 
industrial applications (4).  
The following sections will give a brief overview on the two major groups of carbon-
carbon bond cleaving enzymes, C-C hydrolases and lyases, many of which are 
known for their biocatalytic potential. The enzymes’ diversity in reactions catalysed, 
mechanisms, substrate scope and cofactor dependence will be outlined.  
 
 
1.3 Carbon-carbon bond lyases  
 
C-C bond lyases catalyse addition-elimination reactions across carbon-carbon double 
bonds. These include decarboxylations, aldol reactions, or nucleophilic substitutions. 
Lyases may form two products from one substrate or vice versa, depending on the 
directionality of the reaction. According to the catalysed reactions, carbon-carbon 
lyases form four groups, namely the carboxy-lyases or decarboxylases, aldehyde 
lyases, oxo-acid lyases and others (Enzyme classes 4.1.1, 4.1.2, 4.1.3 and 4.1.4 
respectively).  
 
1.3.1  Aldolases 
 
Aldolases catalyse the formation of C-C bonds via an aldol addition of "-hydroxy 
aldehydes or ketones, to create ß-hydroxy carbonyl compounds, in some cases 
requiring a cofactor such as pyridoxal-5’-phosphate (PLP) for activity. A donor and 
acceptor molecule are combined via nucleophilic addition - involving formation of a 
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Schiff base intermediate between the enzyme’s active site lysine and the donor 
molecule (class I aldolases)  or by using a zinc ion cofactor acting as a Lewis acid to 
activate a donor nucleophile (class II aldolases) (4,5). Alternatively, they may cleave 
carbon-carbon bonds in the reverse retro-aldol reaction. Fully reversible aldolase 
reactions are well understood and widely applied, also due to their increased 
stereospecificity and applicability on highly substituted substrates compared to their 
abiotic counterparts. They accept, however, only a very limited number of donor 
molecules – only four carbonyl compounds for the most commonly used aldolases 
(3,4,6).  
 
1.3.2 Oxo-acid lyases 
 
Oxo-acid lyases cleave carbon-carbon bonds of 3-hydroxy acids. This can involve, 
for example, aldol reactions as with the widely studied, pyruvate dependent 
N-acetylneuraminic acid lyase (NeuA). NeuA catalyses the aldol condensation 
between N-acetyl D-mannosamine and pyruvate to yield N-acetylneuraminic acid - a 
signalling molecule with diverse biological functions. Other oxo-acid lyases may 
catalyse electrophilic substitutions such as the isocitrate lyase (ICL) in the glyoxylate 
cycle – a bypass to the citric acid cycle. The enzyme produces glyoxylate and 
succinate from isocitrate and thus supplies both a shortcut and supply of 
intermediates to the TCA cycle and gluconeogenesis. (3,7-9).  
 
1.3.3 Carboxylases 
 
Carboxylases mediate the transfer of a carboxylic acid functional group to or from 
their substrates. In many cases the reaction equilibrium is in favour of 
decarboxylation and breaking of carbon-carbon bonds (see Fig. 1.1). The reverse 
reaction has however been observed and can be enhanced by optimisation of 
experimental conditions, i.e. by shifting the equilibrium (10-12). A recent example 
for this type of reaction is the enzymatic carboxylation of a variety of phenolic and 
styrene substrates in carbonate buffer (13). Different decarboxylases catalyse their 
reactions in several ways. They may depend on organic cofactors such as thiamine 
diphosphate (ThDP), biotin or pyridoxal phosphate (PLP), the latter of which is 
especially common with amino acid decarboxylases (3,14,15). Some enzyme-family 
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members also make use of a small inorganic cofactor, usually a mono- or divalent 
metal, to catalyse their reactions. Other decarboxylases, such as certain phenolic acid 
decarboxylases and related enzymes, are independent of any additional cofactors 
(16-19). 
 
Figure 1.1: A schematic carboxylation/decarboxylation reaction. For enzymes the 
equilibrium is usually in favour of carbon-carbon bond cleavage. 
 
 
1.3.3.1  PLP dependent decarboxylases 
 
A large family of enzymes relies on pyridoxal phosphate (PLP) derived from 
Vitamin B6 as a cofactor for catalysis, among them also a variety of decarboxylases. 
The majority are involved in the synthesis and breakdown of amino acids and their 
metabolic importance has rendered them attractive drug targets. As a consequence of 
their basic metabolic functions, PLP dependent enzymes are present in all forms of 
life but are more abundant in the less complex prokaryotes and lower eukaryotes 
(20). They are grouped, both structurally and functionally, into ", ! and # families, 
referring to the position of their substrates’ main catalytic carbon. Reactions 
catalysed by these enzymes range from decarboxylations, transaminations, 
racemisations and eliminations to transfer reactions (21,22).  
 
In PLP dependent enzymes, the cofactor forms a Schiff base with the $-amino group 
of a highly conserved lysine in the active site (Fig. 1.2a). This is known as the 
internal aldimine. As substrate enters the active site, the imine linkage is broken and 
reformed between PLP and the substrate’s amino group. For PLP dependent 
decarboxylases, this corresponds to the primary NH-group of a variety of amino 
acids as shown in Fig. 1.2. The external aldimine thus formed will mediate all 
subsequent catalysis, consistent with observations that PLP-mediated reactions can in 
fact take place (albeit at a reduced rate) without the enzyme being present (23).  
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These first steps are common to all PLP dependent enzymes and only after formation 
of the external aldimine do pathways split according to the final reaction outcome. In 
the case of decarboxylases, the carbon-carbon bond between the substrate’s C" 
carbon and the carboxylic acid is broken, releasing CO2 and forming a quinonoid 
intermediate. The carbanion created by cleaving the C-C bond is highly unstable and 
relies on the conjugated system of PLP and the imine bond to relocate the negative 
charge and act as an electron sink, stabilising the quinonoid. For this to be most 
efficient, PLP and the imine bond lie in a plane orthogonal to the scissile carbon, 
ensuring optimal overlap of orbitals and thus movement of resonant electrons. 
Eventually, reprotonation then leads to release of the amine product and regeneration 
of the internal aldimine (21,23-25).  
 
Figure 1.2: In the absence of substrate, PLP is linked to an active site lysine through an 
imine bond, forming the internal aldimine. As substrate enters, the imine bond is broken and 
reformed with the amino acids primary NH group to give the catalytic external aldimine (a). 
Within the latter, the carboxylate moiety is cleaved off and, following reprotonation at C", 
the imine is broken and reformed with the active site lysine, leading to release of the amine 
product regeneration of the internal aldimine (b) [adapted from (23)].   
 
A well characterised enzyme that represents many of the structural and mechanistic 
features of PLP dependent decarboxylases is the L-3,4-dihydroxyphenylalanine 
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decarboxylase (DDC). DDC removes a carboxyl moiety from its amino acid 
substrate L-3,4-dihydroxyphenylalanine (DOPA) to give the important 
neurotransmitter L-3,4-dihydroxyphenylamine (dopamine). In addition to dopamine, 
the enzyme is involved in the biosynthesis of 5-hydroxytryptamine (serotonin) from 
L-5-hydroxytryptophan and is able to decarboxylate tryptophan to tryptamine. It is 
thus sometimes referred to as a general aromatic amino acid decarboxylase (AADC) 
(26). DDC proteins vary in size from around 50-100 kDa and associate into 
homodimers.  They are members of the fold I type or "-family of PLP dependent 
enzymes whose structure strongly resembles that of mitochondrial aspartate 
aminotransferase (23,27,28). In 2001, the first structure of human DDC was solved 
in its PLP bound state as well as in complex with the inhibitor (2S)-3-(3,4-
dihydroxyphenyl)-2-hydrazinyl-2-methyl-propanoic acid (carbidopa) (29,30). 
 
Figure 1.3: DDC converts L-3,4-dihydroxyphenylalanine (DOPA) into the neurotransmitter 
L-3,4-dihydroxyphenylamine (dopamine). (29).  
 
The active site is located in the centre of DDC, within the large subunit and protected 
from solvent while the enzyme is in a closed state. The latter is obtained by 
significant conformational changes of the asymmetric monomers on binding of the 
cofactor, making dimerisation essential to DDC activity (30). Analysis of substrate 
binding as well as sequence conservation and site-directed mutagenesis experiments, 
have given an important insight into decarboxylation by PLP dependent enzymes of 
the "–family.  The catalytic lysine is highly conserved, even in more distantly related 
animal and plant amino acid decarboxylases (31). The recognition of PLP and 
transaldimination induce a concerted loop movement and closure of the active site to 
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the surrounding solvent. The newly positioned loops bring amino acid residues 
involved in substrate binding into direct proximity of the active site (30). In the 
complex structure of DDC and carbidopa, the bound inhibitor is found in a plane 
orthogonal to the hydrazone bond and the cofactor once the external aldimine has 
fully formed. This corresponds to the proposed arrangement of PLP and its imine 
bond with the native DOPA substrate. In addition, the PLP pyridine ring’s nitrogen 
forms a salt bridge with the carboxylate moiety of an aspartate side chain (Asp 271) 
(29,31).  Both features are thought to enhance the aldimine’s function as an electron 
sink and stabilise the decarboxylated quinonoid intermediate through extended 
resonance (23,29). For catalysis to be completed, the latter then has to be protonated. 
In the structure of human DDC, Tyr 332 was found to be in a suitable position for 
this reaction and was suggested to be a potential proton donor. Eventually, Lys 303 is 
thought to mediate release of the amine product through nucleophilic attack on the 
external aldimine and transaldimination with PLP (31).  
 
Figure 1.4: The internal and external aldimines formed in DOPA decarboxylase between 
Lys 303 and PLP or Lys 303 and the DOPA mimic carbidopa respectively. The catalytic 
lysine and its imine bond with PLP lie in a plane orthogonal to the cofactor’s pyridine ring. 
The same arrangement is observed between PLP and the bound substrate, with the imine 
bond being represented by a hydrazone linkage in the carbidopa inhibitor.  
 
The structural and mechanistic knowledge about PLP dependent decarboxylases is 
essential in the design of drugs against a variety of diseases. Abundance and activity 
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of DDC is strongly correlated to Parkinson’s disease (PD) (32). Another example is 
African sleeping sickness which is caused by the parasite Trypanosomas brucei. It is 
widely treated using "–difluoromethylornithine, an inhibitor of the parasite’s PLP 
dependent ornithine decarboxylase, which disrupts cellular polyamine synthesis (33).   
 
1.3.3.2 ThDP dependent decarboxylases 
 
The use of thiamine diphosphate (ThDP), formerly known as thiamine 
pyrophosphate (TPP), as a cofactor, has been established for a large number of 
enzymes. These include dehydrogenases, transketolases and oxidoreductases as well 
as a variety of decarboxylases. The latter make up the largest family of ThDP 
dependent enzymes and accept a variety of 2-keto acid substrates which lack an 
inherent electron sink to facilitate decarboxylation (34,35). The cofactor is derived 
from Vitamin B1 by phosphorylation and available to prokaryotic and eukaryotic 
enzyme classes. It is made up of two heterocycles, a thiazolium and a 
4’- aminopyrimidine ring, connected through a methyl “bridge” (see Fig. 1.5) 
(35,36).  
 
Analogous to the PLP dependent enzymes, the initial steps in ThDP binding are 
identical for the different enzyme classes. Unlike PLP however, ThDP is not 
covalently attached to the enzyme. The GDGX26N(C)N motif is highly conserved 
and suggested to be essential for binding of a divalent metal such as Mg2+. This in 
turn coordinates the cofactor, with the assistance of a variety of active site residues 
(36). For catalysis to start, the cofactor needs to be bound within the active site in a 
V-shaped conformation. The methylene group is held in place through hydrophobic 
interactions while the pyrimidine ring’s nitrogens form stabilising hydrogen bonds to 
the surrounding active site residues (36,37). Whereas the cofactor usually exists in a 
tautomeric equilibrium between its 4’-aminopyrimidine and the 1,4-iminopyrimidine 
forms, the latter is thought to be favoured by hydrogen bonding with a basic active 
site residue. The V-shaped conformation positions the pyrimidine ring’s 4’ NH-
group close enough to abstract a proton from the thiazolium ring’s C2 carbon. This 
leads to formation of the C2 carbanion and the so-called ylide, which is the dipolar 
active form of the cofactor (see Fig. 1.6) (36-38).  
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Figure 1.5: If ThDP is stabilised in its 1,4-iminopyrimidine form (a), activation of the 
cofactor can occur in response to deprotonation of the thiazole ring’s C2 carbon by the 
pyrimidine ring’s 4’-NH group. This leads to formation of a carbanion and the dipolar 
cofactor ylide (b) [adapted from (37,39)].     
 
As substrate enters the active site, its carbonyl group will be attacked by the 
carbanion (acting as a nucleophile). A covalent bond is formed between them, which 
results in a first tetrahedral intermediate. The cofactor’s thiazolium ring, in particular 
the carbon-nitrogen double bond, can now act as an electron sink during subsequent 
cleavage of the scissile bond. For ThDP dependent decarboxylases, the carboxylate 
moiety is oriented perpendicular to the cofactor, which ensures optimal overlap of 
orbitals. This overlap accommodates free electrons and facilitates their movement by 
closer proximity to neighbouring atoms, ensuring an optimal distribution of charges. 
The resulting high resonance stabilises the intermediate as the carbon-carbon bond is 
cleaved, analogous to the PLP dependent decarboxylases (35,37,40). In addition, the 
substrate binding pocket and cofactor are thought to be positioned at a sufficient 
distance in the protein to create a steric strain on the carboxylic acid and favour 
decarboxylation (38). The 2" carbanion-enamine intermediate formed after bond 
cleavage is also known as the activated aldehyde. It is common to all ThDP 
dependent enzymes, with reaction pathways splitting subsequent to this stage. Its 
protonation will form the third and last intermediate, 2"-hydroxyalkyl-ThDP. 
Deprotonation of this intermediate will lead to separation of the aldehyde leaving 
group in decarboxylases and regeneration of the cofactor ylide (see Fig. 1.6) (35,37).  
Alternatively, the carbanion intermediate can serve as a donor molecule in a 
condensation reaction, leading to formation of a new carbon-carbon bond. The latter 
option is particularly interesting for the commercial use of ThDP dependent 
enzymes. The electrophilic acceptor was found to bind predominantly in one of two 
active site pockets. These pockets are positioned in a distinct spatial orientation with 
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respect to the aldehyde donor and determine the stereochemical outcome of the 
reactions. As the recently discovered S-pocket is largely inaccessible in most ThDP 
dependent enzymes, the majority of reactions are R-selective (41). The 
understanding of structure and mechanisms of ThDP dependent decarboxylases now 
allows for the synthesis of complex, chiral organic compounds (36,41). The most 
prominent example is the synthesis of (R)-phenyl acetylcarbinol (R-PAC) using 
biotransformations. The molecule is a precursor of L-ephedrine which is used, among 
other applications, in the treatment of asthma (37,42,43). 
 
Figure 1.6: The conversion of pyruvate into acetaldehyde, at the expense of CO2, is a model 
reaction for ThDP dependent decarboxylation. It involves three intermediate adducts, the 
sequential decarboxylation, protonation and deprotonation of which lead to release of the 
aldehyde product and regeneration of the cofactor. The second intermediate, the activated 
aldehyde, exists in a tautomeric equilibrium with its enamine form (not shown) (37-39).  
 
The best characterised and most representative of the ThDP dependent 
decarboxylases are pyruvate decarboxylases (PDCs). PDCs are abundant in bacteria, 
yeast and plants and involved in alcohol fermentation processes. The enzyme 
catalyses the conversion of pyruvate to acetaldehyde at the expense of carbon 
dioxide (CO2) (see Fig. 1.6). The aldehyde is then reduced to ethanol or serves as the 
electrophilic acceptor in a condensation side reaction with accumulated aldehyde 
product, leading to the production of acetoin. High resolution structures of apo-, holo 
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and ligand bound protein as well as kinetic studies on mutant PDC enzymes have 
provided detailed information about the general reaction mechanisms of ThDP 
dependent decarboxylases (see above) (35-37).  
 
 
 
Figure 1.7: Various reaction intermediates have been trapped in the active site of a 
Zymomonas mobilis PDC using a weakly active mutant (Glu473Asp, lactyl adduct, a) and a 
triazole ThDP analogue, free pyruvate, b). They show ThDP in its V-shaped conformation, 
with the phosphate moiety coordinated by Mg2+. The proposed catalytic acid-base residues 
Asp27B and Glu473A (A and B denoting different PDC monomers) are within suitable 
distance to act as proton donors and acceptors to the reaction intermediates. Image a shows a 
superposition of the wild type residues (pastel coloured) onto the mutant PDC structure 
(38,40,44).  
 
Most PDC enzymes are made up of homodimers as their basic catalytic unit but 
associate into tetramers in solution. Each monomer is divided into three domains, all 
showing an open "/! fold. Upon entry into the active site, a flexible loop and 
adjacent alpha-helix move to bring catalytic residues into close proximity of ThDP. 
A glutamate residue is thought to deprotonate the pyrimidine ring’s 4’NH group 
which in turn abstracts a proton from the thiazolium ring to create the catalytically 
active ylide (38). As pyruvate enters the active site, its carboxylate group is 
coordinated by two histidine residues, the so-called HH motif which is common to a 
number of ThDP dependent decarboxylases. It is furthermore held in place by 
several hydrogen bonds, involving the aforementioned glutamate (from both 
monomers), the histidines as well as an aspartate residue (37,38). As the ylide attacks 
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the pyruvate’s keto group, a lactyl adduct forms  and the ketone’s oxygen is 
protonated (35). This was proposed to be catalysed by the thiazolium rings 4’NH2 
group.  
If the previously protonated glutamate “returns” a proton to the cofactor’s 4’NH 
group, the negatively charged residue could then destabilise the pyruvate’s CO2 
moiety and enhance subsequent decarboxylation (38). The penultimate step, 
protonation of the C2"-carbanion/enamine intermediate, has been suggested to be 
catalysed by the same glutamate (or a glutamate-histidine-aspartate triad) - 
presumably via a catalytic water that has replaced the carboxylate leaving group. 
(37,38,40). Finally, the catalytic glutamate or an aspartate have been proposed to 
accept a proton from the cofactor’s 4’NH2 or the aforementioned water molecule. 
These could then act as bases and deprotonate the 2"-hydroxyethyl-ThDP, leading to 
release of the acetaldehyde substrate (38).  
 
 
1.3.3.3 Metal dependent decarboxylases 
 
Whereas many decarboxylases make use of complex organic molecules to fix their 
substrates and act as an electron sink during catalysis, others rely on small, inorganic 
cofactors such as metals. A number of enzymes use both for a joint structural and 
catalytic support. Decarboxylases relying on metal ions as their only cofactor may be 
non-oxidative, analogous to the PLP and ThDP dependent enzymes. Others however 
incorporate molecular oxygen into their substrates and thus catalyse oxidative 
decarboxylation reactions (45). Organic cofactor-dependent enzymes often make use 
of imine bonds and conjugated or thiazolium ring systems to relocate electrons and 
stabilise the carbanion intermediate. In contrast to that, metal dependent 
decarboxylases rely on polarizing ions to delocalize the charges within their 
substrates (46).   
 
For decarboxylases employing metal ions and dioxygen as cofactors, the catalysed 
reactions can be oxidative or non-oxidative and always involve the formation of 
radical intermediate species. Oxidative reactions have been observed for a number of 
non-heme, iron-dependent enzymes catalysing the decarboxylation of "-ketoglutarate 
(45). The best studied example of a decarboxylase using molecular oxygen in 
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catalysis, however without inserting any oxygen into the product, is oxalate 
decarboxylase. The enzyme catalyses the conversion of oxalate into pyruvate and 
requires both Manganese and O2 as cofactors for catalysis. The highly coordinated 
Manganese ion in the enzyme’s active site may bind the incoming dioxygen as well 
as oxalate. An electron transfer from metal cofactor to dioxygen followed by a 
second transfer from oxalate to cofactor leads to formation of a superoxide metal 
species and a radical substrate intermediate respectively. Both are thought to stabilise 
the carbanion formed during subsequent decarboxylation. The product anion radical 
then receives an electron from the metal ion as well as being protonated by an active 
site residue, allowing it to dissociate from the cofactor (45,47-49) (see Fig. 1.8). 
Oxalate decarboxylase has a range of potential biotechnological applications in the 
breakdown of harmful oxalate accumulation, particularly in food plants. It can 
furthermore be used in diagnostics of hyperoxaluria, the increased levels of oxalate 
in urine samples (50).   
 
Figure 1.8: The decarboxylation of oxalate relies on the presence of a dioxygen molecule to 
create a metal superoxide. The latter can withdraw electrons from the bound substrate, 
creating a radical intermediate that is amenable to decarboxylation. As the single electron is 
returned from metal to product, the latter is released and the cofactor is regenerated [adapted 
from (45,47-49)].  
 
A number of decarboxylases were found to use divalent metal ions as their only 
cofactor, without the need for dioxygen to relocate electrons during the reaction. The 
most abundant catalytic metals are Mn2+ and Mg2+, although several enzymes were 
found to employ Zn2+ as a cofactor (45,51). The ions coordinate or even ligate to one 
or two of the substrate’s oxygen atoms, especially of the carboxylate leaving group. 
31 
 
The proposed reaction mechanisms vary significantly but generally rely on the 
metals to act as a Lewis acid and accept free electrons during the decarboxylation 
reaction. They subsequently stabilise the negatively charged decarboxylation 
intermediates which are often enolates or dienolates. Protonation by an enzymatic 
acid base residue or an activated catalytic water then allows for product dissociation 
(45,51-55).  
 
A detailed decarboxylation mechanism has been proposed for the Rhizobium 2,6-
dihydroxybenzoate (#-resorcylate) decarboxylase which relies on a Zn2+ atom as it’s 
only cofactor. The enzyme decarboxylates 2,6- dihydroxybenzoate to 
1,3-dihydroxybenzene (see Fig. 1.9) and its structure has been solved in complex 
with the substrate as well as with the substrate analogue and inhibitor 2,6- 
dihydroxybenzaldehyde.  
 
Figure 1.9: The decarboxylation of 2,6-dihydroxybenzoate proceeds via the formation of a 
carbanion intermediate and protonation by a catalytic water. The subsequent electron relay, 
mediated by the catalytic metal, leads to carbon-carbon bond cleavage and release of the 
carboxylate moiety (ligated to the metal cofactor) (adapted from (51)).   
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It was proposed that, upon substrate entry into the active site, the enzyme’s Zn2+ 
cofactor comes into close proximity of the carboxylate’s negatively charged oxygen 
atom whereas the benzene ring’s 2-OH group forms a hydrogen bond with an 
aspartate residue. A charge relay (Fig. 1.9, red line) from the carboxyl oxygen to the 
aspartate, via the positively charged cofactor, ligates the substrate to Zn2+ and lowers 
the amino acid’s pKa (an effect which is enhanced by the polarising effects of a His-
Glu–Asp catalytic triad). The latter can subsequently deprotonate the 
dihydroxybenzoate’s 2-OH group. A second charge relay leads to formation of a C1-
carbanion intermediate, the negative charge of which is stabilised by the metal 
cofactor. An activated water molecule donates a proton to the carbanion after which 
coordinated protonation at C2 and decarboxylation release 1,3 dihydroxybenze  and 
CO2 from the active site (51).   
 
1.3.3.4 Cofactor independent decarboxylases 
 
A common feature of all enzymatic decarboxylation reactions is the need to 
destabilise the substrate in a way that favours removal of the carboxylate moiety. At 
the same time, an electron sink has to be provided which can accommodate the free 
electrons. Often negatively charged intermediates are formed in the process and have 
to be stabilised by the enzyme. Cofactor dependent enzymes can make use of 
complex organic molecules providing both electron sink and stabilising positive 
charges. Alternatively, metals are used to provide the stabilising charge, with 
delocalisation of electrons taking place within the substrate. The effects of both types 
of cofactors are enhanced by enzymes’ surrounding active site residues. Cofactor 
independent decarboxylases on the other hand are unique in that they rely entirely on 
their primary and secondary structure, as well as the inherent properties of their 
substrates, to afford decarboxylation (45). Among other aspects, the absence of 
cofactors and the need for respective recycling systems makes this enzyme family 
particularly interesting for biocatalytic applications.    
A limited number of cofactor independent decarboxylases have been characterised to 
date. These include the "–aryl malonate decarboxylase (AMDase), the malonate 
semialdehyde decarboxylase (MSAD), the 2-Oxo-4-hydroxy-4-carboxy-5-
ureidoimidazoline (OHCU), the orothidine 5’-monophosphate decarboxylase 
(OMPDC) decarboxylase and a variety of phenolic acid decarboxylases (PADs). The 
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first three enzymes listed catalyse decarboxylation reactions involving the formation 
of an enediolate, enolate or enol intermediates respectively. Decarboxylation of 
OMPDC leads to formation of a carbanion intermediate whereas phenolic acid 
substrates are thought to be protonated prior to decarboxylation to give quinone 
methide reaction intermediates (45,56-59). Most cofactor independent 
decarboxylases are thought to bind the scissile carboxylate within a predominantly 
hydrophobic pocket. The unfavourable interaction between non-polar amino acid 
residues and the deprotonated (negatively charged) moiety was proposed to afford 
substrate destabilization. The intermediates formed after decarboxylation are then 
stabilised by positively charged amino acid residues and/or delocalization of 
electrons, either within the substrate or with the help of an enzymatic oxyanion hole. 
Protonation or rearrangement of the stabilised intermediate eventually leads to 
product release (45,56-60).   
 
A well characterised cofactor independent decarboxylase is the "–aryl malonate 
decarboxylase (AMDase) from Bordetella bronchiseptica. The enzyme converts 
"-aryl-malonates into (R)-"-aryl-carboxylates with high enantioselectivity (see Fig. 
1.11). Its structure has been solved in the apo-state as well as in complex with an 
analogue of the proposed enediolate intermediate. AMDase has a molecular weight 
of approximately 24 kDa and exists as a monomer in solution (61). Two !-sheets 
enclose the enzyme’s active site and are surrounded on all four sides by "-helices 
and flexible loops. When the enzyme’s structure was solved, two potential oxyanion 
holes were detected in the active site (the “dioxyanion hole”). Their residues, in 
particular the backbone amides, form an extensive hydrogen bonding network 
around the two oxygen atoms of a benzylphosphate molecule which resembles the 
enediolate. This way the negatively charged intermediate is stabilised, the reaction’s 
activation energy is lowered and decarboxylation facilitated. The substrate’s 
aromatic ring is coordinated through stacking interactions with a glycine pair’s 
amide bond and a proline residue, bringing it into a coplanar conformation with the 
enediolate moiety. The carboxylate leaving group is found within a small 
hydrophobic pocket (see Fig. 1.10) (56).  
From the structures solved, Okrasa et al. have proposed a mechanism for AMDase 
catalysed decarboxylation. As substrate enters the active site, its two carboxylate 
moieties and the aromatic ring are bound and coordinated as described above. The 
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carboxylate group positioned in the small hydrophobic pocket is in its deprotonated 
state and hence negatively charged. The hydrophobic surrounding destabilises the 
group, leading to cleavage of the carbon-carbon bond. Once cleaved, the carbon 
dioxide is neutral and stable within the active site pocket. The free electron pair 
“released” upon decarboxylation relocates and leads to formation of an enediolate 
intermediate. Its negative charge is stabilised by resonance within the molecule’s 
coplanar aromatic ring as well as by delocalisation into the adjacent enzymatic 
oxyanion hole. 
 
Figure 1.10: The AMDase active site possesses a hydrophobic pocket and a dioxyanion hole. 
Whereas the former loosely coordinates and destabilises the carboxylate leaving group 
(dotted line, absent in complex with benzylphosphate analogue), the latter stabilises the 
enediolate intermediate (61) [adapted from (56,62)].  
 
Eventually, for the product to be released, the C" carbon can be protonated by a 
catalytic cysteine in the active site. Its position favours protonation on the 
enediolate’s si-face and yields exclusively the (R)-enantiomer of "-aryl-carboxylate 
product. Mutagenesis experiments in which the catalytic cysteine has been 
introduced or repositioned to the opposite site of the large binding pocket led to 
formation of racemic product or complete inversion of the enzyme’s stereospecificity 
respectively (56,62-64). The enzymatic decarboxylation of "–arylmalonates can thus 
lead to the synthesis of a variety of "–arylcarboxylate products. It involves the 
introduction of a stereocenter and yields products of particularly high enantiomeric 
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excess compared to abiotic synthesis, making the process highly desirable for 
downstream synthetic applications (62).      
AMDase serves as a good model for mechanisms in cofactor independent 
decarboxylases.  Although exact modes of leaving group destabilisation and 
delocalisation of electrons in reaction intermediates vary, the enzyme’s structural 
features and proposed mechanism have much in common with other members of the 
family. The key reaction stages are shared and highlight how the elaborate interplay 
between substrates and catalysts circumvent the need for external cofactors.  
 
Figure 1.11: The decarboxylation of "–aryl malonate by AMDase proceeds via the formation 
of an enediolate intermediate and stereospecific protonation yields the carboxylate product at 
high enantiomeric excess. Substrate and reaction specificity are defined by the enzyme’s 
binding pockets, formation of the unstable intermediate is enabled by delocalisation of 
electrons into the oxyanion hole (adapted from (56,62)).  
  
Outliers in this family are the phenolic acid decarboxylases (PADs). Their catalytic 
mechanisms do not appear to involve charged intermediates and the leaving 
carboxylate is fixed in a polar pocket rather than destabilised (60,65). Yet, they 
catalyse comparable decarboxylation reactions, without the need for an exogenous 
metal or organic cofactor. Their unique structure and mechanisms will be discussed 
in chapters three and four.  
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Cofactor Stabilisation of intermediate (electron sink) 
Organic Resonance within cofactor, especially via imine bonds 
Metal/ O2 Radical species, metal superoxide 
Metal Positive charge of metal, resonance within substrate 
None Resonance within substrate, neutral intermediates (PADs) 
 
Table 1.1: All decarboxylases face the formation of unstable reaction intermediates as 
catalytic bottlenecks and have developed various mechanisms to lower the free energy of 
such transition states. The cofactor independent decarboxylases are unique in not requiring a 
second, exogenous catalyst in this process, which makes them particularly interesting targets 
for a wide range of biocatalytic applications. 
 
 
 
1.4 Carbon – carbon bond hydrolases 
 
Hydrolases acting on C-C bonds belong to enzyme commission (EC) subgroup 3.7.1 
and accept a variety of diketones as substrates. They mediate reactions using a 
catalytic water molecule and are, in most cases, independent of complex organic 
cofactors. The cleaved substrate’s leaving group is added onto the water hydroxyl 
group to give a carboxylic acid in addition to a methylketone product (see Fig. 1.12).  
 
Figure 1.12: Carbon-carbon hydrolases may cleave diketone substrates to give a carboxylic 
acid as well as a methylketone product. As for the corresponding lyases, reaction equilibria 
strongly favour C-C bond cleavage over formation [adapted from (66)].  
 
Various hydrolytic mechanisms exist that have been suggested to share a number of 
common features (67). In many mechanistic aspects, carbon-carbon hydrolases 
resemble the previously described lyases. The substrates may be subjected to a 
nucleophilic attack, either by an enzymatic residue or an activated water molecule. 
This requires the molecule to provide an electron sink, in other words an 
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electrophilic functional group which readily takes up a free electron pair. This sink is 
either inherent or can, in some cases, be created during the reaction by an enol-keto 
tautomerisation (68,69). After the nucleophilic attack, an oxyanion is thought to form 
which is a tetrahedral or enolate intermediate, and has to be stabilised, often but not 
always, by way of an enzymatic oxyanion hole (66,70). As described in section 
1.3.3.4, this “hole” structure provides hydrogen bonding between backbone amides 
or side chains and the reaction intermediate – an interaction which would be 
exclusive for this stage and not formed with the final product, thus lowering the 
overall activation energy for the reaction (67). Protonation of the leaving group often 
leads to cleavage of the carbon-carbon bond. For certain groups of hydrolases this is 
then thought to involve the formation of an acyl-enzyme intermediate and a second 
tetrahedral intermediate, which is released as the enzyme partner is re-protonated – 
analogous to the peptide cleavage by serine proteases (67). In whichever way the 
reaction is catalysed however, this C-C bond cleavage differs from those of 
hydrolytic reactions on heteroatomic carbon bonds, which are more polar and thus 
more reactive.  
Equilibria for the reversal of carbon-carbon hydrolysis are extremely unfavourable. 
The reaction can only be achieved by depriving the enzyme of catalytic water 
molecules, as is possible in organic solvents (71).  A number of enzymes of 
biocatalytic importance are known to be active in a variety of organic solvents, 
among these also carbon-carbon bond hydrolases. Of the latter, two !-diketone 
hydrolases, for example, have recently been shown to retain their full or partial 
activity, even at high solvent concentrations (72). A reversal of the C-C cleavage 
reaction into carbon-carbon bond formation has been observed for numerous lyases 
but only for a single hydrolase and with very low yields to date  – it remains to be 
determined now if other hydrolases can catalyse the formation of carbon-carbon 
bonds in a similar manner (3,71). The biocatalytic potential for such reactions would 
be considerable as C-C bond hydrolases can act on a variety of substrates, including 
ß-diketo acids and neutral ß-diketones, esters and thioesters. 
 
1.4.1 Serine hydrolases 
 
Structurally, many C-C bond hydrolases belong to the superfamily of "/ß hydrolases 
that consist of a central, multistranded ß-sheet surrounded by "-helices. Three loops, 
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at C-terminal ends of these helices, each carry a residue of an active site catalytic 
triad (73). Typically these residues are a nucleophile, a histidine and an acid. 
Identity, function and requirement, especially for the nucleophile, vary within the "/ß 
hydrolase family (74). This is consistent with the large variety of reactions catalysed 
by members of this superfamily, despite the strong similarities in the overall fold. 
They range from hydrolysis of carbon-carbon and carbon-heteroatom bonds to 
lipase, dehalogenase and esterase activities (73).  
All "/ß hydrolases known to cleave carbon-carbon bonds possess a highly conserved 
serine, histidine and aspartate as part of their catalytic triad. They share a common 
catalytic motif (Gly-X-Ser-X-Gly), centred around the nucleophile which is also 
known as a “lipase box” (73). The particular composition of the catalytic triad is 
reminiscent of the well characterised serine proteases which are also members of this 
structural superfamily. Their reaction mechanism has long served as a model for 
serine dependent carbon-carbon hydrolysis (see Fig. 1.13).  
 
Figure 1.13: The cleavage of peptide bonds by trypsin proteases serves as a model reaction 
for serine dependent hydrolases [adapted from (75,76)]. 
 
The nucleophile in these enzymes is deprotonated by histidine, creating an 
imidazolium cation side chain which can in turn be stabilised by the triad’s aspartate. 
As a peptide is recognised and bound by the enzyme, the deprotonated serine carries 
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out a nucleophilic attack on the substrate’s carbonyl, leading to formation of a first 
tetrahedral intermediate which is stabilised within the enzyme’s oxyanion hole. The 
catalytic histidine (the most conserved residue in all characterised "/ß hydrolases) 
then fulfils a triple function: protonation of the negatively charged intermediate 
allows for bond cleavage and separation of the leaving group. The residue then 
activates a water molecule which attacks the acyl-enzyme intermediate to give a 
second tetrahedral intermediate. For the product to be released, this then needs to be 
protonated, catalysed again by the same histidine side chain. This last reaction 
regenerates the triad’s amino acid side chains for a new round of catalysis (76).      
 
1.4.1.1 Serine MCP hydrolases 
 
A large number of bacterial serine dependent carbon-carbon hydrolases are involved 
in the breakdown of aromatic compounds. This process constitutes part of the so-
called meta-cleavage pathway and the enzymes are known as MCP hydrolases 
accordingly. Natural and non-natural aromatic compounds (often substituted with a 
variety of functional groups) are abundant but often harmful to the environment.  
Due to the ring structure’s resonance the molecules are very stable and their 
degradation challenging to microorganisms (77). To be accessible substrates for 
hydrolysis, the aromatic substrates have to be hydroxylated and cleaved by the 
upstream action of dioxygenases or monooxygenases (in the case of phenols). This 
cleavage occurs either between (intradiol) or adjacent (extradiol) to the two hydroxyl 
groups and gives ortho and meta cleavage products respectively. These can then be 
further degraded by serine dependent hydrolysis (77-79).    
 
The best characterised MCP hydrolases are the 2-hydroxy-6-keto-nona-1,9-dienoic 
acid 5,6 hydrolase (MhpC) and the 2-hydroxy-6-keto-6-phenylhexa-2,4-dienoic acid 
hydrolase (BphD). Both act on 2-hydroxy-6-oxo- dienoic acid (HODA) substrates to 
give two carboxylic acid products: 2-hydroxypenta-2,4-dienoic acid (both MhpC and 
BphD) as well as succinic and benzoic acid (MhpC and BphD respectively) (see Fig. 
1.14).  
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Figure 1.14: MhpC and BphD catalyse the hydrolytic cleavage of HODA ring fission 
products into two carboxyalic acid products.  
 
The structures of both enzymes have been solved and resemble each other closely, 
with the exception of their quaternary structure (MhpC is a dimer, BphD a tetramer 
in solution). They show the typical "/!–hydrolase fold of twisted beta sheets and a 
distinct "–helical lid domain. Position and conformation of the catalytic triad is 
nearly identical in both enzymes, with each amino acid typically positioned on a 
flexible loop between !–sheets and interconnecting "-helices (see Fig. 1.15). The 
serine residue is positioned centrally on a so-called “nucleophile elbow” which is the 
most highly conserved structural feature of the "/!–hydrolases (see Fig. 1.15) (73). 
In 1997, Henderson et al. and Lam et al. identified the main catalytic steps in MCP 
hydrolysis using MhpC as a model system. In a set of experiments carried out at low 
(sub-optimal) pH to slow down catalysis and observe pre steady-state kinetics, MhpC 
was found to catalyse hydrolysis across the substrate’s C5-C6 bond. This reaction is 
thought to be a two step process: the substrate could enter the active site in its 
thermodynamically more stable dienol form and be protonated by an active site 
acid/base residue to give the keto tautomer. The keto group would then be able to act 
as an electron sink in the subsequent carbon–carbon bond cleavage reaction. The 
presence of a keto intermediate is supported by the observation that no additional UV 
signals seem to be observed, indicating a reduction in conjugation within the 
molecule (69,80).  The authors proposed that the originally unfavourable 
ketonisation is made possible by binding of the (very stable) dienol substrate with its 
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carbonyl in a non-planar and thus destabilising position with respect to the 
conjugated dienol (69). This potential substrate destabilisation was later also 
observed for BphD (see Fig. 1.16) (68). 
 
 
Figure 1.15: As Serine dependent "/! hydrolases, MhpC and BphD show a very similar and 
highly conserved fold and are thought to make use of the equally conserved catalytic triad 
Ser-Asp-His (bold and pale sidechains for MhpC and BphD respectively).  
 
Following determination of these intermediate steps, it remained controversial if 
carbon-carbon bond cleavage is catalysed by a general base mechanism or by way of 
an acyl-enzyme intermediate. The former would involve activation of a water 
molecule (by the catalytic triad’s serine) and its nucleophilic attack on the keto-form 
of the substrate to create a geminal diol intermediate. In the alternative proposal, the 
water is replaced as a nucleophile by the serine which would lead to formation of a 
covalent acyl-enzyme intermediate (81,82). The latter was found to be the case for 
BphD in 2012, when the first complex structure was solved which showed substrate 
covalently attached to the catalytic serine. Parallel quenching experiments supported 
the presence of the intermediate in solution and led to the authors to propose a 
detailed mechanism for covalent catalysis (see Fig. 1.16) (83).   
42 
 
As BphD substrate 2-hydroxy-6-keto-6-phenylhexa-2,4-dienoic acid (HOPDA) 
enters the active site, it is thought to be in its thermodynamically more favourable 
dienolate form. The molecule is bound in two distinct areas, the polar (P) and the 
non-polar (NP) subsite, recognising the dienolate moiety and aromatic ring 
respectively. HOPDA is thought to be bound by BphD in a non-planar and 
destabilising conformation, favouring the formation of a C5 carbanion diketo 
species. This carbanion is subsequently protonated by serine, leading to completion 
of both the keto-tautomerisation of the substrate and activation of the nucleophile. It 
also differentiates the proposed mechanism from the well characterised serine 
proteases which require activation of serine through the histidine – aspartate dyad. 
The activated serine can now carry out a nucleophilic attack on the C6 carbonyl to 
give the first tetrahedral, covalent acyl-enzyme intermediate. An electron relay 
through this intermediate leads to separation of the first product (2-hydroxypenta-
2,4-dienoic acid, HPD) during which the previously formed keto group acts as an 
electron sink for carbon-carbon bond cleavage. The aforementioned aspartate-
histidine dyad is now thought to be required for deprotonation and activation of a 
catalytic water. The latter can then attack the acyl-enzyme adduct to give a second 
tetrahedral intermediate. As the previously protonated histidine donates the hydrogen 
to the serine, hydrolysis is complete, the covalent bond is broken and benzoate 
released as the second reaction product. At the same time, the serine nucleophile is 
reprotonated and thus regenerated for the next round of catalysis. As for many 
carbon-carbon bond cleaving enzymes, all of the BphD reaction intermediates are 
stabilised within an enzymatic oxyanion hole, in this case the backbone amides of a 
methionine and a glycine residue (83).    
BphD is the first MCP hydrolase for which a covalent acyl-enzyme intermediate has 
been observed in a crystal structure. It is unclear to date if catalysis by the closely 
related MhpC is identical as solvent exchange experiments still favour a geminal-diol 
intermediate and general base mechanism (81,83).  
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Figure 1.16: The first crystal structure of an MCP hydrolase (BphD) covalently bound to its 
substrate led to the detailed proposal of a mechanism involving an acyl-enzyme 
intermediate. Nucleophile activation occurs in a concerted reaction with the substrate’s enol 
to keto tautomerisation. Two covalent intermediates are formed before both substrates, HPD 
and benzoate, are released and the active site is regenerated for the next round of catalysis. 
 
1.4.1.2 Serine !-diketone/Friedel-Crafts hydrolases 
 
Outside the bacterial breakdown of aromatic compounds described above, a large 
proportion of carbon-carbon hydrolases accept exclusively 1,3-!-diketones as 
substrates. They are accordingly known as the !-diketone hydrolase subfamily and 
include serine-dependent catalysts of the "/!–hydrolase family as well as serine- 
independent enzymes with alternative folds and mechanisms.  
!–diketones are essential building blocks for a number of applications. In the 
chemical industry they are used as synthetic starting materials or ligands, in the 
pharmaceutical industry they are of interest for their potential antibacterial, antiviral 
and anti-carcinogenic properties (84,85). Aside from the presence or absence of an 
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enzymatic nucleophile in catalysis, !-diketone hydrolases are grouped according to 
their substrate preferences. !-diketo-acid hydrolases require a carboxylate moiety in 
their substrates whereas !-diketohydrolases accept  “neutral” substituents (aliphatic 
or alicyclic) (66). 
 
Within the family of !-diketone hydrolases, only few members depend on a catalytic 
serine. These include the Ayg1p hydrolase from the mould Aspergillus fumigatus as 
well as the 2,6-dihydroxy-pseudo-oxynicontine hydrolase (DHPONH) from 
Arthrobacter nicotinovorans. Both are members of the "/!-hydrolase family and 
posess a serine – histidine – aspartate catalytic triad. Whereas Ayg1p has been 
proposed to hydrolyse its substrate 1,3,6,8 - tetrahydroxynaphtalene by way of a 
covalent acyl-enzyme intermediate, analogous to BphD described above, DHPONH 
is thought to mediate the activation of a catalytic water (86,87). Both Ayg1p as well 
as DHPONH cleave carbon-carbon bonds to separate an acyl leaving group from an 
aromatic ring, analogous to the abiotic Friedel-Crafts reaction. They can thus also be 
grouped with the Friedel-Crafts hydrolases (see Fig. 1.17).   
The DHPONH enzyme was first purified from a recombinant expression host and 
characterised in 2005. The dimeric enzyme was shown to cleave its substrate 2,6-
dihydroxy-pseudo-oxynicontine into 2,6-dihydroxypyridine (DHP) and #-N-
methylaminobutyrate (MAB) and was accordingly thought to be the first hydrolase 
acting on a heteroaromatic substrate. The primary sequence, in particular the 
GXSXG motif, indicated the presence of a catalytic triad centred around a serine 
nucleophile in the enzyme. An apo-structure of DHPONH was subsequently 
determined and allowed for the proposal of two potential reaction mechanisms (see 
Fig. 1.17) (87,88).  
 
Figure 1.17: A number of hydrolases have been shown to catalyse the retro-Friedel-Crafts 
reaction and cleave acyl groups from aromatic rings (a). Depending on the ring’s 
substituents, the substrate can be turned into a !-diketone and the enzyme can cleave a 
carbon-carbon bond to give both methylketone and carboxylic acid products (b). 
45 
 
Upon substrate entry into the active site, the O1 carbonyl is thought to be fixed 
within an enzymatic oxyanion hole, made up of glutamine backbone amides. To give 
the 1,3 diketone moiety required for nucleophilic attack, the O2 hydroxyl then has to 
be deprotonated which was proposed to be catalysed by a glutamate side chain, 
acting as a catalytic base. The same glutamate is thought to transfer the abstracted 
proton onto the C3 carbon, completing diketone formation. The protonation at C3 is 
facilitated by “force” applied onto the atom by the residues of the flexible N-terminal 
domain, favouring its sp3 hybridisation. Pathways then split subsequent to this point. 
In the mechanism favoured by the authors, a water molecule is activated through 
deprotonation by the catalytic glutamate. Its hydroxyl can carry out a nucleophilic 
attack on the C1 keto group, leading to carbon-carbon hydrolysis and separation of 
the MAB product. The water’s second hydrogen is required for reprotonation of O2, 
generating DHP with the aromatic ring as a good leaving group. The Ser-His-Asp 
triad is not directly involved in hydrolysis but essential for supporting the catalytic 
water in this hypothesis. In the alternative mechanism, the C1 carbon can be attacked 
by the serine nucleophile which is in turn activated by the His-Asp dyad. An acyl-
enzyme intermediate is formed and subsequently hydrolysed by the catalytic water 
(activated as described above). The O2 oxygen in this mechanism may be 
reprotonated by the triad’s histidine (87).   
Confirmation as to which mechanism applies in serine dependent hydrolysis of 
DHPON now requires future experiments and ideally a complex structure with 
potential reaction intermediates.  
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Figure 1.18: A mechanism has been proposed for the hydrolysis of DHPON into DHP and 
MAB. After the substrate is converted into a 1,3 diketone (a), the authors suggested 
hydrolysis to proceed through a general base catalysed mechanism and nucleophilic attack 
by an activated water (b). Alternatively, an acyl-enzyme intermediate could be formed and 
subsequently hydrolysed (c) [adapted from (87)].  
 
Another important example of a serine dependent !-diketone hydrolase is the 
oxidised polyvinyl alcohol hydrolase (OPH) from Pseudomonas sp. VM15C which 
cleaves its !-diketone substrates into carboxylic acids and monoketones (89). 
Analysis of its structure, function and mechanism were part of this project and will 
be discussed in greater detail in chapter 6.  
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1.4.2 Non-serine hydrolases  
 
A number of carbon-carbon hydrolases have developed mechanisms which are 
independent of a catalytic serine to act as a nucleophile or as a stabiliser thereof. 
Accordingly, these enzymes show alternative folds to the previously described "/! 
hydrolases and their reaction mechanisms differ. Whereas some of the non-serine 
hydrolases depend on a catalytic metal, others are completely independent of any 
exogenous cofactors.  
 
1.4.2.1 Non-serine hydrolases (metal dependent) 
 
Within the current EC classification for carbon-carbon hydrolases acting on ketonic 
substances, seven enzymes have been shown to bind divalent metals, predominantly 
Mg2+ but also Mn2+, Ca2+ and Zn2+. The best characterised members of this group are 
the fumarylacetoacetate hydrolase (FAH) and the Friedel-Crafts hydrolases 
diacetylphloroglucinol hydrolase (PhlG) and phloretin hydrolase (Phy).  
 
The apo-structure of mouse FAH was solved in 1999 and constituted the first ever 
structure of a carbon-carbon bond cleaving hydrolase. It showed a novel "/! fold, 
different to the previously characterised "/! hydrolases by lacking a lipase box and 
flexible loops carrying the classical catalytic triad. The structure allowed for the 
proposition of a detailed mechanism for serine independent carbon-carbon hydrolysis 
relying on a catalytic metal (90).  While still possessing a catalytic triad, including a 
glutamate and histidine acid/base pair, the serine nucleophile in FAH is thought to be 
replaced by a water molecule. The latter is positioned and coordinated by a glutamate 
and the catalytic metal - Mn2+. As it enters the active site, the !–diketone substrate 
fumarylacetoacetate (and all subsequent negatively charged intermediates and 
products) are stabilised by the metal cation and coordinated within an unusual 
oxyanion hole. The latter is made up of side chains (rather than backbone amides) of 
a lysine, arginine and glutamine residue.  After deprotonation and activation of the 
catalytic water by histidine, the hydroxide nucleophile attacks the C4 carbonyl and 
forms a tetrahedral oxyanion (alkoxide) intermediate. Rearrangement of free 
electrons leads to cleavage of the carbon-carbon bond, formation of the first product, 
fumarate, and an acetoacetyl carbanion which is stabilised by resonance. Proton 
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transfer to the latter from the fumarate’s carboxylate or by the oxyanion hole’s lysine 
gives the second product, acetoacetate (see Fig. 1.19). If mediated by the catalytic 
histidine, this transfer would also regenerate the active site’s base for subsequent 
rounds of hydrolysis (90,91).  
In addition to Mn2+, which is essential for catalysis, a second metal (probably Na2+) 
is thought to be required for FAH structural stability and has been proposed to be 
involved in intersubunit communication (92,93). 
 
Figure 1.19: The structure of FAH was solved in complex with the substrate mimic 4-[(2-
carboxyethyl)hydroxyphosphynil]-3-oxobutyric acid (CEHPOBA). The catalytic metal is 
highly coordinated within the active site and positions the catalytic water and substrate (grey 
dashed lines, image a, water not shown). During the reaction (b1 – b4), a lysine is shown to 
act as the final proton donor to the carbanion/enolate intermediate. Alternatively, the 
hydrogen could originate from protonated fumarate product [adapted from (90,91)].    
 
Other examples of non-serine, metal dependent carbon-carbon hydrolysis can be 
found with the Friedel-Crafts hydrolases (which also include the serine dependent, 
metal independent Ayg1p and DHPONH, see above). The best characterised reaction 
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of this kind is the hydrolysis of diacetylphloroglucinol (DAPG) into 
monoacetylphloroglucinol (MAPG) and acetate as catalysed by the 
diacetylphloroglucinol hydrolase (PhlG). PhlG is part of a large operon in 
Pseudomonas species whose genes and respective protein products produce and 
transport DAPG as an important antimicrobial compound. The enzyme was first 
characterised by Bottiglieri et al. and found to be a 35 kDa carbon-carbon hydrolase 
which associates into a homodimer in solution. The purified enzyme showed very 
narrow substrate specificity and would not hydrolyse any natural DAPG derivatives 
such as mono- or triacetylphloroglucinol (TAPG) (94). In 2010, the 3-dimensional 
structure of PhlG was solved to 2 Å resolution and, despite the absence of complexed 
substrate or product, provided information about the strict substrate specificity and a 
potential reaction mechanism. 
In accordance with the lack of sequence motifs common to "/! hydrolases, such as 
the lipase box, PhlG showed a novel Bet-v1-like fold, making it the first carbon-
carbon hydrolase member of this structural superfamily. The structure revealed two 
features important to substrate specificity and reaction mechanism. Buried within the 
hypothesised C-terminal active site, the authors detected electron density into which 
only a transition metal could be fitted. The latter was identified as a divalent zinc 
atom which is highly coordinated by two histidine and two glutamate residues. The 
authors have proposed this Zn2+, together with a single water molecule, to be 
essential in catalysis. In the suggested reaction mechanism, the metal is thought to 
lower the water’s pka sufficiently to allow for the loss of a proton, turning it into a 
hydroxyl nucleophile. The latter could then attack the scissile carbon-carbon bond 
between the DAPG’s aromatic ring and the acetyl moiety to form a tetrahedral 
intermediate. Rearrangement of free electrons and protonation of the formed acetic 
acid would complete the reaction (see Fig. 1.20). The metal-coordinating glutamate 
residues have been suggested to shuttle the proton abstracted from the catalytic water 
to the MAPG product (95).  
Modelling of the entrance channel from protein surface to the proposed active site 
presented a dumbbell shaped cavity which could, allowing for minor conformational 
changes on binding, accommodate the DAPG substrate. The distribution of polar and 
aromatic residues within this channel was shown to reflect interactions with the 
substrate. These include %-stacking interactions between phenylalanine and 
tryptophan residues and the aromatic ring as well as hydrogen bond formation of 
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tyrosine residues and an asparagine with the DAPG hydroxyl groups and the scissile 
acetyl moiety respectively (see Fig. 1.21). Higher substituted phloroglucinol 
derivatives such as TAPG would not fit into this channel whereas others may not be 
positioned appropriately, explaining the narrow substrate spectrum of PhlG. Both 
substrate specificity and reaction mechanism have also been addressed by site-
directed mutagenesis (SDM) experiments which supported the structural findings 
(95).  
 
 
Figure 1.20: PhlG catalyses the hydrolysis of DAPG to give MAPG and acetic acid. The side 
chain shown could represent either of the two metal coordinating glutamates which are 
thought to help shuttle the proton separated from the activated water molecule (dashed line) 
to the acetate product [adapted from (95)].  
 
PhlG represents a structurally novel carbon-carbon hydrolase and the first known to 
catalyse a serine-independent retro-Friedel-Crafts acylation using a catalytic 
transition metal. The enzyme shows low sequence similarity to a number of 
hypothetical and uncharacterised proteins as well as to a second metal-dependent 
Friedel-Crafts hydrolase. The latter, phloretin hydrolase (Phy), cleaves the plant 
derived flavonoid phloretin into phloroglucinol and phloretic acid (96). Its structure 
and mechanism were analysed as part of this project and will be discussed in greater 
detail in chapter 5. 
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Figure 1.21: The PhlG active site is defined by the divalent zinc atom, penta-coordinated 
through glutamate and histidine sidechains as well as the catalytic water (a). The cavity is 
restrictive in size, contributing to the narrow substrate specificity. It is made up of aromatic 
residues thought to be involved in %-stacking interactions with the DAPG benzene ring 
(phenylalanines and tryptophan) as well as the hydrogen bond donors proposed to fix the 
substrate’s hydroxyl and acetyl moieties (tyrosines, histidine and asparagine respectively) 
[adapted from (95)].   
 
1.4.2.2 Non-serine hydrolases (cofactor independent) 
 
In addition to the examples described above, a number of hydrolases have developed 
mechanisms of carbon-carbon bond cleavage completely independent of either serine 
nucleophile and/or exogenous cofactors like divalent metals.  
 
The best characterised member of this family is the oxocamphor hydrolase (OCH) 
acting on !–diketone substrates. The enzyme hydrolyses its substrate 6-oxocamphor 
into (2R,4S)-"-campholinic acid and (2S,4S)-"-campholinic acid with a 6:1 excess of 
the former diastereoisomer. It thus catalyses the important but rare biocatalytic 
carbon-carbon bond cleavage of a prochiral substrate to give a diastereomeric 
product at high enantiomeric excess (ee) (see Fig 1.22) (97,98). Structurally, OCH is 
a member of the crotonase superfamily(99), named after the first characterised model 
enzyme Enoyl-CoA hydratase (crotonase). Members of this family show a common 
fold of two perpendicular !–sheets surrounded by "-helices, known as the !!" unit. 
Despite significant structural similarities, members of the crotonase superfamily 
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catalyse a diverse range of reactions on carbon-heteroatom as well as carbon-carbon 
bonds. The latter include decarboxylation, C-C bond formation and hydrolysis. 
Crotonases have thus attracted much attention as potential biocatalysts (70).   
When OCH was isolated and characterised, the enzyme was found to be the first 
member of the crotonase family not to rely on its substrates’ forming a thioester bond 
to a coenzyme A (CoA) molecule. Without the addition of exogenous cofactors, 
OCH hydrolysed a number of non-enolisable "," disubstituted mono- and bicyclic !–
diketone substrates into keto acids (97,98). The condensation of two esters to form a 
diketone is known as a Claisen condensation (or Dieckmann condensation if it occurs 
within a single molecule to give a cyclic product). Accordingly, hydrolysis by OCH 
is known as a retro-Claisen reaction.    
OCH has a monomeric weight of 30 kD and associates into a dimer of trimers in 
solution which is a typical feature of many crotonase type enzymes. Each monomer 
has an individual active site, situated within a central hydrophobic pocket. Structures 
of wild type and mutant OCH as well as the Anabaena !–diketone hydrolase 
(ABDH) orthologue in their apo- and complexed states have provided an insight into 
hydrolysis of cyclic !–diketones by crotonase like enzymes (99-101).  
Before hydrolysis can take place, the camphor has to be converted into the 6-
oxocamphor through hydroxylation followed by oxidation at the 6-endo position. As 
this diketone enters the OCH active site, a histidine-aspartate dyad is thought to 
activate a catalytic water for nucleophilic attack at the (pro-S) side. This leads to 
formation of a tetrahedral oxyanion and defines the strict stereochemistry at the 
product’s C4 carbon. The tetrahedral oxyanion rearranges into an enolate 
intermediate with simultaneous breaking of the C-C bond and ring opening. 
Protonation of the enolate intermediate at the product’s C2 carbon, subsequent 
tautomerisation and relaxation of the ring structure lead to formation of the (2R,4S) 
and (2S,4S)-"-campholinic acid products at a 6:1 ratio. As an equivalent ratio is 
found in the abiotic retro-Claisen reaction of 6-oxocamphor, it has been proposed 
that protonation and tautomerisation are non-enzymatic and under thermodynamic 
control (98,99,101).   
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Figure 1.22: Hydrolysis of 6-oxocamphor (derived from camphor by hydroxylation and 
subsequent oxidation (a)) proceeds through attack of a nucleophilic water at the substrate’s 
(pro-S) site. Non-enzymatic protonation at the C2 carbon gives the product with a 6:1 excess 
of the  (2R,4S) over the (2S,4S) diastereomer (b) [adapted from (101)].  
 
A number of features distinguish the described structures and mechanism from 
previously characterised crotonase-like enzymes, leading to the suggestion that 
coenzyme A independent members may form their own subfamily (101). In contrast 
to crotonase family members with coenzyme A-bound substrates, OCH and its 
ABDH orthologue have a strict requirement for non-enolizable substrates (97). 
Furthermore, neither enzyme possesses a classical oxyanion hole motif for 
stabilisation of negatively charged enolate intermediates. In the product complex 
structure of an OCH mutant enzyme, the enolate-derived carbonyl was shown to be 
in close proximity to a tryptophan as well as the catalytic histidine residue. The 
intermediate’s negative charge may thus be stabilised by hydrogen bonding 
interactions with side chains of both residues rather than through the backbone 
amides of standard oxyanion holes (see Fig. 1.22 and Fig. 1.23). The unusual 
presence of two spatially separated intermediates may even require a second 
oxyanion hole equivalent. Asp154 has been proposed to fulfil this role by stabilising 
the tetrahedral intermediate prior to bond cleavage (101).   
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Figure 1.23: OCH, like many enzymes of the crotonase fold, associates into a dimer of 
trimers in solution. The active site (close up) is unusual in its lack of a defined oxyanion 
hole. In its place, the enolate intermediate is thought to be stabilised by hydrogen bonding to 
side chains of a histidine (not shown) and a tryptophan. Histidine 145, which is thought to 
act as a catalytic base, is positioned and stabilised by aspartate 154 [adapted from (101)].   
 
Their ability to catalyse desymmetrisation reactions makes crotonase type hydrolases 
like OCH highly valuable for biocatalytic applications. They are furthermore 
interesting engineering targets, especially with a view to improve or invert their 
stereochemistry (97,100).   
 
1.4.3 Carbon-carbon bond forming hydrolases 
 
To date, only one C-C hydrolase is thought to have catalysed the reverse reaction, i.e. 
the formation rather than cleavage of carbon-carbon bonds. In experiments analysing 
the catalytic promiscuity of E.coli MhpC, Li et al. have observed the formation of a 
monoethyl ester product resulting from #–acylation of a dienol substrate in organic 
solvents. Yields for this reaction were however very low (1.6 %) and insufficient for 
NMR analysis of the product (102).  
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1.5 Project aims 
 
The enzymes described above are examples of the growing family of lyases and 
hydrolases acting on carbon-carbon bonds. They show a large variety in structures, 
mechanisms and cofactor requirement but share the ability to overcome unfavourable 
reaction energies and cleave inherently non-reactive bonds. Within this project and in 
collaboration with Professor Wolfgang Kroutil’s group from the University of Graz, 
three carbon-carbon bond cleaving enzymes, a lyase and two hydrolases, were 
analysed with respect to their structure, mechanisms and substrate scope. None of 
these enzymes depend on complex organic cofactors and/or recycling systems 
thereof, making them attractive targets for biocatalytic applications. As a 
consequence, all work could be carried out as part of the Marie Curie Biotrains 
network and involved, in addition to the lyase and hydrolase work described, the 
structural analyses of biocatalytic enzymes from other network partners.   
 
The first enzyme analysed was a phenolic acid decarboxylase from Bacillus subtilis 
(BsPAD). This lyase is the member of a well-characterised family of enzymes which 
decarboxylate their substrates to give industrially useful styrene derivatives. 
Although apo-structures of BsPAD and other related enzymes were available, their 
catalytic mechanism remained speculative in the absence of a ligand complex. The 
aim of this work was thus to prepare a mutant library, collect kinetic data and trap 
the enzyme’s substrate in the active site of a weakly active mutant. In collaboration 
with the University of Graz, BsPAD would furthermore be the candidate for a 
cascade catalysis with a fungal oxygenase from Trametes hirsuta. If used in a one 
pot reaction, this cascade is hoped to allow for the production of high value natural 
vanillin from plant derived renewable resources. 
 
To analyse the enzyme catalysed hydrolysis of carbon-carbon bonds, two targets 
were chosen which were thought to differ in structure, function and mechanism. 
Phloretin hydrolase from Eubacterium ramulus (Phy), is involved in plant derived 
flavonoid hydrolysis in the human gut and catalyses a rare enzymatic retro-
Friedel Crafts reaction. At the start of this work, the structure of Phy was unknown 
but thought to differ from previously characterised C-C hydrolases. Its mechanism 
was, accordingly, speculative. The aim of the project was thus to obtain information 
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on structure, mechanism and substrate scope of this unusual member of the C-C 
hydrolase family.  
Oxidised polyvinyl alcohol hydrolase (OPH) from Pseudomonas sp. VM15C was 
previously shown to cleave !–diketone substrates and can be used for degradation of 
the latter in waste-water treatment. As previous attempts to purify the protein from a 
recombinant host were unsuccessful, primary aim of this work was to create a 
soluble expression construct, followed by determination of the enzyme’s structure 
and mechanism.  
 
Ultimately, if the reaction of either hydrolase could be reversed, this would create an 
important foundation for the enzymatic synthesis of carbon-carbon bonds in high 
value chemical building blocks.  
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Chapter 2: General Methods  
 
The following chapter will give a brief theoretical background on selected materials 
and methods which are particular to this work. Detailed experimental setups and 
protocols will be given separately with the individual projects. 
 
2. 1 Gene cloning, expression and protein purification 
 
2.1.1 Ligation-independent cloning 
 
All enzymes characterised as part of this project were purified to high homogeneity. 
Their respective genes thus required a selective expression system which would 
supply an affinity-tagged construct for inducible protein production and purification 
from a recombinant host. For this purpose, the YSBLIC3C vector was chosen into 
which all genes could be introduced by way of ligation independent cloning (LIC).  
The LIC method was first developed in 1990 by Aslanidis and de Jong (103). Within 
the York Structural Biology Laboratory it was later optimised and adapted for its use 
with a derivatised Novagen pET-28a vector. This created the YSBLIC and 
YSBLIC-3C vectors which have since allowed for the standard and high throughput 
cloning and expression of a large number of hexahistidine tagged protein constructs 
(103,104). The method is based on the creation of complementary nucleotide 
overhangs in both vector and insert DNA which anneal spontaneously. This 
circumvents the need for a ligase reaction and, as it significantly reduces the 
tendency of vector DNA to self-anneal, no phosphatase treatment is required.  
To prepare the respective overhangs, the pET-28a vector has been modified to 
introduce a LIC site between the multiple cloning site’s NcoI and NdeI restriction 
sequences. This site consists of two 3’-5’ nucleotide stretches deficient in 
deoxyadenosine triphosphate (dATP), a BseRI recognition sequence and a restriction 
site for the human rhinovirus (HRV) 3C protease (see Fig. 2.1). Upon BseRI digest, 
the vector is linearised such that the dATP deficient nucleotide stretch is exposed at 
each strand’s 5’ end. Complementary stretches, deficient in deoxythymidine 
triphosphate (dTTP) nucleotides, are attached to the 5’ ends of insert DNA by a 
polymerase chain reaction (PCR) using specifically designed LIC primers.   
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Figure 2.1: Ligation independent cloning into the YSBLIC-3C plasmid allows for high 
throughput preparation of affinity tagged gene constructs. The vector provides a BseRI 
recognition site (brown) for linearization and a sequence encoding the HRV-3C protease 
cleavage site (green) between hexahistidine tag (purple) and gene of interest (yellow) 
[adapted from presentation slides prepared by Mark Fogg and (104)].  
 
The 5’-3’ exonuclease activity of T4 polymerase is subsequently used to synthesise 
5’, single stranded, 14 nucleotide overhangs on both vector and insert. The addition 
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of excess dTTP and dATP to the vector and insert reactions respectively, ensures that 
the presence of a complementary base inhibits the T4 enzyme’s exonuclease activity 
as the nucleotide deficient sequence ends.  The highly complementary 5’ single 
stranded overhangs thus created anneal spontaneously if vector and insert DNA are 
combined.  
This process creates circular plasmid DNA that is stable enough for the 
transformation of a highly competent E. coli cloning strain. The microorganism’s 
repair and amplification system will close the nicks between vector and insert and 
allow for production of high copy numbers of recombinant plasmid (see Fig. 2.1) 
(103,104). The presence of a kanamycin resistance marker then allows for selection 
of recombinant clones on antibiotic-containing growth medium.  
The YSBLIC3C vector allows for the expression of a gene which, when transcribed 
and translated in the cell, will give rise to a hexa-histidine tagged protein construct 
ideal for affinity purification. The affinity tag can be cleaved specifically using the 
HRV3C protease if required (104). 
 
2.1.2 In-Fusion cloning 
 
In addition to the LIC cloning described above, the In-Fusion™ technique was used 
by the University of York’s Technology Facility to prepare fusion constructs 
between the oxidised polyvinyl alcohol hydrolase and a variety of solubility 
enhancing protein tags. The technique allows for the insertion of genes (amplified 
with gene and vector specific primers) into any vector of choice. Analogous to the 
LIC method, 15 nucleotide overhangs are created on the insert. These are then 
specifically recognised by the proprietary In-Fusion enzyme™ and fused to their 
complementary vector sequences. The method is suitable for both prokaryotic and 
eukaryotic expression systems (105).  
 
2.1.3 Gene expression and protein production in E.coli recombinant hosts 
 
The Gram-negative bacterium Escherichia coli was chosen as a host system for all 
projects described in this work. Its fast growth rates and high levels of gene 
expression and protein production make it an ideal candidate for small to large scale 
purification processes [pET manual].  
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The most commonly used expression strain is E.coli BL21 (DE3). The cells possess 
a T7 RNA polymerase gene (provided by the lysogen DE3) which is under the 
control of a lac-promoter system. It is ideal for protein production from pET vectors, 
such as YSBLIC-3C, the multiple cloning sites of which are, in return, under the 
control of a T7 promoter. By intracellular inhibition of the lac-repressor through 
allolactose or its analogue isopropyl !-D-1-thiogalactopyranoside (IPTG), gene 
expression and subsequent protein production can be initiated. The control of gene 
expression levels can thus improve yields and/or enhance solubility of recombinantly 
produced protein.  
The BL21 strain was originally derived from B834, a methionine auxotroph (Met-) 
variant of E.coli which, like all the “B” strains, lacks the lon and outer membrane 
(omp) protease genes. The B834 strains are commercially available as (DE3) variants 
and are commonly used for the expression of selenomethionine labelled proteins 
required in macromolecular crystallography. They have also been shown to help with 
the controlled production of proteins which are particularly toxic to their 
recombinant host (106,107).  
As an alternative to E.coli BL21 or B834 (DE3) cells, the Rosetta (DE3) variant is 
frequently used for the expression of genes with unusual codon usage, particularly of 
eukaryotic or viral origin. The strain provides an additional plasmid encoding tRNAs 
complementary to the rarely used codons of arginine, glycine, isoleucine, leucine and 
proline. Their presence can prevent mismatching of amino acids and premature 
termination of the translation process and thus lead to translation of heterologous 
gene targets in E.coli (107,108).  
 
All three strains described above can be obtained as pLysS variants. These contain, 
on an additional plasmid or the rare-tRNA encoding plasmid in case of Rosetta 
strains, the T7 lysozyme gene. This gene’s protein product specifically binds and 
inhibits T7 RNA polymerase. The pLysS variants thus limit background expression 
of the gene of interest in the uninduced cells. After induction and inactivation of the 
lac-repressor, sufficient T7 RNA polymerase is produced to outweigh the inhibitory 
effect of lysozyme and induce expression of the gene of interest. This control of 
basal or background gene expression is thought to help cell viability and stable 
production of protein products which are toxic to the host cells.  
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In addition to the regulation of expression levels of the gene of interest, a variety of 
E.coli strains have been engineered to enhance folding and solubility of 
recombinantly produced proteins. The Lemo21 (DE3) strain allows for fine-tuning of 
T7 RNA polymerase expression and thus indirectly controls the lac promoter in 
pET28-based YSBLIC3C plasmids (109,110). Without addition of L-rhamnose to 
cultures, Lemo cells are comparable to regular BL21(DE3) pLysS strains, expressing 
T7 lysozyme and thus inhibiting background expression from the lac-promoter as 
described above. Addition of an L-rhamnose gradient to cultures allows for titration 
of T7 lysozyme expression and activity of the lac-promoter accordingly. For toxic 
proteins this can prevent or lower the formation of inclusion bodies. The Arctic 
Express™ strain makes use of the co-expressed cold shock chaperonins cpn60 and 
cpn10. Expression at low temperatures induces production of these chaperonins 
which may then, in turn, support the folding of a protein of interest (111,112). 
 
2.2 Purification of recombinant proteins by affinity and size-exclusion 
chromatography 
 
2.2.1 Metal-affinity chromatography 
 
A significant advantage of gene expression and protein production from the 
YSBLIC-3C vector is the presence of a cleavable N-terminal hexahistidine tag. This 
allows for purification of the protein of interest by immobilised metal affinity 
chromatography (IMAC). The method was first introduced for general protein 
purification in 1975 and is based on the interaction between the basic side chain, in 
particular the imidazole ring, of histidine and a divalent metal ion acting as a Lewis 
acid (113). This metal can be Zn2+ or, less commonly, Co2+ and is immobilised onto 
a carbohydrate resin to which it shows a higher binding affinity than to the protein 
ligand. Of the metal’s six coordination sites, four interact with the resin whereas two 
are free to interact with the protein (see Fig. 2.2) (114). The nature of the interaction 
between metal and histidine side chains allows for comparatively high specificity 
binding of the tagged protein. When eluted, purities exceeding 90% can be observed 
accordingly. This specific elution is either based on a variation in pH or, as applied 
in this work, by replacement of the histidine side chains with increasing 
concentrations of free imidazole in an elution buffer (113,114).     
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2.2.2 Size-exclusion chromatography 
 
As IMAC yields protein of high, yet insufficient, purity for macromolecular 
crystallography, a second chromatography step is commonly added to each 
purification.  This process, known as gel filtration or size exclusion chromatography 
(SEC), is based on separation by molecular weight and frequently used as a final step 
in the purification of macromolecules. The SEC columns used for this project are 
made up of Sephadex™, an inert and stable packed bed mixture of cross linked 
dextran and agarose. The spherical particles form a porous sieve through which 
larger molecules can pass without considerable interaction with the stationary phase 
while smaller molecules diffuse into the pores. A heterogeneous protein sample will 
be separated accordingly: the higher molecular weight its components have, the 
earlier they elute from the column. SEC thus allows for purification of proteins from 
contaminants of different molecular weight. When calibrated with an appropriate 
marker, SEC columns can also be used to determine the molecular weight as well as 
the mono- or multimeric state of a previously uncharacterised protein (115).  
 
Figure 2.2: The metal ion (green) in IMAC purification columns is highly coordinated by the 
carbohydrate resin, in this case to give Ni-nitriloacetic acid (Ni-NTA). Two of its 
coordination sites are free to interact with the histidine side chains. A gradient of imidazole 
can replace these interactions and specifically elute the tagged protein [adapted from (114)].  
In the subsequent SEC step, the protein of interest is separated from lower or higher 
molecular weight contaminants as a consequence of their longer and shorter retention times 
on a porous stationary phase respectively.  
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2.3 Improvement of protein solubility 
 
A considerable number of proteins are insoluble when produced in heterologous 
expression systems. Reasons for this are diverse and cannot always be derived from 
their sequence or experimentally. They include post-translational modifications (in 
particular for eukaryotic proteins), the presence of signal sequences, requirements for 
chaperones, unfavourable expression conditions and others. Whereas some of these 
problems can be overcome by the use of genetically engineered expression systems 
(see above), others may require optimisation of genes, protein production and 
purification methods.   
 
2.3.1 Removal of Signal sequences 
 
The presence of signal sequences on the gene of interest may target the translated 
protein to the membrane/cell wall or certain cellular compartments in vivo. If it is not 
essential to protein folding or function, removal of the signal sequence may retain the 
protein in the cytosol and help with its purification from soluble cell fractions.  
 
2.3.2 Buffer screening -The Sparse Matrix approach 
 
In 2000, Lindwall and co-workers designed and published a buffer-based screen 
aimed at improving the solubility of overexpressed proteins. This screen was based 
on the observation that transfer of gene expression and protein production into a 
heterologous host often leads to the formation of inclusion bodies. The latter contain 
aggregated, mis- or partially folded proteins which are hoped to be solubilised 
(refolded) in the appropriate conditions. The authors proposed three variables to 
influence aggregation or allow for retrieval of protein from inclusion bodies already 
formed (116). By altering a buffer’s pH, the protein is moved closer or further from 
its isoelectric point (pI). The charge, especially of surface exposed residues, 
determines the interaction between a protein and its surrounding solvent (the 
solvation state) and is thus thought to affect the formation of aggregates. Similarly, 
the salt content of a protein’s environment can alter its solubility as it is described in 
the so-called Hofmeister series. Their influence on electrostatic repulsive forces or 
hydrophobic interactions is thought to affect correct protein folding, either stabilising 
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or preventing it (117). A third set of conditions, the presence of additives such as 
sugars, alcohols and detergents, is thought to further influence folding and stability, 
either directly or by preventing the protein from interacting with other components of 
the host cell. The detergents in particular could interact with surface-exposed 
hydrophobic residues and thus prevent or disrupt aggregation between 
macromolecules.  
With a randomized collection of thirty buffers, the authors hope to cover conditions 
optimal for recovery of a soluble target protein. They propose that the combination 
of pH, salts and other additives may resemble the polypeptide’s natural 
microenvironment better than the mild standard buffer preparations commonly used 
today (116).     
 
2.3.3 Preparation of fusion constructs 
 
In addition to altering the protein’s expression and purification environment as 
described above, its solubility can be enhanced by the attachment of a solubility tag. 
The method has been used for several decades and with a large variety of constructs, 
from simple polypeptides to full-length protein tags. The rationale for increased 
solubility of the fusion construct is often unclear (118). 
The most commonly used protein solubility tags are the E. coli maltose binding 
protein (MBP) and the Schistosoma japonicum glutathione S-transferase (GST).  
Others include the ubiquitous green fluorescent protein GFP, the hydrophilic E. coli 
thioredoxin A (trxA) and N-utilization substance A (NusA) as well as the immunity 
protein 9 (Im9).  MBP in particular has been shown to improve the solubility of 
proteins which would, without the fusion, be expressed but largely remain unfolded 
or partially folded in cellular inclusion bodies. The exact mechanisms by which the 
fusion supports solubility are however still unknown. It has been suggested to 
stabilise some of its “passenger proteins” to favour their native folding over 
aggregation whereas others may be positioned suitably for molecular chaperones to 
assist in folding (118-120). There are no structural or functional similarities between 
the commonly used protein solubility tags (118) and mechanisms of solubilisation 
may have to be determined individually in the future.  
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2.4 Alteration of single amino acids by site-directed mutagenesis 
 
An essential requirement for the characterisation and optimisation of proteins, in 
particular those involved in biocatalytic processes, is the ability to change single 
amino acid residues. These changes are usually (but not essentially) focused on the 
enzyme’s active site. They can be used to knock out or reduce activity to highlight 
the importance of selected catalytic residues or to trap a substrate, reaction 
intermediate or product in the active site. Alternatively, residues can be altered to 
change substrate scope, regio- and/or enantioselectivity or to simply increase a 
catalyst’s known activity.  The most common method to change single or multiple 
selected residues is by amplification of template DNA using mutagenic primers.  
Early DNA modifications were chemical- or radiation induced. The first site-directed 
mutagenesis (SDM) experiments were carried out in 1978 by Hutchison and co-
workers who changed wild type and mutant single stranded phage DNA into their 
respective counterparts. Amplification of template DNA using mismatched primers 
and subsequent transfection of E.coli hosts then allowed them to select for the 
desired phenotypes (121). The method has since been optimised and is now routinely 
carried out on double-stranded DNA vectors using a set of two primers 
complementary to the gene of interest. These can be fully or partially overlapping, 
the latter being preferred for templates with a high ratio of guanine and cytosine 
(GC-rich DNA).   
The SDM reaction is in many aspects analogous to regular PCR-based gene 
amplifications (see Fig. 2.3). The mutagenic primer pair anneals to the single strands 
of a heat-denatured DNA plasmid template and is extended in opposite directions 
(5’-3’). The primers’ overall complementarity to the gene of interest allows for tight 
binding to the template, despite the presence of one to three mismatched bases per 
mutation and one or several mutations per primer.  Increased extension times as 
compared to single gene amplifications then lead to replication of the full template. 
The resulting single stranded circular DNA associates into a double stranded, nicked 
plasmid suitable for direct use in transformation reactions, without the need for 
ligation. The nicks will subsequently be repaired in the recombinant host. In early 
experiments, the ratio of template to amplified DNA (cycle number) would 
determine the relative amount of mutant clones after transformation of a host system 
by the template/mutant DNA mixture. The use of DpnI restriction endonuclease has 
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resolved this problem by specifically degrading the methylated parental DNA while 
leaving the non-methylated amplification products intact (2,122,123).  
 
Figure 2.3: SDM using a pair of mismatch primers is an efficient method of altering single or 
multiple residues on a gene of interest (yellow, mutation shown in red). After amplification 
(a), the newly synthesised strands (purple) associate into a double stranded, nicked plasmid; 
primers only anneal and extend from the original template (grey) (b). Methylated “parental” 
DNA is specifically recognised and digested by the DpnI restriction endonuclease whereas 
the mutant plasmid remains intact (c). A recombinant host transformed by this plasmid can 
repair the nicked strands and amplify the mutant vector. It can then be used for sequencing, 
gene expression and production of the mutant protein [adapted from (123)]. 
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2.5 Determination of protein kinetics 
 
Within this project, all enzymes that could be purified with sufficient yields were 
subjected to experiments allowing the observation of substrate turnover and the 
determination of kinetic rate constants. This involved native proteins as well as a 
number of active site mutants.  The detailed analysis of enzyme kinetics can give 
important information on the mechanisms of substrate binding and turnover. It 
defines both efficiency and specificity of the catalyst. Kinetic data thus complement 
structural data or provide important information in their absence. 
 
2.5.1 Michaelis Menten kinetics 
 
The most basic model for enzymatic conversion of a substrate into a product by way 
of a single transition state (the enzyme-substrate complex) was proposed in 1913 by 
Leonor Michaelis and Maud Menten (124). It was based on the observation that an 
enzymatic reaction initially follows a linear relationship between substrate 
concentration and reaction velocity before levelling off and reaching a plateau. Once 
the plateau is reached, a further increase in substrate concentration has no significant 
effect on the rate of the reaction (see Fig. 2.4).  Michaelis and Menten derived an 
equation describing the catalytic rate at a specific substrate concentration, taking into 
consideration the protein’s maximum catalytic potential and the strength of substrate 
binding:  !! ! !!"#!!!!! ! !! 
     Eq. 2.1 !!!! ! !"#$% ! !!! 
   
Their equation holds true as long as an enzyme reaction is in its “steady state”, i.e. a 
constant equilibrium between the formation and dissolution of the enzyme bound 
transition state.  
The Michaelis-Menten equation provides all constants required to describe simple 
catalysis, i.e. the conversion of a substrate into a product by way of an energetically 
less favourable, enzyme bound transition state. The starting point for the equation is 
the assumption that catalysis is composed of four different sub-reactions, each 
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defined by a rate constant k. The formation of an enzyme substrate complex [ES] 
from free enzyme [E] and free substrate [S] is followed by the release of free product 
[P] from regenerated enzyme [E]. These two reactions are described by the reaction 
constants k1 and k3. k3 is known as the enzyme’s catalytic efficiency and thus also 
called the rate constant kcat.  Each can, in theory, occur in reverse. As the re-
association of product into the transition state (k4, red) is negligible however, only 
the dissociation of enzyme-substrate complex into free molecules is considered in the 
equation and given the rate constant k2.  
 
! ! !!!!!!! !" !!!!! ! !  
Eq. 2.2 !!! ! !! ! ! !! ! !! ! !!! ! !!! 
 
The first parameter described within the course of the reaction is KM, the Michaelis 
constant. It is both an indicator at which concentration the enzyme reaction reaches 
half its maximal velocity and can be a sign of how strongly a substrate is bound. 
When the substrate concentration corresponds to the Michaelis constant, the initial 
velocity of a reaction is equal to half the maximum velocity: 
 !! ! ! ! !!"#! ! !! !!!!!!!!"! ! ! !!!!!"#$!!!!!!!! ! !! !!!"# 
Eq.2.3 
 
It is obtained by setting the rate of enzyme substrate complex formation and 
breakdown equal (as in the definition of steady state kinetics) after which the 
equation can be limited to the rate constants alone: 
 !! ! ! ! ! !! ! !" ! !! ! !" ! !! ! !! ! !" ! !! ! !! ! !"  
 !!!!! ! !!! ! !!"!! !!! !!!!!!!! ! !!!!! ! ! !!!!!"! ! !! 
Eqs. 2.4, 2.5 
 [!!! ! !"#$% ! !!! ! ! 
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For the Michaelis constant to be high, the concentration of [ES] and the rate constant 
k1 for its formation accordingly need to be low and vice versa for low KM values.  
KM can thus be an indicator of how tightly a substrate binds to an enzyme (the 
enzyme’s specificity). As the equation however also includes k3 (kcat), its 
contribution to KM has to be taken into consideration prior to evaluating substrate 
binding affinities.   
Catalytic activity is well described by KM, Vmax and kcat under saturating substrate 
conditions, i.e. when the total amount of enzyme corresponds approximately to the 
amount of enzyme in complex with substrate ([Etot] = [ES], Vmax = kcat [Etot]). The 
enzymatic reaction has to be defined by the kcat/KM value however when substrate 
concentrations remain significantly below KM.  At this point it is assumed that most 
of the active sites are unoccupied (i.e. [Etot] = [E]) and knowledge about the turnover 
number kcat and the Michaelis constant can be combined to give a new determinant of 
the initial rate V0: 
 !! ! !!"# !" !!! ! ! ! !!"! !!!!!"! !!!!!!! ! !!"#!! ! !!"! !!! 
Eq. 2.6 !!"#!! ! !!!!"! !!! ! !!! !!!! 
 
Accordingly, the kcat/KM ratio defines the rate of catalysis for a fixed concentration of 
substrate below the KM and (predominantly) free enzyme and is stated as the number 
of substrate molecules turned over per second by one mole of enzyme.  The kcat/KM 
rate could be particularly important for analysing “natural” protein kinetics as it has 
been proposed that the KM resembles the substrate concentrations a protein would 
encounter in vivo (125,126) .  
 
2.5.2 The Lineweaver-Burk plot 
 
For enzymes following simple Michaelis-Menten kinetics, rate constants can be 
derived from a graph plotting substrate concentration versus reaction rate V0 (see Fig. 
2.4). As the resulting curve can only provide approximate values however (especially 
for Vmax, which is approached but never reached), their reciprocals are often plotted 
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in addition. These produce what is known as the Lineweaver-Burk plot. It produces a 
straight line, the x- and y-axis intercepts of which correspond to -1 x KM-1 and -1 x 
Vmax-1 respectively. The line’s gradient corresponds to KM/Vmax (see Fig. 2.4, inlet) 
(125,126). !! ! !!"# ! !! ! !!  
 !!! ! ! ! !!!!"# ! !!! ! !!!!!"# ! !!!! !!!!"# ! !!! !!!!!!! !!!!! !!!"# ! !!!!"# ! !!!! 
Eq. 2.7 
 
Figure 2.4: The reaction kinetics for enzymatic conversion of a substrate into its product, 
described by the Michaelis Menten equation, can be visualised by plotting the substrate 
concentration dependent reaction rate (KM = blue square, Vmax = dashed square). 
Alternatively, the reciprocal values of both can be a represented in the Lineweaver-Burk plot 
(inlet window). The latter facilitates determination of the rate constants and the kcat/KM ratio 
which correspond to intercepts of a linear trend line with the graph’s axes and its gradient 
respectively.  
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The Lineweaver Burke plot presents disadvantages in the determination of protein 
kinetics as the fitting of a straight line can be unreliable, particularly for the densely 
clustered data points collected at higher substrate concentrations. As a consequence, 
substrate dependent initial reaction velocities ([S]/V0) were plotted exclusively in the 
course of this work. From this, kinetic parameters could be determined by 
computational fitting of a Michaelis Menten curve or manual estimation of KM and 
Vmax values from the resulting graph (see Fig. 2.4) 
 
The knowledge of an enzyme’s catalytic efficiency and its tendency to bind a certain 
substrate are essential for all biocatalytic processes. Michaelis-Menten kinetics thus 
provide the basis for protein engineering, ligand screening, process scale-up and 
optimisation. The method of determining kinetic constants for a reaction depend on 
the protein, its substrate and, if applicable, cofactors involved in catalysis. The 
measurements required can be based on the consumption of substrate, the appearance 
of product or the turnover of cofactor molecules accordingly. 
 
2.6 Analytical techniques 
 
2.6.1 UV spectrophotometry  
 
UV spectrophotometry can be used for real-time observation of substrate turnover by 
an enzyme. It is based on absorbance differences between substrate and product or 
the reaction states of a cofactor (for example if it is oxidised or reduced).  
As monochromatic light is passed through a solution of substrate, electrons 
(particularly within %-bonds) are transferred into a higher energy level when “hit” by 
a photon and thus absorb part of the incoming energy. This absorbance A (or the 
difference in transmitted light T) can be measured. It corresponds to: 
 ! ! !!! !!!!!! ! ! !"#! 
 
I0 corresponds to the incoming radiation and I to the transmitted radiation.      Eq.2.10 
 
72 
 
Atoms and molecules have an absorbance maximum at a defined wavelength which 
corresponds to the energy difference between the excited and ground state. It can lie 
within the visible electromagnetic spectrum (between 400 and 700 nm) or in the 
range of ultraviolet radiation (10 – 400 nm).  
Ultraviolet-visible (UV-VIS) spectroscopy makes use of this property. A substrate 
solution is exposed to monochromatic light at a wavelength corresponding to the 
previously determined absorbance peak of either substrate, product or cofactor. The 
transmitted light intensities are measured by a detector and used to determine the 
change in absorbance (see equation 2.10). As protein is added, catalysis changes the 
solution’s absorbance properties. In other words, substrate breakdown, product 
formation or turnover of cofactor can be observed in real time as a consequence of 
the molecules’ changes in absorbance spectra. Using Beer’s law, the change in 
absorbance can then be transformed into a change in concentration, i.e. the molecular 
units of catalytic turnover and reaction rates: 
 !! ! !!! ! ! ! !!!!!!!!!!!! ! !! !! ! !! 
Eq. 2.9 
 
The change in concentration c of product, substrate, or a specific cofactor state can 
thus be calculated from the change in absorbance if the molecule’s extinction 
coefficient $ and the pathlength l are known (127). 
 
2.6.2 High performance liquid chromatography 
 
Whereas spectrophotometric methods are used to observe real-time enzymatic 
catalysis, other methods rely on the quantitative and qualitative analysis of reaction 
samples taken at various time points. High-performance liquid chromatography 
(HPLC) is a highly sensitive method enabling the user to detect even trace amounts 
of product and follow turnover of substrate and/or cofactor. The molecules of interest 
can be extracted into an organic or aqueous phase and are subsequently separated on 
a chromatography column. As a consequence, these methods can be used for both 
purification as well as analysis.  
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Separation of a reaction sample’s components on a HPLC column is achieved 
through their differential interaction with the stationary phase (the packing material) 
and a mobile phase (the solvent). These interactions are usually based on polarity. 
For normal-phase HPLC, the columns packing material is a polar substance which 
will interact with polar functional groups in the sample. The organic solvent is non-
polar and will preferentially enhance transport of less or non-polar molecules 
accordingly. In reverse-phase HPLC, which is the most commonly used method, 
these conditions are inverted – the stationary phase is non-polar (it contains long 
hydrocarbon chains) whereas the water-based solvent is polar. As for UV-VIS 
spectroscopy, HPLC can be used to determine protein kinetics. It is the method of 
choice when high sensitivity and a large detection range (with respect to a sample’s 
chemical composition and concentration) are required. Once the molecules of 
interest are eluted from the column, a detector measures their absorbance. In 
combination with the retention times unique to substrate, product or cofactor, this 
allows for both qualitative and quantitative assessment of each reaction and can be 
used to visualise a catalytic process, as described above.  
The stationary phases of HPLC columns can also be composed of chiral materials. 
As stereoisomers of the same molecule interact differently with such surfaces, chiral 
columns allow for their separation and identification (128).   
 
2.6.3 Gas chromatography 
 
Components in an enzyme-catalysed reaction can also be detected and separated by 
gas chromatography (GC). In GC based analysis, all components to be measured 
have to be extracted into an organic solvent after the enzymatic reaction – analogous 
to HPLC based methods. The resulting solution is then heated until it reaches its gas 
phase. GC analysis is thus limited to molecules that are sufficiently volatile, yet 
stable, at the required temperatures. The heated sample is mixed with an inert carrier 
gas (the moving phase) and transported through a small diameter (<1 mm), spiral 
column. This column is lined with the stationary phase, a material that specifically 
interacts and retains the carbon-rich analytes over the carrier gas. The interactions 
between stationary phase and analytes can be based on polarity (as described above), 
solubility/volatility or other chemical interactions. As for HPLC, GC columns with 
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chiral stationary phases allow for the differentiation between stereoisomers of the 
same molecule.  
Unlike UV-VIS spectroscopy and HPLC, the molecules of interest are not identified 
or quantified based on their absorbance properties. As each reaction component 
leaves the column, it passes through a flame. Decomposition of the organic analytes 
leads to formation of ions (particularly carbocations in organic compounds) which 
are attracted to an electrode. The resulting current is measured: its strength is 
proportional to the analyte’s concentration, the retention time between injection and 
signal serves as an identifier as it is unique for its molecular composition. The 
experimental output (voltage) does not allow for direct calculation of the analyte’s 
concentration, as with Beer’s law for UV based methods. As a consequence, GC 
methods rely on reference samples and calibration curves for quantitative results 
(129,130).  
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Figure 2.5: HPLC (a) and GC (b) analysis are used for qualitative and quantitative analysis 
of enzymatic reaction samples. Both methods rely on the transport of analytes by a carrier 
substance. The molecules of interest are retained to various degrees by a stationary phase in 
the analytic column. Their relative amount is then determined by UV absorbance (HPLC) or, 
after combustion, through the specific current the analytes’ ions create on a measuring 
electrode (GC). Whereas UV signals can be converted into concentrations directly, the 
electric signal has to be evaluated with the help of a previously prepared calibration curve 
(129,130).  
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Chapter 3:  Preparation of a BsPAD mutant library 
 
 
3.1 Introduction 
 
3.1.1 Phenolic acid decarboxylases 
 
Phenolic acid decarboxylases (PADs) belong to the family of cofactor-independent 
carbon-carbon bond lyases. They catalyse the removal of a carboxylate functional 
group from a number of natural phenolic acids and show varying substrate scopes 
and specificities between the different family members. PADs are predominantly 
found in bacteria (the Gram positive Bacillus, Lactobacillus, Pseudomonas, 
Aerobacter and Pediococcus species and the Gram negative Klebsiella oxytoca) as 
well as in lower eukaryotes like yeast. They constitute an important defence 
mechanism for their hosts as they come into contact with plant derived phenolic 
acids. The latter are abundant in nature and can be found in plants where they cross-
link the cell wall polysaccharides and hence become a breakdown product during 
lignin degradation (131). They share a common aromatic ring substituted by at least 
one hydroxyl moiety in para-position to a crotonic ((E)-2-butenoic) acid side chain, 
making them derivatives of cinnamic acid (see Fig. 3.1). Some of the most abundant 
phenolic acids are ferulic-, p-coumaric- and caffeic acid (132). 
 
Figure 3.1: Phenolic acids are identified by their phenol ring, substituted with at least one 
hydroxyl, and their carboxylic acid functional group. Their decarboxylation leads to 
formation of a p-hydroxystyrene (a).The phenolic acid substituents (R) may vary in number, 
character and position. The most abundant phenolic acids are: ferulic acid (R = (CH3-O, b1), 
p-coumaric acid (no R, b2) and caffeic acid (R = OH, b3).  
77 
 
In the food industry, phenolic acids contribute to off-flavours, especially in their 
volatile form, and may negatively influence aroma and taste, not least because of 
their astringent properties. Depending on their application however, they also have 
desired properties, especially in the production of fermented foods and alcoholic 
beverages and in their function as antioxidants (131-133). Natural phenolic acids 
have been shown to exert inhibitory growth effects on microorganisms exposed to 
them. For the extensively studied Lactobacillus species for example, this has been 
suggested to be due to disruptions to the cytoplasmic membrane (131). As a 
consequence, many microorganisms have evolved PAD enzymes for their specific 
decarboxylation in a process known as the phenolic acid stress response (133). As 
the carboxylate moiety is removed, the acids are converted into volatile styrenes (see 
Fig. 3.1), which are considerably less toxic to the organisms.  
 
The crystal structures of four prokaryotic PADs have been solved to date. All 
associate into dimers and show the conserved overall protein fold of a central, 
flattened !-sandwich flanked by an "-helical region on one end and flexible loops on 
the other, more open (solvent exposed) side (see Fig. 3.2). The structural 
conservation is most pronounced for the sandwich motif, which is thought to 
accommodate the proteins’ active sites. It also reflects the high primary sequence 
conservation between PAD proteins, of both known and unknown 3-dimensional 
structure, in this area (60,133,134).  
Several mechanisms could be proposed for phenolic acid decarboxylation. The most 
comprehensive PAD mechanism was published by Hashidoko et al. in 1998 (135) 
for the enzyme from Klebsiella oxytoca (KoPAD). It was based on experiments in 
which the reaction’s stereochemistry could be observed using deuterium labelled 
substrates and nuclear magnetic resonance (NMR). This mechanism was later 
supported by the availability of PAD crystal structures (including one ligand 
complex) and modelling approaches (60,134,135). Though differing in the 
assignment of catalytic residues, all hypotheses include specific substrate recognition 
of the carboxylate and the para-hydroxyl group, deprotonation of the latter and an 
electron relay through the protein. Protonation at the C8-carbon is then thought to 
lead to the formation of a para-quinone methide intermediate. This will eventually 
be subject to decarboxylation, followed by a second electron relay and formation of 
the phenolic acid’s respective styrene derivative (60,134,135) (see Fig. 3.3).  
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Figure 3.2: The superposition of all four PAD crystal structures determined to date shows a 
clear conservation of the overall fold, particularly around the core of the protein. The native 
enzyme sources were Bacillus subtilis (BsPAD, green, 2P8G), Bacillus pumilus (BpPAD, 
purple, 3NAD), Enterobacter sp. Px6-4 (EPAD, grey, 3NX1) and Lactobacillus plantarum  
(LpPAD, blue, 2GC9).  
 
Figure 3.3: Detailed reaction mechanisms have been suggested for the enzymatic 
decarboxylation of phenolic acids. The proposals differ in their assignment of enzymatic 
residues as catalytic acids (A, green) or catalytic bases (B, blue). Also the nature of the 
proton donor for the substrate’s scissile C8 carbon (A, green) is unclear [adapted from 
(135)].  
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Other, unrelated enzymes involved in the turnover of identical or similar substrates 
also provide information towards possible mechanisms and catalytic residues. 
Tyrosines forming a ‘pincer’ - like arrangement for recognition of the substrate’s 
phenolic hydroxyl and arginine residues stabilising a quinone-methide intermediate 
have been observed in the Hydroxycinnamoyl-CoA hydratase lyase (HCHL) of 
Pseudomonas fluorescens as well as the Vanillyl-alcohol oxidase (VAO) from 
Penicillium simplicissimum (136,137).  
 
3.1.2 PAD enzymes in Biotechnology 
 
The interest in PAD enzymes for biotechnological applications stems from both their 
use in substrate degradation and in product formation. The release of phenolic acids 
and their decarboxylated phenol derivatives can have desired as well as unwanted 
effects in the food industry. Both contribute (off-)flavours and the latter gives 
astringent properties, especially to fermented foods and beverages (131). A thorough 
understanding of the fermentation process and the potential use of genetically 
modified organisms could thus be of advantage.  
Phenolic acid decarboxylation into styrene derivatives is, in addition, an important 
starting point for various potential downstream processes. Polymerisation of the 
styrene products as well as the selective transformation of the ferulic acid 
decarboxylation product, 4-vinylguaiacol, to give vanillin, would allow for the 
formation of high value chemicals from natural, renewable resources (138).  In 
addition, the PAD reaction was shown to be reversible in vitro, leading to carbon-
carbon bond formation. This would allow for the fixation of gaseous carbon dioxide 
waste and its use in the production of valuable chemicals (13).   
 
3.1.3 Bacillus subtilis Phenolic acid decarboxylase (BsPAD) 
 
As described above, decarboxylase activity has been observed for a number of 
microorganisms, in particular the Gram positive Bacilli. Of these, the soil dwelling 
Bacillus subtilis was found to be the first microorganism to decarboxylate all three of 
the most abundant phenolic acids.  The padC gene responsible for this ability, a 
528 bp open reading frame, was first isolated and cloned into an E. coli host by 
Cavin and co-workers (18). Within the recombinant host, it could be expressed and 
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translated into a 161 amino acid polypeptide, the Bacillus subtilis phenolic acid 
decarboxylase (BsPAD). The purified protein had a molecular weight of 
approximately 20 kDa and was shown to assemble into a dimer in solution. It 
specifically decarboxylated ferulic-, p-coumaric- and caffeic acid (in descending 
order of catalytic efficiency) into 2-methoxy-4-vinyl phenol, 4-vinyl phenol and 4-
vinyl-2-methyl phenol respectively (see Fig. 3.4).  Other substrates lacking either the 
para-hydroxyl group or a double bond in the crotonic acid side chain (i.e. a 
conjugated system) were not turned over by the enzyme (18). Prior to the availability 
of structural data, sequence alignments and the preparation of chimeric libraries gave 
a first insight into the relationship between BsPAD and other previously 
characterised PAD enzymes. Differences in substrate specificity appeared to be the 
result of a few amino acid alterations between otherwise highly conserved sequences. 
(18,133).  
The first crystal structure of the BsPAD apo enzyme (PDB code 2P8G) was 
determined by the Joint Center for Structural Genomics initiative (JCSG) in the 
United States in 2007. It shows the typical PAD features previously described (see 
section 3.1.1), including the two prominent beta sheets surrounding and enclosing the 
enzyme’s active site as a !-sandwich. One end of this tunnel-like structure is covered 
by "-helices, the other by flexible loops connecting the !-strands. (see Fig. 3.4). A 
tail like structure, comprising a long flexible loop and another "-helix, lies adjacent 
to the !-sheets and forms the C-terminal end of the polypeptide. In its dimeric state, 
these termini face in opposite directions.  
When superposed with homologous enzymes, BsPAD shows a strong conservation in 
three-dimensional structure, particularly around the central region (see above and 
Fig. 3.2). In this area, a number of residues can be identified which have been 
implied in catalysis for structurally and/or functionally related proteins such as the 
aforementioned LpPAD, KoPAD, VAO and HCHL (60,135,136,139) (see Fig. 3.4). 
These residues include a potential catalytic acid for removal of the substrate’s 
phenolic hydroxyl (Glu64), a step essential for initiation of the first electron relay in 
PAD enzymes. For this part of the reaction to occur, the acid is required to be in its 
deprotonated state prior to catalysis. The resulting negative charge, in addition to 
those developing during substrate deprotonation and formation of the quinone-
methide intermediate, may be stabilised by a positively charged arginine side chain 
(Arg41). A threonine residue in position 68 (as well as a second threonine in position 
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98, identified in the course of this project) may coordinate and/or activate a catalytic 
water which has been proposed to serve as a potential proton donor to the 
intermediate (60). For substrate recognition, either of the phenolic hydroxyl or the 
carboxylate moiety, two closely positioned tyrosine residues (Tyr11 and Tyr13) 
could be of importance (136,139). Both may also play a role in the observed 
substrate specificity of the enzymes in question. A third tyrosine in position 19 was 
previously found to constitute part of a hydrophobic pocket and may further 
contribute to substrate recognition and binding, the latter involving its rearrangement 
on binding of a phenolic acid molecule (60,136,139). 
 
Figure 3.4: The crystal structure of BsPAD resembles that of other, related prokaryotic PAD 
enzymes, particularly around the conserved central region (see Fig. 3.2). The enzyme was 
the first example of a PAD able to convert three phenolic acid substrates, ferulic-, p-
coumaric- and caffeic acid (in decreasing order of catalytic efficiency). Putative catalytic 
residues, inferred from homologous and/or mechanistically related enzymes, are shown. 
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3.1.4 Project aim 
 
At the start of this project, a structure of the BsPAD enzyme had been solved in the 
absence of a ligand. In addition, partial information regarding the overall reaction 
cycle was available from homologous enzymes and mechanistically related catalysts. 
To understand the complete and detailed mechanisms of phenolic acid 
decarboxylation however, it is necessary to identify and understand the interactions 
between catalytic active site residues and the substrate, reaction intermediate(s) and 
product. For this reason, a mutant library encompassing the potential catalytic 
residues outlined above was prepared. From this it was hoped to gain an insight into 
their importance for the reaction. This could ultimately allow for confirmation of 
previously suggested reaction mechanisms or the proposal of a new type of 
decarboxylation reaction. In addition, it was hoped that a weakly active mutant 
protein could be used to fix a ligand molecule in crystallisation experiments, 
eventually leading to the determination of a complex structure. 
 
 
3.2 Materials and Methods 
 
 
3.2.1 Production and purification of wild type BsPAD 
 
3.2.1.1 Cell culture and protein production  
 
The padC gene encoding the wild type phenolic acid decarboxylase from Bacillus 
subtilis (18) (BsPADwt) was amplified and cloned into the YSBLIC3C vector by 
William Eborall, a Biochemistry B.Sc. project student at York in 2008. This 
construct, hereafter named YSBLIC3C:BsPAD was then kindly provided for further 
experiments.  
For gene expression and protein production, competent E. coli BL21 cells were 
transformed by the YSBLIC3C:BsPAD vector. The cells were then plated onto a 
solid lysogeny broth medium (LB agar plates) containing 30 µg/ml kanamycin and 
incubated at 37°C for 12-18 h. From this plate, single colonies were picked and used 
to inoculate overnight cultures of 5 mL liquid lysogeny broth (LB medium) at the 
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same concentration of the selective antibiotic. These were, in return, used for the 
inoculation of 0.5-4 L of LB protein production cultures, with a 1:100 ratio of starter 
culture to fresh medium. These cultures were again grown in the presence of 
30 µg/ml kanamycin and induced with isopropyl !-D-1-thiogalactopyranoside 
(IPTG) at a final concentration of 1 mM as soon as their optical density at 600 nm 
(OD600) had reached a value of 0.6-1.0. Cultures were then incubated for 16 h at 
18 °C while shaking at 180 revolutions per minute (rpm). Harvested cells were 
resuspended in 30 mL of 50 mM Tris/HCl buffer with 300 mM NaCl at pH 7.5 
(hereafter named “resuspension buffer”) per litre of culture and disrupted by 
sonication at 12-14 amplitude microns for 3 x 45 s. The soluble fraction was 
obtained by centrifugation in a Sorvall RC5B Plus centrifuge at 15,000 rpm for 
30 min. 
 
3.2.1.2 Protein purification by Ni2+-affinity chromatography 
 
As a consequence of the cloning procedure, the expressed protein carried an 
N-terminal hexahistidine tag and could be purified in two subsequent steps. A 5 mL 
HiTrap™ Chelating HP column was charged using 0.1 M Ni2SO4 and washed with 
three column volumes of resuspension buffer prior to loading of the soluble 
supernatant obtained from crude lysate centrifugation (see above). After loading, the 
column was washed with resuspension buffer containing 30 mM imidazole (hereafter 
named “low imidazole buffer”) and attached to an ÄKTA™ fast protein liquid 
chromatography (FPLC) system. The latter allowed for an automated wash step of 
ten column volumes, using low imidazole buffer, prior to elution of the protein in a 
100 mL gradient from low to “high imidazole buffer” (50 mM Tris/HCl buffer with 
300 mM NaCl and 500 mM imidazole at pH 7.5).  Elution of the target protein was 
detected by measuring the column eluent’s absorbance at 260 and 280 nm. Peak 
fractions were then collected accordingly and concentrated for subsequent 
purification by size-exclusion chromatography.  
 
3.2.1.3 Protein purification by size-exclusion chromatography 
 
Following Ni2+-affinity chromatography, peak fractions were collected as described 
above and concentrated to a final volume of 2 mL. This sample could be purified by 
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size-exclusion chromatography using an S75 Superdex™ gel filtration column 
attached to the ÄKTA™ FPLC system. After loading of the protein sample it could 
be separated from impurities according to molecular weight and was eluted in 
resuspension buffer at an average flow rate of 0.5-1.0 mL/min. Peak fractions were 
detected as described above and pooled. The combined sample’s absorbance was 
then measured at a wavelength of 280 nm (A280) and, using Beer’s law, the protein 
concentration was calculated from A280, the known path length and the protein’s 
unique extinction coefficient. The latter was predicted from its primary sequence 
using the ProtParam server (140).  
Purified protein was frozen in liquid nitrogen and stored at -18 °C for later use in 
kinetic experiments. For crystallisation experiments, a part of the purified batch was 
retained and stored at 4 °C. 
 
3.2.1.4 Hexahistidine-tag cleavage 
 
A portion of the purified BsPAD was set aside to remove the hexahistidine tag. For 
this, the protein concentration was adjusted to 1 mg/mL and incubated with HRV-3C 
protease at a ratio of 1:10 (w/w) for 16 h. To separate the protein from its cleaved tag 
and the protease, a second Ni2+-affinity purification was carried out as described 
above. As the low imidazole buffer was replaced by resuspension buffer, imidazole 
free, cleaved BsPAD was eluted whereas the separated histidine tag and the 
3C protease were retained on the column until a 0-500 mM imidazole gradient was 
applied.  
 
3.2.1.5 Determination of protein purity 
 
During each purification, 10 µL samples were taken from sonicated whole cells or 
insoluble lysate, soluble lysate, affinity column flow through and selected peak 
protein fractions. Each sample was mixed with a denaturing loading buffer and 
heated to 94°C for approximately 5 min. Its protein contents and purity were then 
visualised by electrophoresis on a 12% sodium dodecyl sulphate polyacrylamide gel 
(SDS PAGE). For estimation of protein size, a Biorad™ low molecular weight 
marker was run in parallel on each gel.   
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3.2.2 Site-directed mutation of active site residues  
 
For analysis of the proposed BsPAD active site’s key catalytic residues, a mutant 
library including seven single and one double mutant was prepared by site-directed 
mutagenesis. Residues mutated included two tyrosines thought to be involved in 
recognising and binding the substrate’s para-hydroxyl group or carboxylate (Tyr11 
and Tyr13), a potential constituent of a flexible loop restricting access to the active 
site (Tyr19), two residues acting as stabilisers and catalytic acid during catalysis 
(Arg41 and Glu64 respectively) as well as two nucleophiles implied in the 
coordination of a potential catalytic water (Thr68 and Thr98) (60).  This process 
involved amplification of the wild type template plasmid using mutagenic primers, 
digest of parental DNA, transformation of a host organism by the mutant plasmid, 
amplification and isolation of the plasmid and subsequent determination of the gene 
sequence to confirm the desired mutation (see chapter 2, section 2.4.). 
 
3.2.2.1 Primer design 
 
A set of two complementary primers were designed for each single and for the 
double mutation and are shown in table 3.1. These primers contained one to three 
mismatches with respect to the wild type BsPAD gene in the centre of their 
sequence. 
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Pos.  Mut. Primer sequences 
 
 
11 
Tyr 
& 
Phe 
Fwd: ggaagccacatgatt ttt acgtatgaaaacgga 
 
tccgttttcatacgt aaa aatcatgtggcttcc 
 
Rev: 
 
13 
Tyr 
& 
 Phe 
Fwd: cacatgatttatacg ttt gaaaacggatgggaa 
 
ttcccatccgttttc  aaa cgtataaatcatgtg 
 
Rev: 
 
11, 13  
Tyr 
& 
Phe 
Fwd: ctttatcggaagccacatgatt ttt acg ttt gaaaacggatgggaataccgag 
 
tattcccatccgttttc  aaa cgt aaa aatcatgtggcttccgataaagttttccattgc 
 
Rev: 
 
19 
Tyr 
& 
Ala 
Fwd: gaaaacggatgggaa gcc gagatttatattaaa 
 
tttaatataaatctc  ggc ttcccatccgttttc 
 
Rev: 
 
41 
Arg 
& 
Ala 
Fwd: ggaatggttgccgga gcc tgggttcgagatcag 
 
ctgatctcgaacccaggctcc ggc aaccattcc 
 
Rev: 
 
64 
Glu 
& 
Ala 
Fwd: aaagtgtcttggaca gcg ccgactggcacggat 
 
atccgtgccagtcgg cgc tgtccaagacacttt 
 
Rev: 
 
68 
Thr 
& 
Val 
Fwd: acagagccgactggc gtg gatgtttcattaaac 
 
gtttaatgaaacatc cac gccagtcggctctgt 
 
Rev: 
 
98 
Thr 
& 
Ala 
Fwd: gcatgaacatcctgaaattgcggtttgctaccaaaatg 3' 
 
cattttggtagcaaaccgcaatttcaggatgttcatgc 3' 
 
Rev: 
 
Table 3.1: Primers used for the preparation of a BsPAD active site mutant library by site-
directed mutagenesis. Nucleotide triplets encoding the altered amino acid are highlighted in 
red. Position (Pos.) and nature of the mutation (Mut.) are shown on the left.  
 
 
3.2.2.2 Site-directed mutagenesis 
 
The mutagenic primers were used to amplify the YSBLIC:BsPAD vector as part of 
the reaction mixture shown in table 3.2 (top). The reaction was carried out using a 
Fisher Scientific TC-312™ thermocycler and the conditions outlined in table 3.2 
(bottom). 
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Reaction component Concentration Volume [ul] final concentration 
 
forward primer  
 
20 pmol/µL 
 
1 
 
0.4 µM 
reverse primer 20 pmol/µL 1 0.4 µM 
template DNA 
(YSBLIC:BsPAD) 
50 ng/uL 1 1 ng/µL 
deoxyribonucleotides (dNTPS) 25 mM 1 0.2 mM 
pfu turbo® hot start DNA 
polymerase buffer 
5x 5 1x 
pfu turbo® hot start DNA 
polymerase 
2.5U/ µL 1 0.05 U/ µL 
deionised water - 40 - 
 
Cycles Temperature [°C] Time [min:sec] Reaction 
 
1 
 
95 
 
0:30 
 
initial denaturation 
25 
95 0:30 denaturation 
50 1:00 annealing 
68 6:00 extension 
- 4 ' hold/storage 
 
Table 3.2: Reaction components (top) and amplification conditions (bottom) for the 
preparation of a BsPAD active site  mutant library by site-directed mutagenesis. 
 
 
3.2.2.3 Protein production and purification of BsPAD mutants 
 
 Following the amplification, a restriction digest with DpnI endonuclease allowed for 
selective removal of non-mutated (hemimethylated) template DNA. For this, 10 units 
of New England Biolabs™ DpnI restriction endonuclease were added to each 
reaction. The samples were centrifuged at 13,000 rpm for one minute prior to 
incubation at 37°C for 3-5 h.  An E. coli cloning strain (E. coli XL-1 blue or E. coli 
XL10 gold) was subsequently transformed by 5 µL of digested plasmid DNA.  
Colonies resulting from the transformation were used for the preparation of 5 mL 
overnight cultures in LB medium containing 30 µg kanamycin per mL of culture.  
88 
 
Subsequent isolation of plasmid DNA was achieved using a Sigma GenElute™ 
plasmid miniprep kit according to the supplier’s specifications. After extraction, 
300-500 ng of isolated plasmid DNA were supplied to the University of York’s 
Technology Facility for determination of the gene of interest’s nucleotide sequence 
and confirmation of the desired mutation. Sequencing chromatograms were 
evaluated using the ChromasLite™ software and the resulting nucleotide sequence 
was translated into amino acids using the Swiss Institutes of Bioinformatic's Expasy 
server (141).  The final output could then be compared to the BsPAD wild type 
sequence by pairwise sequence alignment using the EMBOSS Needle web server.     
 
After sequence verification, an E.coli expression strain (E.coli BL21 (DE3)) was 
transformed by the mutant plasmids. The genes of interest were expressed and the 
proteins produced and purified as described for the wild type BsPAD enzyme. To 
avoid contaminations, particularly for parallel purifications of several proteins,  5 mL 
HiTrap™ Chelating HP columns were stripped with three column  volumes of 0.1 M 
EDTA and 0.5M NaCl followed by  three column volumes of 0.5 M NaCl prior to 
recharging with NiSO4 and equilibration with three column volumes of resuspension 
buffer as described above.  
 
3.2.3 Analysis of enzyme kinetics  
 
3.2.3.1 Spectrophotometric analysis 
 
Kinetic data for the wild type protein and the active site mutants were initially 
collected by spectrophotometric analysis of substrate conversion. Comparison of 
UV-spectra for ferulic and p-coumaric acid and the products of their 
decarboxylation, 2-methoxy-4-vinyl-phenol and 4-vinyl-phenol respectively (all 
obtained from Sigma, Poole, Dorset, UK), show a significant decrease in absorbance, 
exclusive to the substrates, at a wavelength of 310 nm (data kindly provided by 
William Eborall).  According to this, a kinetic assay was previously developed (142). 
Within this assay, substrate concentrations ranging from 5-160 µM (ferulic acid) or 
5-450 µM p-coumaric and caffeic acid), were prepared to a total volume of 1 mL in a 
solution of resuspension buffer. A GBC Cintra™ spectrophotometer was then used 
to measure the drop in absorbance the addition of 6 µg (corresponding to 3.2x10-10 
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moles) of purified BsPAD enzyme causes to this series of substrate concentrations. 
Absorbance changes where measured over a timeframe of 50-80 s, within a linear 
region of the observed spectra.  Each sample was prepared and measured in 
triplicate. Michaelis Menten kinetics (Vmax, KM and kcat as well as kcat/KM) were 
approximated for the wild type protein and three substrates (p-coumaric-, ferulic- and 
caffeic acids) using Beer’s law and the equations described in section chapter 2, 
section 2.6.1. Phloretic acid, which lacks carbon chain structures essential for its 
conversion by BsPAD, served as a negative control and was tested at a concentration 
of 50-400 µM. The same assay was carried out for each mutant and ferulic acid as a 
substrate. Michaelis Menten kinetics determined for the wild type protein varied by 
several orders of magnitude from literature reference values. This was found to be a 
consequence of signal saturation at higher substrate concentrations and led to 
abandonment of any further spectrophotometric assays. 
Phloretic acid was additionally tested as a potential inhibitor of BsPAD. For this, the 
effect of increasing concentrations of phloretic acid on a decarboxylation reaction 
was shown. In the first set of measurements, decarboxylation in a 125 µM 
p-coumaric acid solution was compared to reactions containing 125 µM p-coumaric 
and 0, 125 or 250 µM phloretic acid. Measurements were performed as described 
above. For the second set, decarboxylation in a 200 µM p-coumaric acid solution was 
compared to the same reaction in solutions containing 200 µM p-coumaric acid and 
0, 200 or 400 µM phloretic acid.  
 
3.2.3.2 HPLC analysis 
 
As an alternative to UV spectroscopy, a HPLC assay was developed which allowed 
for qualitative and semi-quantitative observation of substrate degradation and 
product formation by the BsPADwt and the active site mutant proteins. Enzyme 
reaction samples were prepared by incubating 6 µg (3.5x10-10 moles) of purified 
protein in 1 mL of buffer containing 1 mM ferulic acid. The same assay was also 
carried out using BsPADwt as well as the weakly active mutants Tyr11Phe, 
Tyr13Phe, Tyr19Ala and Thr98Ala and a substrate concentration range of 
0.25 - 2.5 mM ferulic acid. Enzyme-free buffer solution with ferulic acid was used as 
a negative control and furthermore served in the preparation of a substrate calibration 
curve. 
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After 6 h of incubation at 30°C in a waterbath, 500 µL of ethyl acetate were added to 
500 µL of each enzyme reaction and centrifugation at 14,000 rpm for 2 min 
separated aqueous and organic phases. The latter was retrieved and evaporated 
overnight to obtain decarboxylated product and non-converted substrate. Prior to 
running, samples were re-dissolved in 50% methanol. HPLC analysis was carried out 
on a Waters Alliance® high performance liquid chromatograph, using a SunFire™ 
C18 column (internal diameter 4.6 x 250 mm, 5 µm particle size) at a temperature of 
25°C and a flow rate of 1 mL/min. Running conditions were optimized using 
substrate and product standards to achieve optimal separation of peaks. Calibration 
and protein reaction samples were then eluted in an isocratic flow of 50% solvent A 
(water) and 50% solvent B (methanol + 0.1% acetic acid). Samples were injected in 
50 µL aliquots, each prepared and run in duplicate. Peaks were then detected at a 
wavelength range from 210-400 nm and evaluated using the Empower™ 3 
chromatography data software. Peak areas of ferulic acid and vinyl guaiacol were 
determined at 280 nm and compared to the standard curves for quantitative analysis.  
 
3.2.3.3 GC analysis 
 
The HPLC analysis described above provided data on comparative activity between 
the wild type and mutant BsPAD enzymes. Due to solubility problems at substrate 
concentrations exceeding 2.5 mM however, no Michaelis Menten kinetics could be 
determined. This problem was overcome by optimising the ferulic acid stock 
preparation with the kind help of Dr Aashrita Rajagopalan from the University of 
Graz.  Solubility was maintained into concentrations exceeding 10 mM by adjusting 
the buffer solution’s pH while solubilising the acidic substrate. In addition, repeated 
sonication of the solution in a waterbath was required during the solubilisation 
process.  
After this optimisation of substrate solubility, a GC based assay was developed to 
determine full Michaelis Menten kinetics for the wild type and a subset of weakly 
active mutant proteins (Tyr11Phe, Tyr13Phe and Tyr19Ala). For preparation of 
product standards, a 0.5-10 mM concentration range of 3-methoxy-4-vinyl-phenol 
was prepared in ethyl acetate and injected onto a HP5 column using a HP-6890 gas 
chromatograph from Agilent. Helium was used as a carrier gas, the detector 
temperature was set to 320 °C. For the column, a temperature gradient from 90-
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180 °C was applied at a rate of 3 °C per minute and peak areas were measured for 8 
different substrate concentration standards. As previous GC experiments had shown 
the presence of product peaks in ferulic acid standards, the injector temperature was 
lowered to 165 °C. When testing a 10 mM ferulic acid control sample under the 
conditions described above, this did not yield a significant product peak. For 
determination of enzyme kinetics, purified protein was added to 1.0 mL of buffer 
containing 0.5 – 10.0 mM ferulic acid and the samples were incubated without 
shaking at 30 °C. The amount of protein added to the reaction samples had to be 
optimised for detection and varied between wild type and mutant BsPAD, ranging 
from 0.3 µg (1.6 x 10-11 moles, BsPADwt) to 3 µg (1.6 x 10-10 moles, BsPADTyr19Ala) 
and 6 µg (3.2 x 10-11  moles, BsPADTyr11Phe and BsPADTyr13Phe). The reaction was 
stopped after 20 min after which substrate and product could be extracted twice in 
500 µL of ethyl acetate. The combined samples could be injected onto a HP5 GC 
column using the method outlined above. Each reaction was performed in duplicate 
to obtain statistically significant results. Using the previously prepared standards, 
initial reaction velocities (V0) could eventually be plotted against substrate 
concentrations. The Michaelis constant and maximum reaction velocity Vmax were 
approximated and kcat values could be determined subsequently as described in 
section chapter 2, section 2.5.1.  
 
 
3.3 Results 
 
3.3.1 Production and purification of wild type BsPAD 
 
The wild type BsPAD protein could be produced recombinantly in an E. coli 
BL21(DE3) expression strain and was purified to high homogeneity. A litre of 
culture routinely yielded approximately 35 mg of protein after two purification steps. 
The sharp elution peak resulting from increased concentrations of imidazole during 
Ni2+-affinity chromatography indicates that the protein carried the desired hexa-
histidine tag. Elution of BsPAD in low imidazole buffer after his-tag cleavage also 
indicated that the N-terminal HRV-3C protease recognition site was intact and 
allowed for removal of the small peptide tag with high precision. Visualisation of 
purified BsPAD protein on a denaturing SDS PAGE gel confirmed the purity 
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previously suggested by elution of a single peak during size exclusion 
chromatography. The elution volume during gel filtration as well as the protein 
band’s position on a gel corresponded to a molecular weight of approximately 
40 kDa (dimer in solution) and 20 kDa (monomer) respectively (see Fig. 3.5). This is 
in accordance with the expected literature values (18). The purified protein 
preparations were stable at 4 °C for several days, protein frozen in liquid nitrogen 
retained activity over many months. From the latter, BsPAD kinetic properties could 
thus be analysed with respect to substrate degradation and product formation.  
 
3.3.2 Preparation of a BsPAD mutant library 
 
Using site-directed mutagenesis, eight active site BsPAD mutants were prepared. 
These included seven single mutants (Tyr11Phe, Tyr13Phe, Tyr19Ala, Arg41Ala, 
Glu64Ala, Thr68Val and Thr98Val) as well as one double mutant 
(Tyr11Phe/Tyr13Phe). Sequencing of the mutant YSBLIC:BsPAD plasmids 
confirmed the successful introduction of each of the listed amino acid alterations 
without the appearance of other, undesired, mutations (see Fig. 3.6).  
 
3.3.3 Production and purification of a BsPAD mutant library 
 
After confirmation of the desired mutation by sequencing, all mutant genes were 
expressed and translated into soluble protein in a similar way to the wild type 
protein. No significant BsPAD inclusion bodies were observed on SDS PAGE gels 
(see Fig. 3.5). Within the library, protein production levels varied but were generally 
slightly reduced compared to the wild type PAD enzyme.   
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Figure 3.5: BsPADwt protein was purified by Ni2+-affinity (a) and size-exclusion 
chromatography (b). The protein elutes from a size-exclusion column in a single peak which 
does not show any major impurities on an SDS PAGE gel. The protein’s molecular weight of 
approximately 22 kDa (b-I) is reduced to 19 kDa after removal of the hexa-histidine tag 
(b-II). 
 
 
 
 
Figure 3.6: A sequence alignment between the Tyr11Phe/Tyr13Phe mutant (top line) and the 
BsPADwt protein (bottom line) shows the site-specific introduction of mutations into the 
active site.  
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Figure 3.7: All mutant BsPAD genes were expressed and translated into soluble protein. 
Size-exclusion chromatograms and SDS PAGE gels of BsPAD Thr68Val and Tyr19Ala 
mutants are shown to represent proteins with conservative and non-conservative mutations 
respectively.  
 
3.3.4 Analysis of enzyme kinetics 
 
3.3.4.1 Spectrophotometric analysis of BsPAD wild type and active site mutants  
 
To observe decarboxylation of ferulic, p-coumaric and caffeic acid by BsPAD, a 
spectrophotometric assay was developed previously (142). The assay makes use of 
the drop in absorbance at 310 nm between the phenolic acid substrate and its 
decarboxylated styrene derivative products. When a concentration range of 5-180 or 
5-450 µM of substrate was measured for ferulic as well as p-coumaric and caffeic 
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acid respectively, apparent Michaelis-Menten kinetics were observed for the wild 
type protein. In addition, decarboxylation could be observed for the Tyr19Ala mutant 
(see Fig. 3.8 d).  
 
Figure 3.8: Concentration dependent decarboxylation could be observed for BsPADwt protein 
and ferulic acid, p-coumaric acid and caffeic acid substrates (a-c). Of the mutant library, 
only the Tyr19Ala mutant showed activity, albeit at a significantly reduced level compared 
to the wild type protein (d). The BsPADwt decarboxylation of caffeic acid and the Tyr19Ala 
mutant’s reaction with ferulic acid appear to be subject to substrate inhibition (red data 
points).  
 
On plotting concentration dependent reaction velocities for the BsPADwt reaction, 
Vmax, KM and kcat values of 3.5 x 10-10 moles/s, 35 µM and 1.0 s-1 were estimated for 
the ferulic acid substrate, 1.5 x 10-9 moles/s, 180 µM, 4.3 s-1 for p-coumaric acid and 
1.8 x 10-11 moles/s, 25 µM and 0.05 s-1 for caffeic acid. For the latter, a steep drop in 
reaction rates was observed at concentrations above 60 µM, indicating the presence 
of substrate inhibition. Kinetic constants estimated for the active site mutant, 
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BsPADTyr19Ala, showed a significantly decreased maximum velocity and turnover 
numbers as well as an increased Michaelis constant of 3.3 x 10-11 moles/s, 0.10 s-1 
and 20 µM respectively. No activity could be observed for any other mutant within 
the course of the assay. The reaction constants for the BsPAD wild type protein 
differed significantly from previously published literature values (18). On closer 
inspection of the absorbance values, especially for ferulic acid, it was observed 
however that concentrations > 80-100 µg/mL led to signal saturation at the given 
wavelength of 310 nm. This makes measurements in this area unreliable (as can be 
seen from the high standard deviations in figure 3.8 c and d).  
Phloretic acid is very similar in structure to p-coumaric acid but lacks the carbon 
chain structures suggested to be essential for its conversion by BsPAD, namely a 
conjugated carbon chain essential for the catalytic electron relay (see Fig. 3.9). The 
molecule is thus not expected to be decarboxylated by the enzyme, could however 
act as a possible inhibitor that might block the BsPAD active site. However, no clear 
competitive inhibition could be observed when the molecule was assayed against 
ferulic or p-coumaric acid (see Fig. 3.9).   
     
Figure 3.9: When tested as a potential inhibitor, phloretic acid (right) did not appear to 
compete for the enzyme’s active site with the p-coumaric acid substrate. The 
substrate : inhibitor ratios are shown above each data point. 
 
3.3.4.2 HPLC analysis 
 
To overcome the limitations of signal saturation observed in spectrophotometric 
assays, a HPLC-based assay was developed. While the overall concentration range 
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was still limited, this assay allowed for the qualitative and semi-quantitative 
comparison of decarboxylation by wild type and mutant enzymes.  
 
 
Figure 3.10: A HPLC peak chromatogram shows ferulic acid degradation and vinyl guaiacol 
formation by BsPADwt, proteins of the active site mutant library and an enzyme free reaction serving 
as a negative control (top). The experiment allowed for qualitative and semi-quantitative evaluation of 
decarboxylation of ferulic acid into vinyl guaiacol (bottom image, green and blue bars respectively). 
The numbers on top of each column represent substrate turnover/product formation relative to the 
wild type protein in per cent (%).  
 
When comparing catalysis at a fixed concentration of ferulic acid (1 mM) and after a 
reaction time of six hours, all substrate was converted by BsPADwt. The 3-methoxy-
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4-vinylphenol product peak was observed after an expected retention time of 
15.5 min. The negative control (enzyme free reaction) presented a peak for the non-
converted substrate after a retention time of 5.2-6.5 min, depending on the 
experimental setup. Both correspond to standards run in advance of the reaction 
samples (results not shown).  The Thr68Val and Thr98Ala mutants also retained high 
activity levels, with an apparent product formation above 50% compared to the wild 
type protein. Alterations of the three tyrosine residues in positions 11, 13 and 19 led 
to a significant reduction in enzymatic activity with 16, 24 and 31% respectively of 
substrate being converted within the course of the assay. The Arg41Ala and 
Glu64Ala single mutants as well as the Tyr11Phe,Tyr13Phe double mutant did not 
yield any detectable formation of the vinyl guaiacol product.  
 
Figure 3.11: Initial attempts were made to determine kinetic constants for the 
decarboxylation of ferulic acid by BsPADwt and mutant enzymes. Only the Tyr11Phe, 
Tyr13Phe and Tyr19Ala mutants approach maximum velocities within the concentration 
range assayed.  The Thr98Ala variant and wild type protein show a linear relationship 
between substrate concentration and substrate consumption (! c ferulic acid).  
 
On analysing ferulic acid concentration dependent decarboxylation by BsPADwt and 
the weakly active mutants Tyr11Phe, Tyr13Phe, Tyr19Ala and Thr98Ala, only the 
first two mutants approach saturating concentrations. The wild type protein and other 
active site mutants however show a linear range of substrate turnover/product 
formation for the concentrations assayed. Their data did thus not allow for the 
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determination of Michaelis constants. Catalytic rate and efficiency could not be 
determined with the available data as the assay time of six hours exceeds the linear 
range of product formation.  
 
3.3.4.3 GC analysis 
 
To obtain quantitative data and, eventually, rate constants for the decarboxylation of 
ferulic acid by BsPADwt and three of the weakly active mutant enzymes, the 
experimental set-up was optimised and samples adapted for analysis by gas 
chromatography. The initial limitations of substrate concentration were overcome by 
adapting the solution’s pH and repeated sonication during the solubilisation process. 
With this method, solutions exceeding concentrations of 10 mM ferulic acid were 
easily prepared. In addition, the initial reaction pH remained equal for all samples 
analysed.  
The GC method developed allowed for detection of the vinyl guaiacol product with a 
retention time of approximately 9.6 min, corresponding to a column temperature of 
approximately 120 °C. When a concentration range from 0.5 – 10 mM of the styrene 
product was assayed, a linear calibration curve could be prepared from the resulting 
peak areas (see Fig. 3.12, inlet). In initial experiments, inlet temperatures of 250 °C 
were shown to degrade ferulic acid into vinyl guaiacol on entering the 
chromatography column. A control reaction with 10 mM ferulic acid was thus run to 
exclude such signal interference from residual substrate in reaction samples. With a 
reduced inlet temperature of 165°C, no product peak could be detected at the 
corresponding retention time.  
For enzyme reaction samples, product formation was analysed after 20 min. This 
allowed for the determination of reaction rates V0 within a time frame corresponding 
to linear product formation, see Fig. 3.12. Reaction rates of ferulic acid-
concentration dependent vinyl guaiacol formation were then plotted, allowing for the 
estimation of reaction constants Vmax and KM. From these, the turnover number kcat 
and catalytic efficiency values (kcat/KM) could be determined for the wild type as well 
as the assayed mutant enzymes and are listed in table 3.3. Due to the lack of data 
points at substrate concentrations below 0.5 and 2.5 mM (for wild type and mutant 
enzymes respectively) the increase in initial reaction velocity may in fact be steeper 
and the Michaelis constants lower than the approximated values.    
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BsPAD variant Vmax [moles/s/µg] KM [mM] kcat [s-1] kcat / KM [s-1/M] 
Wild type 6.8E-10 < 4.5 4.3 9.6 x 103 
Tyr11Phe 1.1E-10 < 1.0 0.35 3.5 x 102 
Tyr13Phe 9.7E-11 < 1.0 0.31 3.1 x 102 
Tyr19Phe 1.5E-10 < 0.75 0.95 1.3 x 103 
 
Figure 3.12/Table 3.3: : Kinetic constants of ferulic acid decarboxylation were estimated for 
the BsPADwt protein and three of its active site mutants within a period of linear activity (20 
min, top graph, inlet). After extraction of the substrate and product into ethyl acetate, 
measurements were taken using an optimised gas chromatography assay. Vinyl guaiacol 
peaks observed at a column temperature of 120 °C were quantitated using a previously 
prepared standard curve. The mutant activities are also depicted individually (bottom graph).   
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The BsPADwt protein shows the highest reaction velocity with an estimated Vmax of 
2.3 x 10-6 moles/s/µg (where Vmax units were normalised for protein concentration as 
the amount of enzyme added to the reactions varied between wild type and mutant 
assays). With 4.5 mM, the Michaelis constant is equally the highest of all the 
variants tested. The turnover number of wild type protein amounts to 4.3 x 104 s-1 
while the kcat/KM value is 9.6 x 106 s-1/M. Replacing a tyrosine in position 19 with an 
alanine led to a 4-fold reduction in the enzyme’s kcat value when compared to the 
wild type protein, as well as a 9-fold reduced Michaelis constant. The mutation of 
tyrosine in position 11 and 13 to phenylalanine had a comparable effect on both 
mutants and led to the strongest reduction in activity of all enzymes assayed. The 
catalytic turnover number was reduced by a factor of 10 when compared to BsPADwt 
and was accompanied by a 4-fold decrease in KM.  
 
 
3.4 Discussion  
 
The microbial decarboxylation of phenolic acids has long been of interest for 
biotechnological applications. Many of the enzymes known to catalyse this reaction 
have thus been identified, isolated and characterised from prokaryotic and eukaryotic 
sources. Previous kinetic studies on mutant PAD enzymes and deuterium exchange 
experiments, as well as structural information from unrelated proteins with similar 
substrate spectra, have allowed for the proposal of several mechanisms. Except for 
one substrate analogue complex however, a ligand-bound structure of PAD enzymes 
remained elusive and the suggested mechanisms awaited structural conformation. 
Despite knowledge of the enzyme’s apo-structure, the phenolic acid decarboxylase 
from Bacillus subtilis, BsPAD, previously lacked kinetic as well as structural 
information on ligand binding. The aim of this project was thus to provide both. A 
mutant library of previously proposed catalytic residues was prepared and the 
mutations’ effects on catalysis assayed. It was thus hoped to create a weakly active 
PAD enzyme and solve its structure with a substrate, intermediate or product 
molecule “trapped” in the active site.   
 
Each of the mutations introduced to the BsPAD active site affected catalysis, 
however to varying degrees. The first two alterations analysed were the mutation of a 
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Tyr11 and Tyr13 to phenylalanine. In enzymes such as the vanillyl alcohol oxidase 
(VAO) from Penicillium simplicissium hydroxycinnamate and the hydratase-lyase 
(HCHL) from Pseudomonas fluorescens, ligand bound structures have shown their 
substrates’ phenolic hydroxyls to be coordinated by tyrosine pairs during enzymatic 
catalysis (136,139). In contrast to this, models of ligand binding in a high-resolution 
apo-structure as well as mutagenic studies of the Lactobacillus plantarum PAD 
enzyme (LpPAD) suggested the two tyrosines to form hydrogen bonds to the 
phenolic acid’s carboxylate. They could thus stabilise the CO2 leaving group. In 
either position, both residues could be important determinants of substrate binding 
and specificity (see Fig. 3.13). The change from tyrosine to phenylalanine is 
conservative and replaces the wild type side chain with a side chain of similar size. 
The effect on protein folding was thus expected to be minimal and the mutant gene 
sequences were translated into soluble proteins. The mutation does however remove 
the side-chain’s hydroxyl group and thus its ability to form potential hydrogen bonds 
with a substrate. When analysed by UV-VIS spectroscopy, no substrate conversion 
could be observed within the course of the assay, indicating that the mutants would 
be either inactive or catalysis was reduced to a level too low to be observed with this 
method. The latter was shown to be the case using HPLC based analysis of ferulic 
acid decarboxylation. After a period of six hours, only small amounts of substrate 
could be converted by either of the two mutants. When kinetic constants were 
determined, turnover numbers were significantly reduced compared to the wild type 
enzyme which corresponds to previous findings for the LpPAD protein. All three 
experiments thus indicate an importance for both residues, Tyr11 and Tyr13, in 
catalysis. Although, when compared to the wild type, the reduced Michaelis constant 
may be an indicator of tighter substrate binding, this value has to be seen in context 
of the overall reduced activity and catalytic efficiency (kcat/ KM). The hydrogen 
bonding functions of both tyrosine side chains are thus likely to be involved in 
substrate binding and important for overall catalysis.  
 
Each individual residue is however not absolutely essential to catalysis as the lack of 
one hydrogen bond donor only reduces the overall reaction rate. Removal of both, as 
it was shown with the Tyr11Phe/Tyr13Phe double mutant, completely abolishes 
catalytic activity.  In neither UV-spectrophotometric nor HPLC based assays, i.e. 
short or long term analysis of substrate turnover, could any ferulic acid 
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decarboxylation be observed. It is thus likely that, upon substrate binding, the 
phenolic acid is recognised and bound to the active site by way of hydrogen bond 
formation to Tyr11 and Tyr13. The lack of one side chain may, to some degree, be 
compensated for by the binding abilities of the other. Lack of both renders the 
protein completely inactive. Which part of the phenolic acid substrate is bound by 
the two tyrosine residues cannot be defined by kinetic data alone and requires the 
presence of structural data which will be discussed in chapter 4. 
 
Figure  3.13: Whereas the unrelated but mechanistically similar enzymes VAO and HCHL (a 
and b) suggest a role for a role Tyr11 and Tyr13 in substrate binding at the para-hydroxyl 
group, modelling of the phenolic acid ligand into an LpPAD structure has implied an 
important function in recognition and binding of the carboxylate moiety (d). In contrast to 
both proposals, a mechanism independent of either tyrosine residue has been suggested 
based on the complex structure of an Enterobacter PAD enzyme (c) [adapted from 
(60,134,136,139)]. 
  
A further tyrosine side chain in close proximity to positions 11 and 13 is Tyr19. 
When the apo-structure of a phenolic acid decarboxylase from Lactobacillus 
plantarum (LpPAD) was solved, the authors modelled a p-coumaric acid molecule 
into the enzyme’s active site (60). The LpPAD Tyr26 side chain, which is equivalent 
to BsPAD Tyr19, was found to be part of a hydrophobic pocket surrounding the 
central, non-polar core of the phenolic acid substrate. This pocket is thought to 
contribute to substrate binding and specificity by forming a confined space for the 
aromatic ring and aliphatic side-chain. When Tyr19 is replaced by an alanine in 
BsPAD, catalysis is reduced, albeit at lower levels than for the Tyr11 and Tyr13 
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mutants described above. Turnover can still be observed in real-time experiments 
such as UV-VIS spectroscopy. The Tyr19 equivalent in LpPAD has previously been 
suggested to be part of a flexible loop involved in restricting access to the enzyme’s 
active site (60). The reduced turnover and catalytic efficiency of the mutant could 
thus be explained by the enzyme’s altered efficiency in switching between open and 
closed active site conformations. Both substrate access and release would be 
impaired. Alternatively, as Tyr19 only constitutes a small part of this loop and the 
effect of its mutation on catalysis is considerable, the residue may interact with 
substrate or solvent. This possibility has to be analysed in the context of a ligand 
complex structure and is discussed in chapter 4. A third function of this residue, 
proposed for the conserved equivalent in EPAD, could be the fixation of the 
substrate’s carboxylate moiety by hydrogen bonding. In view of the significant 
residual activity observed however, this role can more likely be assigned to 
alternative residues, such as Tyr11 and or Tyr13, as described above.  
 
For decarboxylation to be initiated, the para-hydroxyl group’s proton has to be 
removed by a catalytic acid. A side-chain able to fulfil this function would have to be 
positioned at one end of the active site pocket (which end cannot be defined for 
certain in the absence of a ligand complex). Based again on both apo-structure and 
modelling of the ligand complex (60) however, the residue most likely to act as the 
catalytic acid was proposed to be a glutamate in position 64 (see Fig. 3.14). Mutation 
of this amino acid to alanine renders the mutant protein completely inactive, 
supporting its function as one of the main catalytic residues. A similar mechanism 
was proposed for the EPAD protein. The catalytic residue assigned to this step 
however (Glu134), differs significantly from the findings for BsPAD described here 
and for LpPAD (60). 
 
For catalysis to be initiated by deprotonation, the Glu64 side chain has to be 
deprotonated and hence negatively charged in the absence of a ligand. Furthermore, 
the phenolic acid’s para-quinone methide intermediate will be negatively charged 
after its deprotonation. This surplus of free electrons (negative charge) is 
energetically unfavourable and requires stabilisation by a positively charged active 
site residue (see Fig. 3.14). Based on the BsPAD apo-structure, the substrate-binding 
model for the LpPAD homologue and, again, a similar function in the non-related 
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VAO and HCHL enzymes (60,136,139), this stabiliser is most likely an arginine in 
position 41. In accordance with this proposed function as well as kinetic data from a 
comparable LpPAD mutant, replacement of Arg41 with an alanine residue abolishes 
all catalytic activity in the enzyme. The stabilisation of high-energy intermediates 
and thus reduction of activation energy for a chemical reaction is the key feature of 
enzyme-based catalysis (143). Loss of a stabilising side chain such as arginine 
should thus return reaction rates close to those of a non-catalysed decarboxylation 
reaction. The latter would not be detectable within the course of the assays described. 
Again, the assignment of catalytic residues described here differs compared to the 
previously proposed EPAD mechanism in which an asparagine (Asn23) and a water 
molecule have been suggested to create an appropriate polar environment for 
deprotonation (134). 
Both Arg41Ala and Glu64Ala are non-conservative mutations. Replacement of the 
charged, extended side chains with the short, non-polar alanine could lead to 
disruptions in protein folding. Both proteins were however predominantly produced 
in their soluble form by the E. coli host, the Glu64Ala mutant also crystallised under 
varying conditions (see chapter 4). It was thus assumed that the observed changes in 
catalytic activity are more likely the consequence of a lack in catalytic residues 
rather than partially or misfolded mutant proteins.  
 
Figure 3.14: Modelling of a PA ligand into the LpPAD active site as well as previous 
mutagenesis experiments have suggested an importance for the highly conserved BsPAD 
Glu64 and Arg41 side chains in deprotonation of the phenolic hydroxyl and stabilisation of 
negative charges respectively (a). For the latter residue, similar observations of charge 
stabilisation have been made in the unrelated VAO and HCHL enzymes (b) [adapted from 
(60,136,139)].  
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When preparing the active site mutant library, the last two residues altered (from N- 
to C-terminus) where two threonines in position 68 and 98. Whereas the former 
underwent a conservative substitution to valine, the latter was changed to an alanine. 
In previous literature on LpPAD, Thr68 (or rather its respective counterpart in the 
homologous enzyme) had been suggested to coordinate a water molecule and 
constitute part of a large polar network surrounding the substrate’s hydroxyl group 
(60). The water molecule could serve as a proton donor during formation of the 
para-quinone methide intermediate and would thus be essential for catalysis to 
progress from the kinetically unfavourable intermediate to the decarboxylated 
styrene product. A similar step, without the assignment of an activating or 
coordinating amino acid residue, has been proposed for catalysis by the EPAD 
homologue. The change of Thr68 to a valine should replace the former with a 
sterically similar side-chain. As it lacks a hydroxyl group at the C8 carbon however, 
the valine side chain is non-polar. This property change reduces the mutant’s 
catalytic activity and makes the residue a potential candidate for coordination of the 
catalytic water through polar interactions, as described above. As considerable 
residual activity is observed however, Thr68 could not be the only coordinating 
residue for this water. Its replacement by a non-polar side chain must thus be 
compensated for by another coordinating residue. Alternatively, activity of the valine 
mutant could be an indicator that another amino acid, rather than the catalytic water, 
acts as a proton donor to the C8 carbon. During preparation of the mutant library, 
preliminary, low resolution structural data became available for one of the mutant 
proteins, BsPAD Tyr19Ala (see chapter 4). A highly conserved threonine in position 
98 was found to be positioned in close proximity to an area of unmodelled electron 
density. As the latter was thought to represent a molecule of p-coumaric acid, Thr98 
was suggested to be of potential catalytic importance. When the residue was replaced 
non-conservatively with an alanine however, activity levels remained close to those 
of the wild type protein, as could be seen from the long-term, HPLC based 
decarboxylation assay.  It is thus likely that, despite its proximity to the substrate, 
Thr98 does not fulfil a significant catalytic function. 
 
In summary, the mutant library prepared gave a first insight into the functional 
importance of various BsPAD active site residues. Two tyrosines in position 11 and 
13 are likely to be important for substrate recognition and binding. Whereas the lack 
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of one can be compensated for by the other, a double mutant is catalytically inactive. 
A third tyrosine in position 19 is less essential to catalysis itself, may however 
constitute part of a flexible loop which is involved in restricting access to the 
enzyme’s active site. Alternatively, the residue may have other functions which are 
less obvious in the absence of structural data. Mutations in two of the amino acid 
residues completely abolish all enzymatic activity, supporting their proposed 
functions in catalysis. Arg41 is thought to be essential in stabilising negative charges 
arising from formation of the para-quinone methide intermediate. A glutamate in 
position 64 is the most likely catalytic acid/base and thought to remove a proton from 
the para-hydroxyl group – thus initiating catalysis. Thr68 may be important, albeit 
not essential, in the coordination of a catalytic water. The latter could in turn 
protonate the kinetically unfavourable intermediate and allow for formation of the 
styrene product. As for Tyr19, confirmation of this function requires structural data 
in addition to the kinetic information presented above. 
The findings presented herein coincide and/or agree with kinetic and structural data 
presented previously for the Lactobacillus plantarum PAD protein (60). In contrast 
to this, the residues assigned to key functions in substrate binding and catalysis, 
differ signicantly from those proposed for the Enterobacter homologue EPAD (134). 
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Chapter 4:  Structure determination of a BsPAD mutant in complex with 
p-coumaric acid 
 
 
4.1 Introduction 
 
4.1.1 Structures of phenolic acid decarboxylases 
 
To date, the three-dimensional structures of four bacterial phenolic acid 
decarboxylases have been determined. These include the PAD enzymes from 
Lactobacillus plantarum (LpPAD), Enterobacter species Px6-4 (EPAD), Bacillus 
subtilis (BsPAD) and Bacillus pumilus (BpPAD) (60,134,144). Their coordinates 
have been deposited in the protein data bank (PDB) with the accession codes 2GC9, 
3NX1, 2P8G and 3NAD respectively. All proteins show high degrees of sequence 
conservation and are equally well conserved in their secondary, tertiary and 
quarternary structures (see Figures 4.1 – 4.3).  
The most significant feature of all phenolic acid decarboxylases is their common 
core of two sheets of five anti-parallel !-strands which assemble into an orthogonal 
!-sandwich. The latter is a common tertiary structure in enzymes and characterised 
by the spatial arrangement of the !-sheets into a flattened “sandwich-like” structure. 
As with the classical !-barrel, the last !-sheet (from N- to C-terminus) forms a 
network of backbone hydrogen bonds to the first, creating a stable and rigid pore like 
structure. !-barrels and sandwiches are often characterised by alternating polar and 
non-polar amino acids in the primary protein sequence. As a consequence of the !-
sheet architecture, in which the amino acid side chains alternately face opposite 
directions, this allows for an overall structure of a hydrophilic core and a non-polar 
frame or vice versa. The former is particularly common in membrane proteins 
integrated into the cellular lipid bilayer. For cytosolic !-barrel proteins and PAD 
enzymes acting on small, hydrophobic substrates, a polar “wall” protecting a non-
polar core and active site is commonly found (60,134,145).  
In their three-dimensional structure, PAD enzymes show significant similarities to 
members of the lipocalin family (which are made up of four-stranded, anti-parallel !-
sheets (144,146)) and the fatty acid binding proteins or FABPs (which show the PAD 
like arrangement of five-stranded anti-parallel !-sheets) (60,147). Both enzyme 
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families are known to bind small hydrophobic ligands and show extended flexible 
loops between the first two !-sheets of their core structure. These loops are involved 
in restricting access to the active site and are also common (in position and function) 
to the characterised PAD enzymes (60,144,146).  
 
Figure 4.1: PAD enzymes show strong similarities in secondary and tertiary structure to 
members of the FABP and lipocalin protein families.  Their !-sheet core structure arranges 
into an orthogonal !-sandwich, as shown for LpPAD, in which the most N-terminal and C-
terminal !-sheets can hydrogen bond to form a continuous, flat barrel.   For the lipocalin and 
FABP fold only the core structures are shown, missing N- and C-terminal elements are 
represented as dashed lines.  The flexible loop in control of active site accessibility is 
highlighted in bold for each protein [adapted from (60,146)].   
 
The PAD active sites vary in size. Whereas the LpPAD protein shows a narrow 
binding cavity with solvent accessible volume only slightly above the estimated 
volume of the ligand, the EPAD enzyme presents a significantly larger pocket. A 
feature all proteins share however is a reduction in the active site’s accessible 
volume when the proteins’ change from their “open” into a “closed” and (most 
likely) ligand bound state (60,134).  
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As described above, the active site of PAD proteins comprises a hydrophobic pocket 
and is thus lined with non-polar residues. The exceptions are a few selected polar 
residues thought to be key players in catalysis. They are stabilised inherently through 
the formation of salt bridges and hydrogen bonds. They include, among others, 
glutamate, arginine and threonine side chains (60,134,144).   
 
 BsPAD --------MENFIGSHMIYTYENGWEYEIYIKNDHTIDYRIHSGMVAGRWVRDQEVNIVK 52 
 BpPAD --------MDQFIGLHMIYTYENGWEYEIYIKNDHTIDYRIHSGMVGGRWVRDQEVNIVK 52 
 LpPAD -MTKTFKTLDDFLGTHFIYTYDNGWEYEWYAKNDHTVDYRIHGGMVAGRWVTDQKADIVM 59 
 EPAD  MNTFDKHDLSGFVGKHLVYTYDNGWNYEIYVKNDNTIDYRIHSGLVGNRWVKDQEAYIVR 60 
 :. *:* *::***:***:** * ***:*:*****.*:*..*** **:. ** 
 
 BsPAD  LTEGVYKVSWTEPTGTDVSLNFMPNEKRMHGIIFFPKWVHEHPEITVCYQNDHIDLMKES 112 
 BpPAD  LTKGVYKISWTEPTGTDVSLNFMPEEKRMHGVIFFPKWVHERPDITVCYQNDCIDLMKES 112 
 LpPAD  LTEGIYKISWTEPTGTDVALDFMPNEKKLHGTIFFPKWVEEHPEITVTYQNEHIDLMEQS 119 
 EPAD   VGESIYKISWTEPTGTDVSLIVNLGDSLFHGTIFFPRWVMNNPEPTVCFQNDHIPLMNSY 120 
 : :.:**:**********:* .   :. :** ****:** :.*: ** :**: * **:. 
 
 BsPAD  REKYETYPKYVVPEFAEITFLKNEGVDNEEVISKAPYEGMTDDIRAGRL---------- 161 
 BpPAD  REKYETYPKYVVPEFADITYIHHAGVNDETIIAEAPYEGLTDEIRAGRK---------- 161 
 LpPAD  REKYATYPKLVVPEFANITYMGDAGQNNEDVISEAPYKEMPNDIRNGKYFDQNYHRLNK 178 
 EPAD   REAGPAYPTEVIDEFATITFVRDCGANNESVIACAASE-LPKNFPDNLK---------- 168 
 **   :**. *: *** **:: . * ::* :*: *. : :..::  . 
         
 
Figure 4.2: All PADs show a high degree of sequence conservation, particularly throughout 
their N-terminal amino acid residues. An alignment using the CLUSTAL( algorithm is 
shown, highlighting fully conserved residues in green (*), conservation of strongly similar 
properties in blue [:] and conservation of weakly similar properties in coral (.) (148)   
 
All bacterial phenolic acid decarboxylases characterised to date associate into 
homodimers in solution. When determining and analysing the LpPAD apo-structure, 
Rodriguez et al. discovered a so-called “hydrophobic zipper” at the interface 
between the two dimers. This zipper is characterised by polar residues at the core and 
hydrophobic residues at the edges of the subunit interface. Based on the high 
sequence conservation of the residues involved (60), it was proposed to be highly 
conserved between the PAD proteins. For EPAD, dimerisation appears to have 
additional functional consequences. In contrast to other PADs, the active site of 
which is enclosed within individual monomers, one of the EPAD active sites is 
buried within the dimer interface and thought to be catalytically inactive(134).  
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4.1.2 The BsPAD apo-structure 
 
In 2007, the apo (ligand free) structure of BsPAD was solved by the Joint Centre of 
Structural Genomics (149) and deposited in the protein data bank (PDB) under the 
accession code 2P8G. It shows the two prominent !-sheets described above, arranged 
in an orthogonal sandwich fold. One end of this tunnel-like structure is covered by "-
helices, the other by flexible loops connecting the !-strands (see Fig. 4.3).  
The side chains lining the inside of the !-sandwich are, with few exceptions, 
predominantly hydrophobic. A tail like structure, comprising a long flexible loop and 
an "-helix, lies adjacent to the !-sheets and forms the C-terminal end of the 
polypeptide. In its dimeric state, these termini face opposite each other. The same 
features can be seen in several other members of the PAD family as well as in the 
lipocalin proteins.  
 
Figure 4.3: The three-dimensional structure of BsPAD shows the overall !-sandwich fold 
common to all PAD proteins. The two most N- and C-terminal !-strands (!1 and !10), which 
interact through hydrogen bonding, are highlighted (a). A surface view superposed onto the 
enzyme’s tertiary structure highlights the open entry channel to the putative active site and 
the flexible loop thought to be involved in conformational changes (yellow dashed line) (b). 
A structural superposition of BsPAD with LpPAD, EPAD and BpPAD highlights the enzyme 
family’s similarities. Conserved residues are shown in green, moderately conserved residues 
in yellow and non-conserved amino acids in red. 
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4.1.3 Project aim 
 
The project work described in the following sections was aimed at obtaining the 
three-dimensional structure of a BsPAD protein complexed with either ligand, 
reaction intermediate or product. Although a ligand complex structure has previously 
been published for the EPAD protein (134), its implications on substrate binding and 
catalysis differed from kinetic data and modelling studies of PAD homologues such 
as LpPAD (60). This structural work paralleled and followed the preparation of a 
mutant library, as described in chapter 3. It is based on the assumption that an 
inactive or weakly active mutant, with reduced reaction rates and possibly increased 
binding affinities, could trap sufficient amounts of the molecule of interest in the 
protein’s active site. This could allow for successful co-crystallisation of a complex 
or soaking of the ligand into an apo-crystal.  Structural data on ligand binding was 
then hoped to complement kinetic data for the mutant library and thus give an insight 
into the reaction mechanism and, most importantly, the key catalytic residues. This 
knowledge could, eventually, inspire protein engineering experiments to improve or 
alter BsPAD activity and substrate selectivity.   
 
 
4.2 Materials and Methods 
 
4.2.1 Crystallisation of BsPADwt and mutant proteins 
 
For crystallisation and structure determination by X-ray crystallography, each 
BsPAD protein preparation was purified to high homogeneity as described in 
chapter 3, section 3.2. For the wild type, hexa-histidine-tagged protein, three 
crystallisation screens were then set up in 96 well Swissci MRC™ crystallisation 
plates using the sitting-drop vapour diffusion method. The procedure was repeated 
for non-tagged BsPADwt protein. A Mosquito® automated liquid handling robot 
allowed for mixing of 300 nL of protein solution at a concentration of approximately 
20 mg/mL with an equal amount of crystallisation solution (mother liquor). The 
latter included the Hampton PACT screen as well as the INDEX and Clear Strategy 
Screens (CSS I+II) from Molecular Dimensions™ (150,151). The 24 well CSS I+II 
screen was assayed in duplicate. The screens were differentiated only by the addition 
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of 0.1 M MES buffer at pH 5.6 or 0.1 M Tris buffer at pH 8.0, allowed for individual 
adjustment of the solutions’ pH values. In addition to the apo-protein setup, 
crystallisation screens were carried out with protein in a ferulic acid solution. For 
this, a 500 mM ligand stock was prepared in dimethylsulfoxide (DMSO) and diluted 
to approximately 5 mM final concentration in the protein solution. After incubation 
on ice for 60 min, the solution was centrifuged for 2 min at 13,000 rpm to separate 
precipitated protein. Crystallisation screens were then set up as described above.  
As the CSS screen proved most successful in producing protein crystals for the wild 
type, both in the presence and absence of the ferulic acid, it was used as a standard 
screen for all mutant library proteins. Initial 96 well screens were set up as described 
above for the BsPADwt protein, however without the addition of ligands. Potential 
crystal hits were then scaled up and optimised using the hanging drop vapour 
diffusion method. In 24 well Linbro type crystallisation plates, 1-2 µL of protein 
solution were mixed with 1-2 µL of mother liquor at varying ratios and incubated 
over 1 mL of the mother liquor. For the latter, both pH and precipitant concentration 
were varied in optimisation screens. For the Tyr11Phe mutant, various detergents 
were added to the crystallisation conditions to slow down growth and separate the 
fast forming and clustered crystals. These included ethylene glycol, butane-1,4-diol, 
hexane triol and glycerol and were added to final concentrations of 0-10 % 
(volume/volume). Showing the most promising results, crystal growth of the 
Tyr19Ala mutant was eventually optimised from the CSS C11 condition to the 
following solution: 0.2 M KSCN, 17 % PEG 1000, 17 % PEG 8000 and 0.1 M 
Tris/HCl pH 9.0. At this point, protein at a concentration of 20 mg/mL was incubated 
in the presence of 3.3 mM p-coumaric acid ligand, as described above for the wild 
type, before preparing crystallisation trays. This produced well-diffracting crystals 
for which however no significant (refinable) ligand density could be observed in the 
active site after data collection and processing. As a result, the substrate 
concentration was increased to 15 mM p-coumaric acid in further experiments. 
Obtained crystals were cryoprotected in their crystallisation conditions, with the 
addition of 10 % glycerol as well as 15 mM p-coumaric acid, and vitrified in liquid 
nitrogen for storage and data collection.  
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4.2.2 Data collection and processing 
 
Crystals of wild type and Tyr19Ala mutant proteins were tested for diffraction using 
an in-house X-ray radiation source and a MARRESEARCH MAR345 imaging plate 
detector. Only the Tyr19Ala mutant crystals diffracted perceptibly and were sent off 
for data collection at the Diamond Light Source synchrotron in Didcot. For a crystal 
grown in the presence of 3.3 mM p-coumaric acid, 180° of data were collected on 
beamline I-03, at an oscillation angle of 0.5° and to a resolution of 
2.1 Ångstroms (Å) (hereafter called dataset 3.3).  
A second crystal of the same mutant, grown in the presence of 15 mM p-coumaric 
acid, was used for the collection of a 180° dataset with identical oscillation angles, at 
beamline I24. It is hereafter called dataset 15.0. The second dataset’s resolution 
extended to 2.5 Å, however processing was limited to 3.0 Å as the inclusion of 
higher resolution data lead to a significant loss in overall completeness.  
After collection, all data were auto-processed by the Xia2 data reduction software (at 
Diamond), making use of the XDS, XSCALE and CCP4 program suite (152). For 
dataset 15.0, data was additionally re-processed with XDS (153) and two additional 
datasets of 80 and 180 images were created in attempts to lower the Rmerge values and 
compare qualities of the resulting electron density maps.  
 
4.2.3 Structure solution and refinement 
 
The structure of the ligand bound Tyr19Ala mutant was determined by molecular 
replacement. This was performed using MOLREP of the CCP4 suite of programs 
(154) and a single monomer of wild type protein (PDB accession code 2P8G), 
excluding waters, as a model. The dataset was subjected to 10 cycles of rigid body 
refinement using REFMAC5 (155). 5% of the data were retained to calculate Rfree 
values from an independent test set of randomly chosen reflections. These reflections 
are excluded from subsequent rounds of refinement and the difference between 
R values for working and test set thus serve as an indicator for over-fitting of the 
model to the experimental data. The Tyr19Ala model was then built and adjusted to 
electron density maps using Coot (156) and subsequent cycles of restrained 
refinement by REFMAC5. Library files for the ligand were created using PRODRG 
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(157), modelled into the appropriate electron density and refined at an occupancy of 
1.0. Structure validation was carried out as part of the Coot program suite. 
 
Coordinates for the BsPADTyr19Ala complex structure, obtained from dataset 15.0, 
were deposited with the Protein Data Bank (PDB) and were assigned the accession 
code 4ALB. 
 
 
4.3 Results 
 
4.3.1 Crystallisation of BsPADwt and mutant proteins 
 
After purification of the BsPADwt protein, three crystallisation screens were prepared 
for both hexa-histidine tagged and cleaved protein. Whereas the latter did not 
produce any detectable crystals, all three screens containing the tagged protein 
showed formation of a variety of crystal forms. When crystallisation experiments 
were repeated for the CSS screen and in the presence of ferulic acid substrate 
however, only small and densely clustered, broomstick-shaped crystals were 
observed. As scale-up experiments for this condition did not yield any further crystal 
growth, structural work with the wild type protein was abandoned.   
Having produced the most abundant hits for the wild type protein, the CSS (I+II) 
screen was used exclusively for crystallisation experiments with the BsPAD mutant 
library. With the latter it was hoped to obtain crystals with substrate, intermediate or 
product trapped in the active site of a weakly active or inactive mutant. Three of 
these mutants (Tyr11Phe, Tyr13Phe and Glu64Ala) crystallised within 24 hours, 
forming dense clusters of needles. Scale-up experiments in the presence of ferulic or 
p-coumaric acid and a variety of detergents, added to slow down growth and lead to 
the formation of single crystals, were however unsuccessful. A fourth mutant, 
BsPADTyr19Ala, crystallised significantly slower under 96-well, sitting drop 
conditions, within a time frame of several days to weeks. Eventually however, a 
variety of crystal forms appeared in conditions containing varying concentrations of 
potassium thiocyanate (KSCN) and polyethylene glycol (PEG) of different molecular 
weights. Crystal shapes ranged from needle like structures to plates and elipses. 
Crystal conditions from the CSS screen could then be optimised in 24-well scale up 
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trays to yield reproducible crystals growth of the BsPADTyr19Ala mutant protein 
within 24 hours. In the final conditions, 1.5 µL of protein, at a concentration of 
approximately 20 mg/mL, crystallised when mixed with 1.0 µL of mother liquor 
containing 0.2 M KSCN, 17 % PEG 8K, 17%  PEG 1K and 0.1 M Tris buffer at pH 
9.0, in the presence of either ferulic acid or p-coumaric acid (3-15 mM). The final 
crystals have a clothes peg-like appearance of two closely attached needles forming a 
hollow space between them (see Fig. 4.4).    
 
Figure 4.4: Crystals of the BsPADwt protein and its mutant library (top) formed in the 
presence and/or absence of the ferulic and p-coumaric acid substrate. The Tyr19Ala variant 
crystallised in the presence and absence of two of its substrates, p-coumaric and ferulic acid 
(bottom). 
 
4.3.2 Diffraction properties of BsPAD Tyr19Ala crystals 
 
Of all mutant proteins, only the Tyr19Ala variant formed reproducible, single 
crystals in the presence of its phenolic acid substrates. Prior to data collection at the 
synchrotron, crystals grown in the presence of 3.3 mM ferulic acid were tested using 
an in-house X-ray source and the MAR3 imaging plate detector and yielded good 
diffraction of up to 2.5 Å resolution.  This resolution increased to 2.0 Å when 
crystals were exposed to synchrotron radiation at the Diamond Light Source in 
Oxford (see Fig. 4.5). When a dataset was collected and processed however, the 
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electron density appearing in the difference map of the enzyme’s active site was not 
sufficient to allow for modelling and refinement of a substrate complex (see below). 
As a result, co-crystallisation was repeated with ligand concentrations of 15 mM 
p-coumaric acid and produced crystals of similar appearance. Their diffraction 
quality was however inferior to those grown at lower substrate concentrations and 
did not exceed 3.5 Å when tested in-house. At the synchrotron, this resolution was 
improved however and a second dataset was collected to a resolution of 2.5 Å (see 
Fig. 4.5 and table 4.1).  
 
Figure 4.5: X-ray diffraction data was collected for the BsPADTyr19Ala mutant crystallised in 
the presence of 3.3 mM (a) and 15.0 mM (b) at the Diamond Light Source synchrotron in 
Didcot.  
 
 
4.3.3 Data collection, processing and refinement 
 
At the Diamond Light Source synchrotron, 180° of data (360 images at an oscillation 
angle of 0.5°) were collected for dataset 3.3 and 15.0. Both crystals indexed and 
processed in space group P3221, with dataset 3.3 showing signs of twinning in its 
cumulative intensity distribution. With the chosen data collection strategy the 
resulting multiplicity was high (11, see table 4.1). This was intentional and aimed at 
obtaining the most optimal information on ligand binding. 
Data processing was carried out using the Xia2 automated data reduction system 
(152) and repeated manually using XDS for dataset 15.0 (153). For the latter, a 3.0 Å 
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resolution cut-off was applied during all processing procedures as higher resolution 
data was of significantly inferior quality. The manually processed 15.0 data set was 
then used in particular for the preparation of datasets with reduced multiplicity. 
These were aimed at lowering the high Rmerge values observed after Xia2 processing. 
Data reduction led to a decrease in Rmerge from 83% to 77% and 52% in the highest 
resolution shell for datasets of 360, 180 and 80 images respectively. However, the 
signal to noise ratios (I/)I) decreased (see table 4.2) and the maps deteriorated 
significantly.  
 
 BsPAD Tyr19Ala dataset 3.3 BsPAD Tyr19Ala dataset 15.0 
Beamline Diamond IO3 Diamond IO4 
Wavelength (Å) 0.9763 Å 0.9763 Å 
Resolution (Å) 36.19-2.08 (2.19-2.08) 53.60-3.03 (3.10-3.03) 
Space Group P3221 P3221 
Cell dimensions (Å) a = b = 110.6; c = 91.6 a = b = 107.21; c = 92.80 
Cell dimensions (°) 90, 90, 120 90, 90, 120 
Unique reflections 37157 (2637) 11708 (778) 
Completeness (%) 100 99.2 (98.2) 
Rmerge  0.12 (0.97) 0.11 (0.86) 
Rp.i.m. n/a 0.051 (0.39) 
Multiplicity 10.5 (10.4) 10.8 (11.0) 
<I/!(I)> 14.0 (2.6) 21.4 (3.3) 
Rwork/ Rfree (%) 16.5/21.9 (38.2/49.0) 20.1/ 26.3 (32.9/33.7) 
Protein atoms 3950 3852 
Ligand atoms - 36 
Solvent atoms 57 13 
B-factors Protein 36.9 52.5 
B-factors Ligand - 54.7 
B-factors Solvent 34.1 28.1 
Average B (Å2) 36.9 44.6 
r.m.s.d bonds (Å) 0.026 0.011 
r.m.s.d angles (o) 2.15 1.44 
 
Table 4.1: Data collection and refinement values are shown for the Tyr19Ala mutant protein 
co-crystallised with 15 mM p-coumaric acid (3).  Values in parentheses are for the highest-
resolution shell. 
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Number of images 360 180 80 
Rmerge 0.023  (0.83) 0.020  (0.77) 0.013  (0.517) 
I / )I 40.4 (3.3) 29.9 (2.5) 22.2 (2.0) 
Completeness (%) 98.4 (98.9) 97.0 (97.0) 91.0 (99.9) 
Redundancy 9.8 (10.6) 5.1 (5.4) 2.4 (2.4) 
Unique reflections 11624 (774) 11483 (747) 11198 (744) 
Rwork / Rfree (%) 21.6 / 30.7 
 (28.8 / 46.1) 
20.3 / 32.4  
(30.1 / 56.2) 
21.1 / 30.7 
(31.5 / 49.8) 
Protein atoms 3908 3915 3871 
B-factors Protein (Å2) 41.3 39.6 51.1 
R.m.s. deviations Bond 
lengths (Å) 
0.014 0.030 0.014 
R.m.s. deviations 
Bond angles (°) 
1.50 2.57 1.56 
 
Table 4.2: Data collection and refinement values are shown for the Tyr19Ala mutant protein 
co-crystallised with 15 mM p-coumaric acid, processed with XDS and truncated from 360 
images (left) to 180 (middle) and 80 images (right) prior to processing (3).  Values in 
parentheses are for the highest-resolution shell. 
 
Scaled and merged data could be used to determine the structure of the BsPADTyr19Ala 
mutant protein. Calculation of the Matthew’s coefficient (158,159) indicated the 
presence of three monomers in the asymmetric unit (with a solvent content of 55 %) 
for which strong contrasts could be detected during molecular replacement. The 
molecular replacement solution was refined against the original (experimental) 
reflection file, leading to a significant reduction in Rwork and Rfree values and thus 
showing a reduction in bias towards the molecular replacement model.  
 
Using Coot, the protein model could be fit to the resulting electron density map and 
was improved through iterative rounds of building and refinement using REFMAC5. 
For most datasets the difference between Rwork and Rfree, being an indicator of the 
agreement between a current model and the experimental data, remained below 10 % 
(12 % for the XDS 1-180 truncated dataset). 
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4.3.4 Data validation 
 
For the final model of the 15.0 dataset, the Ramachandran plot calculated with Coot 
showed 93.4 % of the BsPADTyr19Ala residues to lie in the most favoured regions 
while 5.1 % and 1.5 % lie in additionally and generously allowed regions 
respectively.  
 
4.3.5 Analysis of the BsPAD Tyr19Ala mutant structure  
 
After the final rounds of model building and refinement of dataset 3.3 and 15.0, the 
BsPADTyr19Ala mutant’s structures could be visualised and analysed using both Coot 
and the molecular graphics program CCP4mg (160). The mutant crystallised in the 
presence of 3.3 mM ferulic acid showed clear electron density for all residues, with 
the exception of the first two N-terminal amino acids.  The crystals growing in the 
presence of 15.0 mM p-coumaric acid showed inferior diffraction quality and 
resulting electron density maps are equally less well defined than those of dataset 
3.3. Most residues could however be fitted well into the density, with the exception 
of a loop region encompassing residues 13 to 16.   
The final structures strongly resemble the BsPAD wild type apo-structure as it was 
deposited in the protein database under accession number 2P8G and can be 
superposed as shown in figure 4.6. The protein associates into a homodimer, with 3 
monomers present in the asymmetric unit. The central orthogonal !-sandwich forms 
a hollow cavity enclosing the putative active site in the centre of each monomer. This 
cavity is, with few exceptions, lined by predominantly hydrophobic residues whereas 
the BsPAD solvent exposed surface is made up of polar side chains. This is a feature 
generally described for PAD proteins (see section 4.1). One opening of the 
!-sandwich is covered by "-helices, connected to the !-strands by way of flexible 
loops. The opposing end of the sandwich is more solvent exposed but also partially 
covered, in this case exclusively by flexible loops. As for the wild type protein, a 
C-terminal helix extends away from the !-sheets, in opposing directions for each 
dimer.  
 
The only significant structural difference between the wild type and both mutant 
protein structures is seen in the flexible loop region which, for the latter, is displaced 
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by 3-4 Å compared to the 2P8G structure (see Fig. 4.6). As described above, electron 
density is not well defined for this area in dataset 15.0, indicating a region of high 
flexibility in the protein. Processing and refinement of the 3.3 dataset showed small 
areas of positive electron density in the mFo-DFc difference map, i.e. electron 
density which cannot be accounted for by the molecular replacement model, in the 
protein’s active site.  The areas were small and insufficient for modelling and 
refinement of a ligand molecule into any of the three monomers. An averaged non-
crystallographic symmetry (NCS) map, however, outlined the potential shape of a 
molecule of ferulic acid, with its carboxylate moiety and methoxy side chain 
protruding from the phenol ring (see Fig. 4.7).  
 
Figure 4.6: The superposition of both BsPADTyr19Ala mutant structures with the wild type 
enzyme as it was deposited in the Protein Data Bank (2P8G) shows little difference in the 
overall secondary and tertiary structure. The exception is a flexible loop (magnified, right 
image), encompassing residues 13 to 16, which restricts access to the mutant enzyme’s 
active site.  
 
For the 15.0 dataset, difference density appeared in the same area of the protein’s 
active site and was sufficient for modelling and refinement of a molecule of 
p-coumaric acid with an occupancy of 1.0.  
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The best fit was obtained if the substrate’s phenolic hydroxyl group was positioned 
at the more C-terminal pole of the active site cavity, in hydrogen bonding distance to 
residues Arg41, Glu64 and Thr68. The substrate’s carboxylate group faces in the 
opposite direction and is positioned close to the tyrosine pair Tyr11 and Tyr13 as 
well as the alanine sidechain which replaces the wild type’s Tyr19 (see Fig. 4.7).  
 
Figure 4.7: The 2mFo-DFc and mFo-DFc electron density maps of the BsPADTyr19Ala 
mutant’s active sites show density for both substrate molecules, ferulic acid (dataset 3.0, left) 
and p-coumaric acid (dataset 15.0, right). The former is only recognisable if the non-
crystallographic symmetry (NCS) averaged 2mFo-DFc density of all three monomers in the 
asymmetric unit is displayed onto a single chain (purple, left). All 2mFo-DFc maps are 
shown at a contour level of 1.0 sigma ()), the mFo-DFc positive difference density is 
contoured at 3.0 ).  
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4.4 Discussion 
 
Since the first solution of a three dimensional PAD enzyme structure in 2006 by the 
Joint Centre for Structural Genomics, the coordinates of three more bacterial 
homologues haven been deposited in the Protein Data Bank.  
In 2010, Rodriguez et al. were able to propose a detailed mechanism based on the 
computational modelling of a ferulic acid molecule into their high resolution LpPAD 
apo-structure (60). One year later, Gu et al. published a the first report of a ligand 
complex between the Enterobacter PAD and the substrate analogue Na-ferulate 
(134). As findings with respect to ligand orientation and functionality of the various 
active site residues in catalysis differed significantly between the two proposals, 
however, further evidence was required to elucidate the key players in PAD 
catalysed decarboxylation.  
After the preparation of a BsPAD active site library, as described in chapter 3, all 
mutant proteins were thus subjected to crystallisation experiments. It was hoped to 
find an inactive or weakly active variant in the active site of which a substrate, 
reaction intermediate or product could be “trapped” and visualised in a three-
dimensional mutant structure.  After screening of all mutant proteins, the Tyr19Ala 
variant proved to be the only enzyme to produce single, diffracting and reproducible 
crystals. Initial attempts of co-crystallisation in the presence of 3.3 mM of ferulic 
acid yielded high quality diffraction to 2 Å and the structure could be determined 
easily by molecular replacement using the BsPADwt structure (2P8G) as a template. 
The difference density observed in the enzyme’s active site was however poor and 
only after combination of information from all three symmetry related active sites in 
the asymmetric unit could the potential outline of a phenolic acid be distinguished. 
Refinement against a molecule of ferulic acid was not possible. This finding was in 
contrast to the structure obtained after co-crystallisation in 15 mM p-coumaric acid. 
The diffraction’s resolution was reduced to 3.0 Å. In the active site however, clear 
difference electron density could be observed and enabled modelling and refinement 
of the ligand phenolic acid with an occupancy of 1.0 (see Figures 4.7 and 4.8) 
 
The difference in diffraction quality between the two datasets 3.3 and 15.0 could be 
the consequence of the latter enzyme’s remaining activity in the presence of excess 
substrate. Despite a significant reduction in catalytic efficiency, the Tyr19Ala mutant 
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still turns over substrate at a rate easily detectable using UV-VIS spectroscopy (see 
chapter 3). In addition, although enzyme and substrate were incubated on ice prior to 
the preparation of crystallisation trays, product formation was discernible through the 
typical smell of the styrene. It is thus likely that enzyme activity (mobility) and the 
presence of a non-homogenous population of substrate, possibly intermediate and 
product could have had a negative impact on crystal order and diffraction quality. 
This is further supported by the observation that the electron density of a flexible 
loop, which is thought to cover the active site during catalysis (see below), is 
considerably less defined in the 15.0 structure. This difference is pronounced even 
after taking the generally inferior map quality into consideration.  
 
On closer inspection of the data collection statistics, a high merging R-factor (Rmerge) 
of 83% in the highest resolution shell could be observed. This Rmerge value originates 
from the comparison of reflection intensities with the average of their symmetry 
related counterparts and has long served as a quality indicator for crystallographic 
data. As the number of reflections however increases with multiplicity, so does the 
distribution of their intensities (161). As a consequence, the overall Rmerge values 
increase for highly redundant data such that collected for the BsPADTyr19Ala crystal. 
As an alternative to Rmerge, the precision-indicating merging R factor (Rpim) can be 
stated which takes the data’s redundancy into consideration and is accordingly 
significantly lower (162,163). To highlight the importance of including redundant 
data, the Tyr19Ala 15.0 dataset was re-processed with the omission of 0, 180 and 
280 images to give datasets of 360, 180 and 80 images respectively. This should give 
an insight into the effects of a loss of multiplicity on the overall quality of electron 
density maps and, in particular, presence of the ligand’s difference density. The high 
symmetry of the P3221 space group means that only 30° of data (60 images at an 
oscillation angle of 0.5°) should be required to collect all (hkl) reflections at least 
once and acquire a complete dataset. As expected, the Rmerge values of the newly 
processed datasets decrease with the reduction in data (and multiplicity). Equally 
however, the I/)I values decrease. I/"I values signify the average intensity of 
reflections divided by their respective average standard deviation and thus 
correspond to the data’s signal to noise ratio (161). Low values indicate an increase 
in the average standard deviation and thus a strong reduction in data quality and 
reliability after loss of the redundant reflections. The general loss in amount and 
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quality of information obtained from the measured reflections thus explains the 
significant reduction in quality of the resulting electron density maps and the ligand’s 
difference density. This holds true for each truncated dataset, even after several 
iterative rounds of model building and refinement.  
 
The BsPADwt and both Tyr19Ala mutant structures are highly similar and superpose 
with low root mean square deviations (RMSDs) of 0.58, 0.68 and 0.37 Å (between 
wild type and Tyr19Ala 3.3, wild type and Tyr19Ala 15.0 and between the two 
mutant structures respectively). The only significant difference can be observed in 
the loop region between residues Tyr13 and Gly16. For the mutant proteins this loop 
is shifted towards the active site’s entry and occludes access for solvent molecules. 
This is most likely the consequence (and at the same time an indicator) of ligand 
binding. For catalysis to occur, the ligand has to be fixed in the active site and its 
mobility would be increased in the presence of more solvent molecules in a fully 
accessible active site. Compared to some of the maximal enzymatic rates of 
catalysis (143), BsPAD is a fast and efficient enzyme, with a catalytic efficiency 
approaching 1 x 104 s-1/M (see chapter 3, table 3.3). An altered side chain close to 
the loop region, as it is present in the Tyr19Ala mutant, may negatively influence 
flexibility and thus hamper catalysis.       
 
At a contour level of 1), the 2mFo-DFc map of the 3.3 dataset shows a small area of 
electron density in the centre of the Tyr19Ala mutant’s active site after molecular 
replacement and refinement. This density is significantly more pronounced in the 
15.0 structure and surrounds additional positive difference density of the mFo-DFc 
map at a contour level of 3 ). The phenolic acid concentration was increased by a 
factor of five during co-crystallisation experiments while all other conditions 
remained unchanged.  The density observed is thus likely to correspond to the bound 
ligand rather than a trapped solvent molecule. The best fit to a molecule of 
p-coumaric acid could be obtained if the latter was oriented with its carboxy-
terminus facing the more N-terminal part of the active site and forming hydrogen 
bonds with the tyrosine pair Tyr11 and Tyr13. The para-hydroxy group at the 
opposite end of the molecule is, in this conformation, within hydrogen bonding 
distance to the glutamate in position 64 and the $-nitrogen of an arginine in 
position 41.  
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In addition, a small area of density could be observed in the 2mFo-DFc electron 
density map which is thought to correspond to a water molecule coordinated by the 
Glu64 and Thr68 side chains. This water has been observed in the homologous 
LpPAD apo-structure and was proposed, once activated, to act as the proton donor to 
the para-methide quinone intermediate (60).  
 
Figure 4.8: At a contour level of 1), an area of unmodelled density was detected in the 
2mFo-DFc electron density map (light blue) of the BsPADTyr19Ala active site. Into this area, 
the p-coumaric acid ligand could be fitted and was shown to form hydrogen bonds with a 
number of active site residues. Electron density for the ligand was clearest at intermediate 
stages of refinement (shown above). The water molecule was built and refined at later stages 
and superposed from the final structure (4ALB). The mFo-DFc electron density map (dark 
blue) is shown at a contour level of 3 ). 
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Figure 4.9: A superposition of the mutant enzyme (surface and ribbons, grey) with the wild 
type structure (2P8G, green ribbons) highlights the loop movement and subsequent closure 
of the active site upon ligand binding.   
 
The ligand conformation observed corresponds entirely to the model previously 
proposed for the LpPAD structure (60) and is in very good agreement with the 
kinetic data obtained for the BsPAD active site mutant library (see chapter 3). Based 
on this information, a detailed reaction mechanism for phenolic acid decarboxylation 
in BsPAD can be proposed: 
As the phenolic acid substrate enters the active site, it is recognised specifically by 
interactions of the active site residues with both of its polar “ends”. The carboxy-
terminus is secured through hydrogen bonding interactions with Tyr11 and Tyr13 
whereas the para-hydroxy group is positioned within hydrogen bonding distance of 
Arg41. A movement of the flexible loop encompassing residues 13 to 16 occludes 
solvent access to the active site (see Fig. 4.9). This locks in the substrate and 
intermediate in close proximity of the catalytic residues and enhances the proximity 
effect responsible for the high efficiency of enzymatic reactions (143).  
To initiate catalysis, the Glu64 sidechain can then act as a catalytic base and 
abstracts a proton from the para-hydroxy group. This leads to an electron relay and 
formation of the para-methide quinone intermediate as described previously. Parallel 
protonation of the intermediate could be accomplished from two different positions 
(see Fig. 4.10, I and II). In the LpPAD apo-structure a highly coordinated water 
molecule was observed in the active site and proposed the act as a proton donor. In 
the same position, electron density which could correspond to a catalytic water, was 
observed in the Tyr19Ala structure. It is found within hydrogen bonding distance to 
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Glu64 and Thr68 and could be coordinated and activated by the latter residue’s side-
chain. This would also explain the significant reduction in activity for the Thr68Val 
mutant. Alternatively, movement of the flexible loop brings the Tyr19 side chain 
(mutated to alanine in this structure) into close enough proximity for the phenolic 
hydroxyl to donate its hydrogen to the intermediate.  This would be an alternative 
explanation for the mutant’s reduced activity but equally imply that the hydrogen 
bond donor function can be replaced by an alternate residue (or a water molecule) in 
the absence of a tyrosine side chain. Eventually, the para-methide quinone 
intermediate collapses and a second electron relay in the opposite direction leads to 
breaking of the C8-C9 bond and release of CO2 (see Fig. 4.10, III and IV).  
 
Figure 4.10: A catalytic mechanism was proposed for phenolic acid decarboxylation by 
BsPAD. In this proposal, Glu64 acts as the catalytic base and initiates the first electron relay 
by deprotonation of the substrate’s para-hydroxy group. Two catalysts could act as proton 
donors to the formed para-methide quinone intermediate – Tyr19 (blue pathway) or an 
activated catalytic water (green pathway) coordinated by Thr68. A second electron relay in 
the opposite direction then leads to decarboxylation and release of the styrene product. The 
positively charged Arg41 side chain acts as a stabiliser, in particular for the Glu64 catalyst.   
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With re-protonation of the para-hydroxyl group by Glu64, the catalytic base is 
regenerated and formation of the styrene product is completed. Movement of the 
flexible loop is likely to be required for exit of the product from the BsPAD active 
site and preparation for a new round of catalysis. Catalytic solvent molecules could 
thus be also be regenerated or exchanged.  
 
In conclusion, the first structure of a BsPAD mutant protein in complex with its p-
coumaric acid ligand is presented. In conjunction with the kinetic data from an active 
site mutant library, the findings lend strong support to the previously proposed and 
widely accepted decarboxylation mechanism from Klebsiella oxytoca. They 
furthermore identify the key catalytic residues in the Bacillus subtilis enzyme and 
thus explain how the reaction is made possible by the protein’s active site structure 
and composition.  
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Chapter 5:  Structural and mechanistic studies into serine-independent carbon-
carbon hydrolysis by phloretin hydrolase 
 
 
5.1 Introduction 
 
5.1.1 Flavonoids 
 
With the growing commercial and pharmaceutical interest in natural compounds, 
many members of the large class of plant secondary metabolites, the flavonoids, have 
been discovered, analysed and chemically synthesised over the last decades.  
The molecules are ubiquitous in plants where they function in a wide variety of 
processes, including pigmentation, photosynthesis and electron transport as well as 
enzyme regulation, hormone activities and anti-infective defence mechanisms. They 
are synthesised from the aromatic amino acids tyrosine and phenylalanine by way of 
cinnamic acid derivatives and their subsequent condensation with several units of 
acetate (164). Most members of the flavonoid family are characterised by a three ring 
structure, two aromatic rings (A and B) interconnected by a pyran or pyrone ring (C). 
(164,165). They can be subdivided, based on their structure, into anthocyanidins, 
flavanones, flavones, and chalcones. The latter three subclasses are all characterised 
by the presence of a ketone moiety in their C-ring or the open, 3-carbon chain in case 
of the chalcones (see Fig. 5.1) (164). As flavonoids are taken up daily, on a 
milligram scale, by humans and other mammals through their diet, their multiple 
functionalities are also exploited by other physiological systems than plants. The 
various subclasses are thought to be beneficial in the defence against microbial and 
viral infections, aid in the protection from many chronic disorders and cancer as well 
as being anti-inflammatory agents. Flavonoids are able to chelate metals and may 
interact directly with proteins, for example through nucleophilic addition (165), but 
they are foremost known for their pronounced antioxidant properties. This feature is 
a consequence of their hydroxylation pattern, especially on the B ring, which allows 
them to donate protons to radical molecules and delocalise charges over their 
conjugated aromatic backbone (166,167).      
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5.1.2 Chalcones and the dihydrochalcone phloretin 
 
Within the flavonoid subclasses, the so-called chalcones differ in their lack of the 
C-ring and connect ring A and B by way of a three-carbon, "-! unsaturated carbonyl 
chain. They are the product of a condensation reaction between hydroxy-
acetophenones and benzaldehyde derivatives, both naturally and in chemical 
(abiotic) synthesis (164,168).  In addition to their proposed benefits to human health, 
chalcones serve as intermediates in the synthesis of heterocyclic compounds (169). 
One of the most abundant flavonoids metabolised as part of the human diet is the 
dihydrochalcone phloretin. The phloretin A ring constitutes a tri-hydroxylated 
phloroglucinol moiety and the "-! bond is, in contrast to other chalcones, saturated. 
In its glycosylated form, phloridizin (2-!-D-glucose), phloretin is abundant in fruits 
such as apples and, as all members of the flavonoid family, thought to contribute to 
human health by acting as an efficient radical scavenger. This feature is attributed in 
particular to the 2,6-dihydroxyacetophenone moiety which allows for free electron 
delocalisation and stabilisation after donation of a hydrogen to the radical (170).  
Phloretin is an intermediate of flavonoid metabolism in the human gut, where it can 
originate directly from cleavage of the phloridizin glucose moiety. Alternatively, the 
sugar moiety of the flavone apigenin may be removed by hydrolysis, followed by 
reduction of a double bond in the 2-3 position, isomerisation to give a chalcone and 
eventually reduction of the open carbon chain’s C=C double bond to give the 
dihydrochalcone phloretin (see Fig. 5.1) (171,172).   
 
5.1.3 Flavonoid metabolism by Eubacterium ramulus 
 
Within the human gut, flavonoid metabolism was found to be dominated by the 
Gram positive, rod-shaped, strictly anaerobic Eubacterium ramulus. The organism 
was first discovered in 1975 (173) and subsequently re-isolated and characterised by 
Blaut and co-workers (172). E. ramulus was found to grow on the flavonoid 
quercetin-3-glucoside and catalyse its breakdown from hydrolysis of the sugar 
moiety down to reduction of the hydrolytic cleavage product 
1,3,5-trihydroxybenzene (phloroglucinol). From these findings, the first detailed 
metabolic pathway for flavonoid metabolism by this organism could be proposed 
(see above and Fig. 5.1) (171,172).  
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Figure 5.1: Flavonoids are plant secondary metabolites and classified according to the 
structure of their C-ring (or the absence thereof in the case of chalcones) (a). After hydrolytic 
removal of the sugar moiety, flavonoids can be reduced and isomerised into chalcones. In the 
proposed E. ramulus pathway, downstream metabolism then involves further reduction to 
give the dihydrochalcone phloretin, which is hydrolysed into phloroglucinol and phloretic 
acid (b). 
 
5.1.4 A Friedel-Crafts hydrolase acting on phloretin  
  
A step of particular interest for biocatalytic applications is the hydrolytic cleavage of 
phloretin into phloroglucinol and phloretic acid (see Fig. 5.1). This reaction 
constitutes a rare enzyme-catalysed hydrolytic retro-Friedel Crafts acylation in 
which a water molecule is introduced into a substrate containing an aryl and adjacent 
keto-group. The disruption of a carbon-carbon bond between the two groups leads to 
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formation of a methylketone and a carboxylic acid. This reaction has been described 
for four different enzymes to date, the 2,6-dihydroxy-pseudo-oxynicotine hydrolase 
from Arthrobacter nicotinovorans (DHPONH) (87), the fungal heptaketide cleaving 
hydrolase Ayg1p (86) (for both enzymes see chapter 1, section 1.4.1.2), the 
diacetylphloroglucinol hydrolase from Pseudomonas fluorescence (PhlG) and a 
phloretin hydrolase from and Eubacterium ramulus (Phy). The enzymes have been 
found in both bacterial and fungal species (95,96,174,175).  
The phloretin hydrolase gene from E. ramulus was the first to be sequenced in 2004. 
It could be recombinantly expressed in an E. coli host from which the translated 
protein was purified and characterised (96).  Phy was shown to be a 30 kDa enzyme 
which associates into a homodimer in solution. Initial substrate screens showed the 
protein to convert phloretin into phloroglucinol and phloretic acid whereas 
structurally related substrates such as the phloridizin glycoside, 1,3-diphenyl-1,3-
propandione and trans-1,3-diphenyl-2,3-epoxy-propan-1-one were not converted. 
The enzyme was shown to be inhibited by the chelating o-phenanthroline and 
accordingly proposed to bind a catalytic metal. Both features distinguish the 
E. ramulus Phy protein from its homologue in Aspergillus niger which displays a 
large substrate range and is only inhibited to a low level by the metal chelating agent 
(96,175).  
 
5.1.5 Phy and PhlG 
 
On closer inspection of the primary sequence, only few enzymes were shown to 
resemble the Phy amino acid sequence, most of them being hypothetical or 
non-characterised proteins. A 24% sequence identity however was found between 
Phy and the above mentioned PhlG hydrolase. 41% of the enzymes’ amino acids are 
similar to each other. PhlG catalyses the hydrolytic conversion of 
diacetylphloroglucinol (DAPG) into monoacetylphloroglucinol (MAPG) and acetic 
acid and thus acts on a structurally similar substrate to Phy. Both enzymes cleave an 
acetyl group off their substrate’s phloroglucinol moiety. Neither Phy nor PhlG 
contain the GXSXG motif common to many other carbon-carbon hydrolases (73) 
and both have thus been proposed to catalyse bond cleavage by a mechanism other 
than the classic catalytic serine triad. When the 3-dimensional structure of PhlG was 
solved in 2010, this notion was supported by the observation that the protein adapts 
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the Bet v1-like fold novel to carbon-carbon hydrolases (95). Furthermore, a metal 
atom was bound in the putative active site, coordinated by four highly conserved 
residues (two histidines and two glutamates). Based on these observations, 
computational modelling of substrate binding and kinetic data on an active site 
mutant library, a reaction mechanism was proposed for PhlG (95). This mechanism 
involves the binding and coordination of DAPG as shown in figure 5.2. A hydrogen 
bonding network was proposed to exist between active site amino acid side chains 
and the substrate’s hydroxyl and acetyl moieties. Activation of a catalytic water by 
the divalent metal, through reduction of its pKa, was suggested to initiate catalysis. 
The resulting hydroxide ion would be able to carry out a nucleophilic attack on the 
substrate’s carbon-carbon bond, between the aryl and ketone moiety, leading to 
formation of a tetrahedral transition state. Rearrangement of the latter would result in 
carbon-carbon bond cleavage and product formation.  
 
Figure 5.2: The P. fluorescence PhlG protein is the closest known sequence homologue to 
Phy and, as the latter, cleaves an acetyl moiety off its substrate’s phlotoglucinol moiety. 
When the structure of a PhlG protein from P. fluorescens was determined, the authors were 
able to model a molecule of DAPG, in its tetrahedral transition state, into the active site (a). 
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The bound metal was shown to be coordinated by two histidines and two glutamates (b) and 
the model also revealed potential interactions of the transition state with active site residues 
through hydrogen bonding (c). Putative active site residues in Phy from E. ramulus are 
listed, with less or non-conserved sidechains highlighted in bold (d).  
 
 
Figure 5.3: Both Phy (a) and PhlG (b) catalyse the hydrolytic cleavage between an aryl and a 
ketone moiety on their structurally related substrates in a formal retro-Friedel Crafts 
acylation reaction 
 
5.1.6 Friedel-Crafts hydrolases in biocatalysis  
 
In recent years, Friedel-Crafts hydrolases have become increasingly interesting 
targets from a biocatalytic perspective (176). The abiotic reaction equivalent requires 
a Lewis acid to activate an acid chloride by removal of the Cl- group. The resulting 
carbocation can then carry out a nucleophilic attack on a benzene ring to give the 
acetophenone product. A reversal of the enzymatic retro-Friedel Crafts reactions 
described above would allow for the production of acylated aromatic intermediates 
for chemical synthesis under milder and considerably greener conditions and 
circumvent the need for a metal catalyst.  
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5.1.7 Project aims 
 
In view of the possible applications of enzymes catalysing a formal retro-Friedel 
Crafts reaction and the potential of reversing this reaction into carbon-carbon bond 
formation, a more detailed understanding of these catalysts is required. For this, 
phloretin hydrolase from Eubacterium ramulus was chosen as a target enzyme, with 
little information being available about either structure or mechanism. It was hoped 
to obtain X-ray crystallographic data on the wild type enzyme to gain information on 
protein folding, metal coordination and substrate binding. Phy shares a number of 
highly conserved, putative catalytic residues with PhlG (see Fig. 5.2). Based on 
computational modelling, previous kinetic analyses of PhlG (95) and using a high 
resolution structure of the latter, a Phy active site mutant library was designed in an 
attempt to shed light on similarities and/or differences to the proposed PhlG 
mechanism. Furthermore, the introduction of two additional hydrogen bond donors 
present in PhlG (Asn132 and Tyr229) but absent in the Phy wild type (Ala126 and 
Phe218) was aimed at expanding the enzyme’s substrate scope. Eventually, a screen 
of Phy and PhlG with previously untested phloroglucinol and hydroxyacetophenone 
derivatives should provide information on both enzymes’ substrate requirements.       
 
 
5.2 Materials and Methods 
 
5.2.1 Ligation independent cloning of the E. ramulus phy synthetic gene  
 
The synthetic, codon optimised phy gene, cloned into a pET21a(+) vector, was 
kindly provided by Professor Wolfgang Kroutil’s group from the University of Graz. 
Initial expression tests showed bands for soluble protein at the correct molecular 
weight on 12% SDS PAGE gels. As the vector sequence however indicated the 
presence of a stop codon between protein and histidine tag, the phy gene was 
subcloned into the YSBLIC3C vector, using the ligation independent cloning 
protocol.  
The LIC3C vector was prepared by amplification of the purified template in the 
E. coli XL-1 blue cloning strain, isolated using a Sigma GenElute™ plasmid 
Miniprep kit and purified from a 1% agarose gel using a Sigma GenElute™ gel 
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extraction kit. The pure plasmid was linearised by incubation with 5 units of BseRI 
restriction endonuclease (NEB™) per µg of DNA at 37 °C for 90 min and 
subsequently gel purified as described above. The hydrolase encoding synthetic gene 
was amplified from the pET21a(+) vector using the YSBLIC-3C specific primers 
sequences shown in table 5.4 (section 5.2.14)  and amplification conditions shown in 
table 5.1.   
 
Reaction component Concentration Volume [ul] final concentration 
 
forward primer  
 
20 µM 
 
1 
 
0.4 µM 
reverse primer 20 µM 1 0.4 µM 
template DNA  50 mM 1 1 ng/µL 
deoxyribonucleotides (dNTPS) 25 mM 1 0.2 mM 
KOD® hot start DNA 
polymerase buffer 
5x 5 1x 
MgSO4 25 mM 3 1.5 mM 
DMSO 100 %  1 2 % (v/v) 
KOD® hot start DNA 
polymerase 
1.0U/ µL 1 0.02 U/ µL 
deionised water - 36 - 
 
Cycles Temperature [°C] Time [min:s] Reaction 
 
1 
 
94 
 
2:00 
 
initial denaturation 
25 
94 0:30 denaturation 
50 0:30 annealing 
72 0:30 extension 
1 72 3:00 Final extension 
- 4 ' hold/storage 
 
Table 5.1: The phy gene was amplified from the pET21a(+) vector in a PCR reaction using 
LIC specific primers and optimised cycling conditions. Reaction components (top) and 
amplification conditions (bottom) are shown and correspond to LIC cloning reactions for 
both full length protein and the truncated construct described below.  
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The gene was then gel purified as described above for the LIC3C vector. For 
preparation of the single stranded overhangs, both plasmid and insert were then 
individually incubated at 22 °C for 30 min under conditions listed in table 5.2. 
 
Vector Insert 
 
Linearised vector 
 
0.5-1.0 pmol 
 
purified gene of interest 
 
0.2 pmol 
T4 polymerase (Novagen™) 5 U T4 polymerase (Novagen™) 1.25 U 
T4 polymerase buffer (10 x) 10 µL T4 polymerase buffer (10 x) 2 µL 
dTTP (25 mM) 10 µL dATP (25 mM) 2 µL 
Dithiothreitol (DTT) 
(100 mM) 
5 µL Dithiothreitol (DTT) 
(100 mM) 
0.5 µL 
H20 To 100 µL H20 To 20 µL 
 
Table 5.2: Reaction components are shown for the T4 polymerase reactions which led to the 
addition of complementary single standed overhangs on linearised vector and insert DNA.   
 
The reaction was stopped by a further incubation at 75 °C for 20 min and (for the 
vector reaction only) purified using a Sigma GenElute PCR clean-up kit. Using 
1.5 µL of vector and 3 µL of insert DNA, the created single stranded overhangs were 
eventually annealed at room temperature for 10 min prior to the addition of 1.5 µL of 
25 mM EDTA and a further incubation for 10 min. For amplification, an 
E. coli XL-1 Blue cloning strain was transformed by the annealing products. The 
resulting colonies were used for the preparation of 5 mL overnight cultures from 
which amplified plasmids were purified with a Sigma GenElute™ plasmid Miniprep 
kit. To check for successful insertion of the gene into its vector, a double digest using 
1 unit each of NcoI and NdeI restriction endonucleases (NEB™) per µL of DNA was 
carried out at 37 °C for 90 min. The result was visualised on a 1% agarose gel. 
Eventually, the vector constructs were sent for sequencing with the University of  
York’s Technology Facility to verify the sequence and completeness of the phy gene 
in its vector. 
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5.2.2 Purification of Phywt  
 
For purification of the Phy protein, competent E. coli BL21 (DE3) expression cells 
were transformed by the YSBLIC3C:phy plasmid and colonies were picked for 
preparation of 5 mL LB starter cultures. The latter were used for inoculation of 2 to 
4 L of autoinduction medium at a ratio of 1:100 (starter culture : growth medium) 
(177). In contrast to the Studier reference, the amount of metals added was reduced 
by a factor of five, with 0.1 mL of 1000 x metal solution being added to each 500 mL 
culture. After inoculation, all cultures were incubated at 37° C for 18 h while shaking 
at 180 rpm. Cells were then harvested by centrifugation at 5000 rpm for 15 min using 
a Sorvall RC5B centrifuge and the resulting pellet was resuspended in 30 mL of 
50 mM Tris buffer (pH 7.5), containing 300 mM NaCl and 30 mM imidazole, per 
litre of culture. Ultrasonication at an amplitude of 14,000 microns for 3 x 45 s, with 
30 s cooling intervals, was used to disrupt cells. Soluble lysate was subsequently 
separated from the crude cell extract by centrifugation at 15,000 rpm for 30 min. The 
resulting supernatant was then loaded onto a 5 mL HiTrap™ Chelating HP Nickel 
affinity column. After recycling of the flow-through for 30 min and a final loading 
step, the column was washed with ten column volumes of the resuspension buffer. 
The hexahistidine-tagged Phy protein was eluted using a 30-500 mM imidazole 
gradient over 20 column volumes. The pooled peak fractions were concentrated and 
loaded onto a Superdex™ S75 gel filtration column and equilibrated with 50 mM 
Tris buffer (pH 7.5) containing 300 mM NaCl. During all stages of purification, 
10 µL samples were taken to evaluate protein purity on a 12% SDS PAGE gel. After 
the final purification step, all proteins were stored at 4 °C to be used in crystallisation 
experiments or flash-cooled in liquid nitrogen and stored at -18 °C for kinetic 
experiments. For a subset of the purified proteins, the N-terminal hexahistidine tag 
was removed by protease digest. For this, protein samples were brought to a 
concentration of 1 mg/mL and incubated with the human rhinovirus (HRV) 3C 
protease at a ratio of 1:10 (w/w) (protease : protein of interest) for 18 h at 4 °C. 
Repeated Ni2+-affinity purification allowed for separation and elution of the cleaved 
protein in gel filtration buffer. The cleaved polypeptide and histidine tagged protease 
were eluted from the column in the same buffer containing a 0-500 mM imidazole 
gradient. 
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5.2.3 Purification of PhySeMet 
 
As only one structural model at comparatively low sequence identity was available 
for determination of a Phy protein structure by molecular replacement (see section 
5.1), a Phy derivative was purified in which methionine residues were replaced by 
selenomethionine. It was hoped that protein crystals of this heavier derivative would 
support phase calculation during structure determination. For purification of a Phy 
selenomethionine derivative, 50-100 µL of methionine auxotrophic E.coli B834 
(DE3) competent cells were transformed by the YSBLIC3C:Phy wild type plasmid. 
The resulting colonies were picked and used for inoculation of 5 mL of LB overnight 
cultures containing 30 µg/mL of kanamycin as the selective antibiotic. These cultures 
were in turn used to inoculate 2 L of PASM-5052 selenomethionine autoinduction 
medium (177) at a ratio of 1:100 (starter culture : expression medium). In contrast to 
the Studier reference, the amount of metals added was reduced by a factor of five, 
with 0.1 mL of 1000 x metal solution being added to each 500 mL culture.  
Selenomethionine cultures were incubated at 37 °C for 22 hours while shaking at 
180 rpm, before cells were harvested and the protein purified as described above for 
the native Phy hydrolase.  
 
5.2.4 Prediction of protein disorder and preparation of a truncated Phy construct 
 
Initial crystallisation screens showed only few conditions in which microcrystals or 
crystalline precipitate formed and the observed hits were difficult to reproduce. In 
view of this result, the protein sequence was analysed for disordered regions. The 
latter may impair the crystallisation process and their removal may help promote 
protein order and crystal formation. For disorder prediction, several programs were 
used and compared, including the RONN (178) and DISOPRED (179) servers. Once 
disordered regions were determined, a LIC3C-specific primer was designed for 
subcloning of the truncated construct. As a full length YSBLIC3C:phy gene had been 
prepared previously, only a forward primer for removal of 10 N-terminal residues 
had to be designed and is shown in table 5.4. The combination of truncated forward 
and full-length reverse gene primers was then used to carry out LIC cloning as 
described above for the full length gene. Reaction components and amplification 
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conditions are outlined in table 5.1. These procedures resulted in preparation of the 
YSBLIC3C:Phy-10N plasmid.  
 
5.2.5 Purification of Phy-10N 
 
The truncated protein, hereafter named Phy-10N, was produced, purified and used for 
the preparation of crystallisation screens as described for the native, full length 
hydrolase. Cells of the E. coli BL21(DE3) expression strain were transformed by the 
YSBLIC:Phy-10N plasmid and cultured for protein production. In contrast to the 
methods described above however, resuspension and purification buffers used were 
based on 50 mM HEPES buffer (pH 7.5) containing 100 mM KCl.  
 
5.2.6 Computational modelling of the Phy 3-dimensional structure 
 
In the absence of structural data, kinetic experiments involving the mutation of 
putative active site residues were guided by computational modelling of the Phy 
tertiary structure. For this, the protein’s amino acid sequence was submitted to the 
PHYRE2 protein fold recognition server.  In subsequent steps, this server creates a 
sequence alignment, predicts secondary structural elements such as "-helices, 
!-sheets and coils. These elements are then compared to a fold library, allowing for 
prediction of a complete tertiary structure for the protein of interest. Confidence 
scores are assigned to each prediction (180).  
 
5.2.7 Preparation of a Phy mutant library  
 
A total of nine Phy active site mutants were designed based on previous kinetic data, 
a modeled ligand complex of the PhlG homologue [He] and a computational model 
of Phy (see sections 5.1.5, 5.2.6 and figure 5.2). All mutant genes/plasmids were 
subsequently prepared by site directed mutagenesis. For this, primers containing the 
desired single point mutation were designed using the PrimerX software and are 
listed in table 5.4 (section 5.2.14). For mutagenesis, each primer pair was used for 
amplification of the wild type YSBLIC3C:phy template under the conditions outlined 
in table 5.3.  
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Subsequent to this amplification, the parental DNA was removed by the addition of 
20 units of DpnI restriction endonuclease to the reaction mixture. After 
centrifugation at 13,000 rpm for 60 s, this digest was incubated at 37 °C for 3-4 h 
after which 50 – 100 µL of supercompetent XL-10 Gold cells were transformed by 
2-5 µL of the mutant plasmid DNA.  
 
Reaction component Concentration Volume [ul] final concentration 
 
forward primer  
 
20 pmol/µL 
 
0.5 
 
0.4 µM 
reverse primer 20 pmol/µL 0.5 0.4 µM 
template DNA (YSBLIC:phy) 100 ng/ul 1 2 ng/µL 
deoxyribonucleotides (dNTPS) 2 mM 5 0.2 mM 
KOD (*) or Pfu turbo™ (**) 
hot start DNA polymerase buffer 
10x 5 1x 
MgSO4(*) 25 mM 3 1.5 mM 
DMSO 100 %  1 2 % (v/v) 
KOD (*) or Pfu turbo™ (**) 
hot start DNA polymerase 
1.0 U/µL (*) 
2.5U/ µL(**) 
1 0.02 U/ µL (*) 
0.05 U/ µL (**) 
deionised water - 33* (36**) - 
 
Cycles Temperature [°C] Time [min:s] Reaction 
1 95 5:00 initial denaturation 
30 
95 1:00 denaturation 
50 1:00 annealing 
72 10:00 extension 
1 95 1:12 final denaturation 
1 72 5:00 final extension 
- 4 ' hold/storage 
 
Table 5.3: The reaction components and amplification conditions shown were used for the 
preparation of a Phy active site mutant library by site-directed mutagenesis. Polymerases 
required varied between mutants: whereas PfuTurbo™ polymerase was used to amplify the 
Phe218Tyr and His203Ala mutants (**), KOD polymerase was used to prepare all other 
variants (*). 
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Colonies resulting from the transformation reaction were picked and used for the 
preparation of 5 mL overnight cultures in LB medium containing 30 µg/mL 
kanamycin as the selective antibiotic. Plasmid DNA was isolated from these cultures 
using a Sigma GenElute™ plasmid Miniprep kit and submitted to the University of 
York’s Technology Facility for sequencing. Using the Emboss Needle webserver 
(181), the obtained results were aligned with the phy wild type gene to verify 
presence and identity of the desired mutation.  
 
5.2.8 Protein production and purification of the Phy mutant library 
 
For protein purification, competent E. coli BL21 (DE3) and B834 (DE3) cells were 
transformed by the mutant plasmid DNA, cultured and soluble proteins purified as 
described for the wild type Phy. The lack of a distinct chromatography peak during 
metal affinity purification was considered to be the consequence of either insoluble 
proteins or a complete lack of gene expression and/or protein production. This was 
observed for the PhyHis251Ala, PhyGlu255Gln and PhyAla126Asn variants. For analysis of 
these proteins, three different expressions strains, E. coli BL21 (DE3), Rosetta (DE3) 
and B834 (DE3), were transformed by the respective plasmid DNA and tested for 
protein production and solubility in small-scale expression tests. Picked colonies 
were used to prepare 5 mL overnight cultures from which 100 mL expression 
cultures could be inoculated at a ratio of 1:100 (starter culture : expression medium). 
For the Glu255Gln mutant, only E.coli Rosetta colonies were obtained and could be 
cultured. At an optical density of 0.6 – 1.0, protein production was induced by the 
addition of IPTG to a final concentration of 0.1 mM and cultures were incubated for 
18 h at 37, 30 or 18 °C. For visualisation of protein production, 10 mL were 
aliquoted from each culture and cells were harvested in a Sorvall RT6000 D 
centrifuge at 5,000 rpm for 15 min. After resuspension in 1 mL of 50 mM Tris buffer 
containing 300 mM NaCl, cells were disrupted by sonication at 14,000 amplitude 
microns for 3 x 3-4 s with 5 s cooling intervals. The crude cell extracts were 
subsequently centrifuged at 13,000 rpm for 30 min. 10 µL samples were taken from 
the supernatant and from insoluble pellets resuspended in 1 mL of buffer, 
representing soluble and insoluble cell fractions respectively. All samples were 
eventually separated and visualised on a 12 % gel using SDS PAGE.  
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As no soluble protein production could be observed from these experiments, further 
purification of the three respective mutants was abandoned.  
 
5.2.9 Crystallisation of Phywt, PhySeMet,Phy-10N and mutant proteins 
 
The purified wild type Phy (native), selenomethionine, truncated and mutant proteins 
were subjected to crystallisation trials in 96 well Swissci MRC™ trays, using 300 nL 
drops in the sitting-drop vapour diffusion method. Crystallisation screens assayed 
included the CSS I+II, PACT and INDEX as well as Newcastle, Hampton, PGA, 
PEG and additive screens for the native, full length, Phywt protein. 
Selenomethionine, truncated and mutant proteins were screened using the CSS I+II, 
PACT and INDEX conditions only. Protein and mother liquor were incubated at a 
ratio of 1:1 (v:v).  
Whereas several of the variants yielded small crystals or crystalline precipitate, only 
the wild type protein (full length, native) gave reproducible, single, diffracting 
crystals using the INDEX screen (Hampton Research) at a protein concentration of 
10 mg/mL and in the absence of the hexa-histidine purification tag. Despite low 
diffraction quality, a crystal grown in PEG 3350 (25% w/v) and 0.1 M Bis-Tris 
propane buffer (pH 5.5) and in the absence of added metals was used to measure an 
X-ray fluorescence spectrum at the Diamond Light Source in Didcot (see below). 
This condition was subsequently scaled up and optimised using 24-well Linbro-type 
crystallisation plates and the hanging drop vapour diffusion method. The best results 
were eventually obtained from crystallisation conditions containing PEG 3350 (26% 
w/v), 0.1 M Bis-Tris Propane buffer (pH 6.0), 1 mM ZnOAc and 250 µM phloretin 
(dissolved as a 500 mM stock solution in DMSO). Crystals were cryoprotected using 
the original mother liquor. The nature and percentage of the cryoprotectants was 
optimised by comparing diffraction qualities of crystals after the addition of 0-20 % 
(v/v) ethylene glycol or 0-20 % glycerol (v/v). All crystals were flash-cooled in 
liquid nitrogen prior to in-house testing. 
 
5.2.10 Crystal testing, data collection and processing 
 
Crystals grown in 96 well or 24 well plates were fished, cryoprotected, flash-cooled 
as described above and tested using an in-house X-ray source and a 
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MARRESEARCH MAR345 imaging plate detector. If a protein diffraction pattern 
was observed, crystals were stored in liquid nitrogen and sent to the Diamond Light 
Source in Didcot for further testing. For a native, wild type Phy crystal, a dataset was 
collected at a wavelength of 0.97631 Å on beamline I03, using a Pilatus detector. 
Data were evaluated and processed using the xia2 automated processing software at 
Diamond and the CCP4 suite of programs (152,160). Alternative models were built 
and used in molecular replacement and refinement by the BALBES molecular 
replacement pipeline (182). For crystals of the PhySeMet heavy atom derivative, three 
datasets were collected at wavelengths of 0.97949, 0.97961 and 0.97630 Å, 
corresponding to the selenium peak, inflection point and remote X-ray energy 
respectively.  
All diffraction data for the selenomethione derivative were evaluated using the xia2 
automated processing software (152) and the SHELXC/D/E software package (183).  
 
5.2.11 Measurement of an X-ray fluorescence spectrum 
 
A weakly diffracting Phy crystal was obtained from the 96 well INDEX screen. This 
crystal had grown in the absence of any metals in the crystallisation solution 
(0.1 M Bis-tris propane (pH 5.5) and 25 % PEG 3350). It could thus be used to 
measure an X-ray fluorescence spectrum and detect metals tightly associated with 
the protein of interest. For this spectrum, the crystal was exposed to radiation at a 
wavelength of 0.9795 Å at beamline I04 of the Diamond Light Source synchrotron in 
Didcot. Emitted fluorescence was detected and measured on a Vortex™ fluorescence 
detector and evaluated using the PYMCA software package (184).    
 
5.2.12 Spectrophotometric analysis of phloretin hydrolysis 
 
To analyse hydrolysis of phloretin into phloroglucinol and phloretic acid, a 
spectrophotometric assay was developed. Making use of a drop in absorbance of 
phloretin at 288 nm, this assay allowed for a real-time observation of substrate 
turnover by the Phywt, Phy-10N and Phymut proteins.  Stock solutions of 1, 10 and 
100 mM phloretin were prepared in dimethyl sulfoxide (DMSO) and added to 
50 mM Tris buffer (pH 7.0) to give a final concentration range of 1 to 150 µM. After 
a flat baseline was observed, 1 µg (0.03 nmoles) of purified Phy enzyme was added 
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to the solution and the decrease in absorbance was measured for 60 s or 100 s for the 
wild type and mutant enzymes respectively. The molar extinction coefficient, $, for 
phloretin was calculated by measuring the absorbance values of nine samples with a 
known substrate concentration of 5 – 80 µM and determined to be 11039 M-1 cm-1 
using Beer’s law. Subsequently, using the same law, the reduction in the each 
reaction sample’s phloretin concentration could be determined from the measured 
drop in absorbance. Maximal substrate concentrations assayed varied between wild 
type and mutant proteins. Further measurements were generally abandoned once a 
plateau could be observed in the initial reaction velocities or absorbance values 
approached signal saturation (Phywt). All measurements were performed in triplicate 
and standard deviations were calculated for each datapoint. From initial reaction 
velocities determined in this experiment it was possible to calculate kinetic constants 
Km, Vmax,  kcat and kcat/KM for phloretin hydrolysis using the Grafit software package 
(185).  
 
5.2.13 Determination of Phy substrate specificity 
 
The substrate range of Phy was analysed at the University of Graz, using gas 
chromatography assays in which the both substrate and products of hydrolysis could 
be detected. Their identity was confirmed using standards and methods previously 
prepared and kindly provided by Dr. Elina Siirola. A total of six potential substrates 
were analysed: diacetylphloroglucinol (DAPG), monoacetylphloroglucinol (MAPG), 
2-hydroxyacetophenone (2-HAP), 4-hydroxyacetophenone (4-HAP), 
2,4-dihydroxyacetophenone (2,4-DHAP) as well as 2,6-dihydroxyacetophenone (2,6-
DHAP). For the enzymatic reactions, an E. coli BL21 (DE3) expression strain was 
transformed by the YSBLIC3C plasmids encoding Phywt protein as well as the 
Ala126Ser and Phe218Tyr mutants designed to introduce additional hydrogen bond 
donors to the active site.  1 L of recombinant cells were cultured, disrupted and cell 
fractions separated as described for the Phy mutant library. The soluble supernatant 
was then flash cooled in liquid nitrogen and dried under vacuum for approximately 
18 h before being stored at 4°C until further use. For determination of substrate 
specificity, the lyophilised lysates were resuspended to a final concentration of 
20 mg/mL in 50 mM phosphate buffer, pH 7.5, and incubated for 30 min to 
equilibrate the enzyme solution. All putative substrates were dissolved as 5 M stock 
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solutions in DMSO and added to each reaction (with the exception of DAPG which 
was added directly) to give a final concentration of 50 mM substrate in 1 mL of 
buffer. Final solvent concentrations did thus not exceed 1% (v/v). Each reaction was 
prepared in duplicate and then incubated at 30°C while shaking at 120 rpm for 
approximately 18 h. After subsequent acidification using 2 drops of concentrated 
hydrochloric acid, all samples were extracted three times in 500 µL of ethyl acetate 
and the combined organic phases were dried over anhydrous Na2SO4. They were 
then analysed using an Agilent Technologies 7890A gas chromatograph and a HP-5 
gas chromatography column. The injector temperature was set to 300°C, assay 
temperatures and retention times are listed  below. 
For all transformations, a PhlG reaction was run in parallel. The corresponding 
protein was prepared as described for Phy, using a recombinant plasmid kindly 
provided by Dr. Elina Siirola. For hydrolysis of DAPG and MAPG, this served as a 
positive and negative control respectively. 
 
GC conditions and retention times: 
MAPG and DAPG: 200°C, hold for 2 min, 10°C/min to 250°C, hold for 3 min. 
Retention times: 4.5 min (DAPG), 3.5 min (MAPG) and 2.2 min (phloroglucinol, 
PG).  2,4-DHAP and 2,6-DHAP: 190°C, hold for 5 min. Retention times: 2.4 min 
(2,4-DHAP and 2,6-DHAP), 1.7 min (1,3-dihydroxybenzene/resorcinol).  
2-HAP: 140°C, hold for 5 min. Retention times: 2.5 min (2-HAP) and 1.9 min 
(phenol). 4-HAP: 140°C, hold for 7 min. Retention times: 5.6 min (2-HAP) and 1.9 
min (phenol).  
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5.2.14 Primers used for LIC cloning of Phy full length and truncated proteins as well 
as for the preparation of an active site mutant library 
 
Variant Forward Primer Reverse Primer 
1 WT ccagggaccagcaatggaagaagatttc
aatatgagcacaccgggtg 
gaggagaaggcgcgttattaaaaggtatctttttc
ttctgcatacaggg 
2 Phy-10N ccagggaccagcaggtgttaaagttggtg
ttagcgaagaagaaaaaaaactg 
gaggagaaggcgcgttattaaaaggtatctttttc
ttctgcatacaggg 
3 His123Ala gatccggaagatgcgtattttgcacg cgtgcaaaatacgcatcttccggatc 
4 Glu154Gln gtggatcattatattatgcaggatgttggtc
cgggtcc 
ggacccggaccaacatcctgcataatataatgat
ccac 
5 His251Ala cgcagggtctgtttgcagcgaatattaaag
aatttacc 
ggtaaattctttaatattcgctgcaaacagaccct
gcg 
6 Glu255Gln gcacataatattaaacagtttaccaatctgg
cag ctgccagattggtaaactgtttaatattatgtgc 
7 Tyr115Phe ggtagcgatctgcgttttaaaatttgggatc
c ggatcccaaattttaaaacgcagatcgctacc 
8 His203Ala ctgtgcagcagcaatgaccgcgaaatgg
catccgtataaag 
ctttatacggatgccatttcgcggtcattgctgctg
cacag 
9 Ala126Asn cggaagatcattattttaatcgtgcatatcc
ggcaagc 
gcttgccggatatgcacgattaaaataatgatctt
ccg 
10 Ala126Ser cggaagatcattattttagccgtgcatatcc
ggcaagc 
gcttgccggatatgcacggctaaaataatgatctt
ccg 
11 Phe218Tyr ctgtttgaaagccgctattggattggttatc
g cgataaccaatccaatagcggctttcaaacag 
 
Table 5.4: Primers used for the amplification of the wild type full length (1) and truncated  
phy (2) genes were optimised for LIC cloning. Rows 3-11 show primers used for the 
preparation of an active site single point mutant library. Nucleotides encoding the desired 
mutation are highlighted in red. 
 
 
5.3 Results 
 
5.3.1 Ligation independent cloning of the E. ramulus phy synthetic gene and the 
truncated construct Phy-10N  
 
To allow for efficient purification by metal affinity chromatography and subsequent 
cleavage of the affinity tag, the synthetic phy gene was sub-cloned into the 
YSBLIC3C vector. Within the vector, the gene is flanked by the NdeI and NcoI 
endonuclease restriction sites. A double digest of the YSBLIC3C:phy expression 
construct could thus confirm the presence of the gene of interest (see Fig. 5.4), 
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subsequent sequencing confirmed its completeness and identity with the deposited 
gene sequence. To remove a region of predicted protein disorder, the truncated 
construct Phy-10N was prepared in addition, lacking the first ten N-terminal amino 
acids. The corresponding gene was amplified and subcloned analogous to phywt. 
 
Figure 5.4: After PCR amplification and LIC cloning, an NcoI/NdeI  restriction 
endonuclease double digest confirmed the presence of the phy gene (appr. 830 kb, green 
boxes) inserted into the YSBLIC3C vector (5.4 kb, blue box) (a). Protein disorder in the first 
ten N-terminal residues was predicted using the RONN server (178) (c) and prompted the 
amplification and subcloning of the truncated phy-10N construct (b).  
 
5.3.2 Purification of Phywt type, PhySeMet and Phy-10N proteins 
 
The native wild type Phy protein as well as its selenomethionine and truncated 
derivatives were produced as soluble enzymes by the E. coli recombinant hosts and 
could be purified to high homogeneity in two to three subsequent steps. Initial 
purification yields for the native protein were low using LB growth medium and 
IPTG based induction of gene expression (results not shown). As a consequence, 
recombinant cells were grown in autoinduction medium, leading to a 200-300% 
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increase in Phy production levels. Protein purity, although negatively influenced by 
the overall increase in cellular protein levels, improved significantly with every 
purification step. The enzymatic removal of the hexahistidine tag and repeated 
purification by nickel affinity chromatography in particular gave protein samples 
with few detectable impurities on SDS PAGE gels (see Fig. 5.5).  
 
Figure 5.5: Soluble Phywt, PhySeMet and Phy-10N protein was produced by the E.coli 
recombinant host and could be purified to high homogeneity using Ni2+-affinity and size 
exclusion chromatography (SEC). FPLC chromatograms show elution of the proteins in 
single, narrow peaks corresponding to the protein fractions visible on 12 % SDS PAGE gels.  
The PhySeMet derivative, produced in minimal autoinduction medium, showed the 
highest of all protein production levels with over 60 mg of protein per litre of culture 
medium after metal affinity purification.  
 
5.3.3 Computational modeling of the Phy 3-dimensional structure 
 
In the absence of crystallographic data for Phy, experiments analysing the catalytic 
function of putative active site residues were based on a computational modelling 
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approach. Using the PHYRE2 webserver (180), a three-dimensional model (Phymod) 
could thus be prepared. With respect to Phy, the only protein structure with 
significant sequence homology determined to date is that of diacetylphloroglucinol 
hydrolase (PhlG) (95). As a consequence, the phloretin hydrolase model produced by 
the PHYRE server strongly resembles the PhlG structure, particularly around the 
core of the protein. This core shows an arrangement of two orthogonal, anti-parallel 
!-sheets surrounding an internal cavity, similar to a !-sandwich. The sheets are 
surrounded on all four sides by "-helices and also close off both ends of the internal 
tubular cavity. The putative active site contains all residues previously proposed to 
be essential for catalysis in PhlG. All equivalent side chains in the Phy model are 
situated in a similar position when the two structures are superposed (see Fig. 5.6).  
 
Figure 5.6: The superposition of Phymod with PhlG suggests high structural similarity 
between the two proteins (a). A superposition of the putative PhlG active site (including a 
modelled DAPG transition state) and the corresponding Phymod side chains highlights 
structural conservation and changes in this area (b).  
The root mean square deviation (RMSD) between both structures is 0.64 Å over 258 
residues. With the Phy model being based on structural data from PhlG, this value is 
however strongly biased.  
 
5.3.4 Preparation, protein production and purification of a Phy mutant library  
 
Based on previous work on the PhlG homologue (95) and the modelling approach 
described above, a Phy mutant library was prepared by site-directed mutagenesis. 
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Using this method, nine single amino acid alterations were successfully introduced 
into eight positions of the Phy primary sequence (see table 5.4). The alteration of an 
alanine in position 126 to an asparagine led to the production of insoluble protein. 
When the residue was mutated to an alternative hydrogen bond donor, a serine, the 
resulting protein was produced in its soluble form.  
Of the remaining seven variant phy genes, five were expressed and translated into 
soluble enzymes. Protein production varied slightly between the mutants but was 
significantly increased for the His203Ala variant. The latter showed protein levels 
increased by up to a factor of ten compared to other mutants. Representative 
SDS PAGE gels of two mutant library proteins (PhyHis203Ala and PhyTyr115Phe), 
purified by size-exclusion chromatography, are shown in Fig. 5.7.  
 
Gene expression and protein production was assayed for mutants not producing a 
detectable peak during metal-affinity chromatography. When induced cultures of 
three E. coli expression systems, incubated at 37, 30 and 18 °C, were analysed by 
SDS PAGE, no significant Phy protein bands could be detected in the soluble cell 
fractions. Protein bands were however generally weak on the prepared gels. 
Significant amounts of insoluble protein at the Phy molecular weight could only be 
detected for the His251Ala mutant. The negative control shows that results remain 
ambiguous however as uninduced expression cells show a band of the same 
molecular weight as the Phy protein (see Fig. 5.7).  
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Figure 5.7: Size-exclusion chromatography results are shown for the PhyHis203Ala and 
PhyTyr115Phe variants, representing non-conservative and conservative amino acid alterations 
respectively (top). Mutants which could not be purified by Ni2+-affinity chromatography 
were analysed for protein production using the E.coli expression strains BL21, Rosetta (Ros) 
and B834 (DE3) and incubation temperatures ranging from 18 - 37°C. Soluble (*) and 
insoluble (-) cell fractions are shown. A possible overproduction of insoluble PhyGlu255Gln 
protein is highlighted (bottom).  
 
5.3.5 Crystallisation of Phywt, PhySeMet, Phy-10N and mutant proteins 
 
The purified Phy wild type protein as well as all of its selenomethionine, truncated 
and mutated derivatives were used in crystallisation experiments in the hope of 
obtaining a three dimensional structure of the enzyme. In several of the 
crystallisation screens carried out with the wild type protein, the formation of oval or 
spherulite shaped structures could be observed. These were present in various 
screens but particularly dominant with the INDEX conditions. From the latter, 24-
well scale-up trays were prepared and presented larger structures of similar 
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morphology but, in parts, with detectable “crystalline” edges (see Fig. 5.8). When 
fished, flash cooled and exposed to synchrotron radiation at the Diamond Light 
Source in Didcot, these crystals showed the typical protein diffraction pattern to a 
resolution of approximately 4 Å. A second, almond shaped crystal form was detected 
in the INDEX screen, several months after its preparation, and diffracted to 
approximately 5 Å at the synchrotron. As this crystal had formed in the absence of 
metals in the crystallisation conditions, it was suitable for the measurement of a 
fluorescence spectrum (described below).  
The apparent zinc binding properties of Phy, revealed by the fluorescence scan, were 
exploited in subsequent optimisation experiments with conditions producing the 
almond shaped crystal. The addition of zinc chloride or zinc acetate as well as the 
variation of polyethylene glycol (PEG) 3350 concentration and pH yielded single 
and reproducible, cube shaped Phy crystals (see Fig. 5.8). When exposed to X-ray 
radiation from an in-house source, the crystals diffracted to 5-8 Å. At Diamond Light 
Source, this resolution was improved to 3.5 Å for a crystal grown in the presence of 
26 % PEG 3350, 0.1 M bis-tris propane buffer (pH 6.0) and 1 mM ZnOAc. The 
diffraction quality was generally higher for crystals grown in the presence of ZnOAc 
than from conditions containing ZnCl.  
With the conditions described above, 24-well crystallisation screens were prepared 
for the PhySeMet derivative. After 24 h, large crystals of various morphologies could 
be observed. These were either single or appeared in larger structures of apparently 
overlapping crystals (see Fig. 5.8).  When a single crystal was fished, diffraction to 
5-6 Å was observed at the Diamond Light Source synchrotron.  
In addition to the full length native Phy and its selenomethionine derivative, single 
crystals and crystalline precipitate were observed for the Phy-10N truncated protein 
and several proteins of the mutant library. For the latter, the only hit which could be 
successfully reproduced and scaled up however was the formation of (originally) 
plate shaped crystals of the PhyHis203Ala mutant in the PACT screen. Using a mother 
liquor containing 0.2 M MgCl, 25% PEG3350 and 0.1 M Bis tris buffer (pH 6.0, 6.5 
or 7.0), rod shaped, twisted crystals were obtained after a 24 h in 24-well trays. None 
of the crystals diffracted when tested using a home X-ray source.   
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Figure 5.8: Crystals of varying morphologies were obtained from the Phywt protein in the 
absence and presence of zinc (1 and 2 respectively), PhySeMet (3 and 4), Phy-10N (5) and the 
PhyHis203Ala mutant enzymes. 
 
5.3.6 Data collection and processing 
 
Complete native and multiwavelength anomalous dispersion (MAD) datasets were 
collected for the Phywt and PhySeMet crystals respectively. Whereas the wild type 
protein crystal diffracted to 3.5 Å, the selenomethionine derivative did not exceed a 
resolution of 4.5 Å.  
After reduction of the collected data, the xia2 autoprocessing software (152) 
determined P3112 to be the most likely space group for both crystals. The cumulative 
intensity distribution of the Phywt dataset indicated the presence of twinning in the 
crystal. Attempts to determine the native Phy structure by molecular replacement 
using the wild type PhlG coordinates (3HWP) failed.  Alternative model building, 
molecular replacement and refinement was, in addition, attempted using the 
BALBES automated molecular replacement pipeline. This allowed for the 
calculation of electron density maps showing partial secondary structure features 
such as "-helical regions. A complete structure of the Phy protein could however not 
be determined.  
As an alternative to molecular replacement, structure solution was attempted using 
the anomalous data collected from a PhySeMet crystal. Data analysis using the 
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SHELXC/D/E software package (183) showed a strong anomalous signal, indicating 
good replacement of methionine in the protein by its selenium derivative. However, 
the signal did not extend into resolution shells high enough to allow for the 
determination of a substructure from experimental phases. The overall diffraction of 
the PhySeMet crystals was also poor and, eventually, structure determination was not 
possible from this dataset.  
 
5.3.7 Measurement of an X-ray fluorescence spectrum 
 
In addition to the diffraction data described above, a fluorescence spectrum was 
collected from a Phywt crystal at the Diamond Light Source synchrotron. When 
evaluated using the PYMCA software (184), the spectrum revealed a single peak. 
This peak corresponds in emission energy to the fluorescence of zinc (approximately 
8.6 kEV) and could be fitted to the metal’s known signal (see Fig. 5.9) (93,184).  
 
Figure 5.9: A fluorescence spectrum was measured on a Phy crystal grown in the absence of 
metals in either buffer or crystallisation conditions. The resulting peak corresponds in energy 
to the known fluorescence peak of zinc and was fitted to this accordingly (red line) (184).  
 
5.3.8 Spectrophotometric analysis of phloretin hydrolysis 
 
Using a spectrophotometric assay that allowed real-time observation of substrate 
turnover, individual reaction kinetics were analysed for the Phywt protein, Phy-10N 
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and all soluble, purified proteins of the mutant library. Both wild type, full length 
and truncated protein showed clear substrate turnover within a period of 60 s. Kinetic 
constants could be determined for both enzymes although the quality of the data 
collected for the wild type was inferior with respect to the observed error margin. In 
addition, phloretin concentrations above 80 µM appeared to induce significant 
substrate inhibition for Phywt. Measurements in this area however also showed 
increased standard deviations and approached signal saturation. The turnover and 
catalytic efficiency of Phy-10N was reduced by a factor of 2-3 compared to the wild 
type. 
 
Figure 5.10: Despite data fluctuation and comparatively large error margins, clear substrate 
turnover was observed for the Phywt as well as the Phy-10N hydrolase and was fitted to 
Michaelis Menten reaction kinetics. At higher phloretin concentrations, apparent substrate 
inhibition was detected for the wild type enzyme (inlet).  
 
Of the six soluble Phy mutants, four showed detectable substrate turnover in 
spectrophotometric assays whereas two variants presented minimal or no phloretin 
hydrolysis (see fig. 5.11 and table 5.5). Alteration of the histidine in position 123 to 
alanine (PhyHis123Ala), designed to interrupt binding with the divalent metal, led to a 
significant loss in activity. The observed substrate turnover was minimal and 
measurements showed large error margins. The data did thus not allow for confident 
determination of kinetic constants. The His203Ala mutant did not show any activity 
when exposed to 5-100 µM phloretin solutions. The second soluble metal binding 
mutant, PhyGlu154Gln, showed clear hydrolysis of phloretin within the course of the 
assay, albeit at reduced levels compared to the wild type. The Michaelis constant KM 
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and catalytic efficiency kcat/KM were reduced by a factor of 2 and 3 respectively. The 
introduction of a novel hydrogen bond in position 126 (PhyAla126Ser) led to a similar 
reduction in the KM but a four-fold decrease in catalytic efficiency. Two conservative 
mutations were introduced in position 115 and 218, changing tyrosine to 
phenylalanine and vice versa respectively (PhyTyr115Phy and PhyTyr218Phe). Both 
alterations had the least effect on the reaction’s Michaelis constant, reducing it by a 
factor of 0.5 (PhyTyr115Phe) and 0.6 (PhyPhe218Tyr). Catalytic efficiencies, however, 
were determined to be a magnitude lower than for the wild type.     
 
Figure 5.11: Using a spectrophotometric assay, phloretin hydrolysis was observed for four 
enzymes of the mutant library. Individual substrate dependent reaction velocities, to which 
standard Michaelis Menten kinetics were fitted, are shown. The bottom graph shows a 
superposition of all mutant reactions.  
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 KM (µM) Vmax (moles/sec) kcat (sec-1) kcat/KM (sec-1M-1) 
PhyWT 13.5 4.6 x 10-10 8.7 6.4 x 105 
Phy-10N 20.6 2.2 x 10-10 4.2 2.0 x 105 
Phy mutation Mutant library 
His123Ala n.d. 
Glu154Gln 6.2 7.0 x 10-11 1.3 2.1 x 105 
His251Ala Insoluble 
Glu255Gln Insoluble 
Tyr115Phe 8.3 1.9 x 10-11 0.4 4.3 x 104 
His203Ala n.d. 
Ala126Asn Insoluble 
Ala126Ser 6.8 5.4 x 10-11 1.0 1.5 x 105 
Phe218Tyr 7.5 2.1 x 10-11 0.4 5.3 x 104 
 
Table 5.5: A summary of kinetic constants determined for the wild type Phy protein as well 
as its truncated and mutant library variants is shown. For two of the mutant proteins, no 
kinetic constants were determined (n.d.) as they showed minimal or non-detectable levels of 
hydrolysis.  
 
5.3.9 Determination of Phy substrate specificity 
 
To characterise the specificity of phloretin hydrolase, a variety of phloroglucinol and 
benzaldehyde derivatives were tested as potential substrates. In a GC based assay, 
both substrate turnover and formation of the hydrolytic product were determined.  
Of the six molecules tested, only one was unambiguously accepted as a substrate by 
Phywt and both tested mutants, PhyAla126Ser and PhyPhe218Tyr. For 
monoacetylphloroglucinol (MAPG), a product peak was observed that corresponded 
in its retention time (2.2 min) to the expected hydrolytic product phloroglucinol 
(PG). Neither diacetylphloroglucinol (DAPG) nor any substrate with less than three 
hydroxyl substitutions on the aromatic ring were converted (see Fig. 5.12).  
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Figure 5.12: Six phloroglucinol and benzaldehyde derivatives were tested as potential 
substrates for the Phy wild type and mutant proteins as well as for PhlG. GC chromatograms 
for the reactions with MAPG and DAPG are shown. The table summarises formation (green 
tick) or absence (red cross) of hydrolytic products within the course of the assay.  
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5.4 Discussion 
 
In recent years, a number of hydrolases have been characterised that are able to 
cleave carbon-carbon bonds, many taking part in the metabolism of aromatic 
compounds. A select number of these hydrolases catalyse the unusual enzymatic 
retro Friedel Crafts acylation and cleave the bond between an aryl and an acyl 
moiety (176). Whereas hydrolases acting on carbon-carbon bonds usually require an 
active side residue to act as a nucleophile, two of these recently characterised 
Friedel-Crafts hydrolases, diacetylphloroglucinol and phloretin hydrolase (PhlG and 
Phy respectively), do not appear to rely on this feature (95,96). Both enzymes show 
novel properties with respect to their reactions, sequence and fold but whereas the 
structure of PhlG has been determined to high resolution (95), little is known about 
the structure, reaction mechanism and substrate specificity of Phy.   
 
When the synthetic phy gene was sub-cloned into an E.coli expression vector, 
soluble protein could be produced. The enzyme was purified at room temperature 
without significant losses in yield and remained in solution over many days (up to 
weeks) at 4 °C. Protein stability was thus assumed to be suitable for crystallisation. 
When initial crystallisation screening however remained unsuccessful, computational 
analysis of the secondary structure was aimed at identifying regions of disorder 
within the enzyme. The truncated construct Phy-10N, lacking the first ten N-terminal 
residues, was designed, sub-cloned, purified and tested for crystallisation.  Again, the 
formation of crystals or crystalline precipitate was minimal. A single crystal obtained 
with the truncated protein did not diffract beyond 4 Å. N-terminal protein disorder is 
thus unlikely to be the reason for a lack of crystal formation and poor diffraction 
quality. When, after several weeks under sitting-drop vapour diffusion conditions, a 
small full-length Phy crystal was obtained, this also diffracted poorly. As a 
fluorescence spectrum was measured on this crystal however, it presented a clear 
peak which could be fitted to the known signal of a divalent metal – zinc. When 
exposed to X-ray radiation, electrons in an atom get excited to a higher energy shell. 
The energy released on their return to the original, lower energy shell is detected as 
fluorescence and its level is unique to the atom type. The crystal used for measuring 
the spectrum is thus highly likely to contain zinc atoms. As it was grown in the 
absence of metals in either crystallisation condition or purification buffers, zinc was 
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most probably scavenged from the E.coli host by the Phy protein. To remain with the 
enzyme throughout purification and crystallisation, it is likely to be tightly attached 
to and highly coordinated by the amino acid side chains. Zinc is known to be of both 
functional and structural importance in certain proteins (186). In phloretin hydrolase, 
the metal may fulfil both. Addition of the chelating agent o-phenanthroline to a Phy 
solution was previously shown to significantly reduce enzymatic activity (96). When 
the original crystal was optimised in the presence of ZnOAc or ZnCl, crystals formed 
within 24 h as opposed to several days or weeks. Zinc may thus be essential or 
highly beneficial to protein folding and stability as well as activity.  
Despite improvements in crystallisation, no structure could be determined for 
phloretin hydrolase within the course of this project. Even after exposure to small, 
high-intensity synchrotron beams, crystals did not diffract beyond 3.5 Å. The 
information contained in the corresponding datasets was insufficient to determine the 
enzyme’s structure by molecular replacement. Despite the strict conservation of 
various active site residues, the overall sequence conservation between Phy and the 
only available, related structure (PhlG) is, at 25 %, comparatively low. At the given 
resolution, the two structures may thus differ too much to allow for the estimation of 
phases for Phy from the PhlG model alone.  
Structure determination by experimental phasing was equally unsuccessful. A strong 
anomalous signal was present in the diffraction data collected from a PhySeMet 
crystal, indicating the good incorporation of selenomethionine into the protein. The 
signal did not, however, extend into the high enough resolution shells and overall 
diffraction did not extend beyond 4.5 Å. The quality of electron density maps is 
dependent on the available phase information. As a consequence, the initial maps 
prepared using experimental phases only extend to the resolution to which an 
anomalous signal is present. With the available data, phase information was not 
sufficient to build reliable electron density maps and determine the Phy structure. 
Improvements in quality of either diffraction data (native and/or anomalous) or the 
availability of better search models may allow the determination of a Phy structure 
using experimental phasing or molecular replacement in the future.    
 
In the absence of crystallographic data, a computational model of Phy (Phymod) was 
prepared. This was used as the basis for the preparation of an active site mutant 
library from which kinetic data were collected. The latter were hoped to give an 
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insight into the catalytic importance of individual residues, similarities between PhlG 
and Phy and a potential reaction mechanism.   
 
The first four residues mutated were two glutamates and two histidines. In the PhlG 
structure all four were shown to surround and coordinate the bound metal.  They are 
highly conserved in proteins showing sequence similarities to Phy and PhlG (95), 
indicating that these homologues may also be metalloproteins.  The mutation of 
His251 and Glu255 to alanine and glutamine respectively resulted in a lack of 
protein production or insoluble polypeptides. Changing the histidine in position 123 
to an alanine reduced activity to levels too low for the determination of kinetic 
constants. Only the conservative replacement of the glutamate in position 154 with a 
glutamine gave soluble, active protein albeit with rates of catalysis significantly 
reduced compared to the wild type. The reduced activity of zinc binding mutants is 
likely the consequence of an essential role the metal is thought to play in catalysis. In 
a potential mechanism, previously proposed for the PhlG homologue and observed 
for a variety of zinc binding enzymes, the metal lowers the pKa of a closely 
positioned catalytic water, allowing its deprotonation and formation of a nucleophilic 
hydroxyl. The negative charge on the latter is stabilised by the positively charged 
divalent metal (95,186,187). The subsequent nucleophilic attack on the substrate 
leads to the formation of a tetrahedral intermediate and eventually cleavage of the 
scissile carbon-carbon bond (see Fig. 5.13) (95). Impaired coordination of the metal 
could thus reduce or even inhibit activation of the catalytic water. In addition, it was 
proposed that two of the metal coordinating residues, Glu160 and Glu274, may 
stabilise the tetrahedral intermediate through additional hydrogen bonds. This would 
further explain the reduced activity of the PhyGlu154Gln mutant (the mutated residue of 
which corresponds to Glu160 in PhlG, see Fig. 5.15).  
The variant’s Michaelis constant is reduced, which may be in indicator of increased 
substrate binding. This is surprising as the mutant’s binding efficiency for the 
substrate should not be significantly altered compared to the wild type. A phloretin 
molecule would remain attached to the active site for longer, however, as 
coordination of the metal catalyst is impaired and turnover reduced.  Furthermore, 
the Michaelis constant is not a universal indicator of binding affinity as it takes the 
turnover rate (kcat or k3) into consideration (188). Especially for reactions in which k3 
is significant with respect to dissociation of the complex into free enzyme and 
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substrate (k2) (see section 2.5.1, equations 2.2 and 2.5), the KM thus has to be 
evaluated in context of the reaction’s kcat. 
In summary, these results support the idea that a metal ion is essential for both 
protein folding and function. The variations in solubility and activity between the 
mutants may be the consequence of varying contributions of the respective side 
chains to metal binding. Alterations of the two more N-terminal residues gives rise to 
soluble protein (PhyGlu154Gln and PhyHis123Ala) whereas the two more C-terminal 
variants are either not fully translated or insoluble (PhyHis251Ala and PhyGlu255Gln). The 
latter are thus likely to be most important to capturing and coordinating zinc and are 
thus essential for structural integrity.  
 
Figure 5.13: Analogous to the mechanism proposed for DAPG hydrolysis by PhlG (95), 
phloretin may be hydrolysed into phloretic acid and phloroglucinol by way of a tetrahedral 
intermediate. The divalent metal is essential to the mechanism as it lowers the pKa of a 
catalytic water, allowing its activation and subsequent nucleophilic attack on the substrate.  
165 
 
In the PhlG homologue, three residues have been in implicated in hydrogen bond 
formation with the phloroglucinol substrate’s hydroxyl groups: Tyr121, His214 and 
Tyr229 (see Fig. 5.2). A sequence comparison between PhlG and Phy reveals two of 
these residues to be fully conserved (Tyr115 and His203) whereas the most 
C-terminal tyrosine is replaced by a phenylalanine (Phe218). When a Phy mutant 
library was prepared, variants were designed in which this hydrogen bond formation 
was either interrupted (PhyTyr115Phe and PhyHis203Ala) or introduced to allow for 
comparison of substrate binding between PhlG and Phy (PhyPhe218Tyr). All mutant 
genes were translated into soluble proteins which could be purified. 
Spectrophotometric assays showed introduction of the two conservative mutations 
(phenylalanine to tyrosine and vice versa) to give rise to active proteins, albeit with 
reduced rates of hydrolysis. The phloroglucinol moiety in PhlG, and even more so, 
the full phloretin molecule in Phy, is highly substituted with polar groups. As a 
substrate, it is thus likely to be coordinated by an extensive hydrogen bonding 
network. Replacement or addition of a single bond donor may interfere with overall 
substrate coordination but would be unlikely to interrupt binding completely. In this 
context, it is surprising to see that a histidine to alanine mutation in position 203 
abolished all enzymatic activity. Although the mutation is non-conservative and the 
structural change had the potential to influence the overall fold, the protein was 
highly soluble and purification yields exceeded those of all other mutants. It is thus 
possible that His203 has an as yet unknown function in either substrate binding or, 
even more likely, catalysis. Considering the differences in molecular structure 
between the diacetylphloroglucinol and phloretin, numerous additional interactions 
are likely to take place between the latter and Phy. Their identification however will 
require a three dimensional structure of the protein, ideally in complex with its 
substrate.  
 
An analysis of the phloretin hydrolase substrate specificity has shown the enzyme to 
hydrolyse the PhlG product monoacetylphloroglucinol (MAPG) but not the diacetyl 
substrate DAPG (see also below). In PhlG, an asparagine side chain is thought to 
form a hydrogen bond to the second acetyl group; the corresponding residue in Phy 
however is an alanine. To assess the importance of bonding in this position and to 
test if Phy could be altered to accept DAPG as a substrate, the respective alanine in 
position 126 was mutated to an asparagine. The alteration gave rise to non-translated 
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or insoluble protein only. This may be the consequence of a change in protein fold 
caused by the larger side chain, changes to the active site environment and geometry 
and/or sterical clashes with other neighbouring residues. This is supported by the 
observation that replacing alanine with a smaller hydrogen bond donor, serine, gives 
rise to soluble protein. As for the PhyPhe218Tyr mutant, introduction of a new hydrogen 
bond donor lowers the overall enzymatic activity; the catalytic efficiency is reduced 
by a factor of 4. This is not surprising as the phloretin substrate does not possess a 
second acetyl moiety. Introduction of the serine in position 126 was designed to alter 
specificity, not to improve turnover of the native substrate. Impaired rather than 
enhanced phloretin hydrolysis was thus expected.  
With respect to their catalytic activity, all mutants designed to alter substrate binding 
properties of Phy show a reduction in their Michaelis constant KM. As the mutations 
should weaken protein-ligand interactions, this observation is, at first glance, 
surprising. In the context of the significant overall reduction however, a lowered KM 
is not unusual for either of these mutants as described above for PhyGlu154Gln.  In 
addition, the Michaelis constants are derived from computational fitting. The 
measurements, at this substrate range and using the assay method described, allow 
for qualitative comparison of wild type and mutant proteins. They show an error 
margin which needs to be taken into consideration when evaluating total figures 
however. This is less significant for overall catalytic efficiencies (which differ by up 
to an order of magnitude) but important for the Michaelis constants, the differences 
of which are subtle.  
 
To determine the substrate requirements for Phy and test if additional hydrogen bond 
donors would allow for hydrolysis of alternative substrates, the conversion of 
MAPG, DAPG and four acetophenone derivatives was tested. Using Phywt, 
PhyAla126Ser and PhyPhe218Tyr as well as the PhlG homologue, neither of the 
acetophenones were converted. DAPG was exclusively turned over by PhlG and the 
MAPG hydrolysis product phloroglucinol was only observed for Phy wild type and 
mutant proteins. These results indicate that, in both Phy and PhlG, all three hydroxyl 
substituents are essential determinants of substrate specificity. Whereas PhlG 
requires the presence of two acetyl groups on the aromatic ring, the second group 
“inhibits” hydrolysis by Phy. The introduction of additional hydrogen bond donors in 
Phy, corresponding to similar functionalities in PhlG, does not alter the enzyme’s 
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specificity. In case of the serine introduced in position 126, this may be the 
consequence of insufficient proximity between the serine side chain’s OH group and 
the DAPG’s hydroxyl. Even if the corresponding residues occupy comparable 
positions within the active site, as implied by the computational model, the serine 
side chain is shorter than the corresponding asparagine in PhlG (see Fig. 5.14). Its 
position may thus not allow for substrate binding and stabilisation by hydrogen bond 
formation. In addition, the Phymod structure shows an isoleucine in position 152 
which, when superposed with the PhlG complex model, comes into very close 
proximity to the substrate’s un-cleaved acetyl group. This potential steric clash could 
be an indicator for differences between the Phy model and the actual structure. 
Alternatively, if the model corresponds to the actual conformation of the active site, 
the phloretin substrate may be bound in an orientation different to the DAPG model.  
 
Figure 5.14: The addition of a serine hydrogen bond donor in position 126 (red, left image) 
does not change the substrate specificity of Phy. The side chain may either be too short 
compared to the corresponding asparagine in PhlG or in an unfavourable position for bond 
formation. Superposition of the modelled PhlG complex with the predicted Phy structure 
also shows an isoleucine residue in a possible steric clash with the DAPG transition state 
(right image), indicating that either modelling of the active site is incorrect in this position or 
the phloretin substrate is bound in a different conformation. 
 
The alteration of a phenylalanine to a tyrosine in position 218 was designed to 
analyse the difference a hydrogen bond donor in this position makes to hydrolysis. 
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This functionality is present in PhlG and absent in Phy although both are thought to 
bind a phloroglucinol moiety’s hydroxyl in this position. The alteration does not 
allow Phy to hydrolyse the PhlG substrate nor does it bind and stabilise less 
substituted benzaldehyde derivatives for catalysis. As with the histidine in position 
203, assignment of a function to this residue thus awaits determination of the Phy 
three-dimensional (complex) structure.  
 
Figure 5.15: A superposition of the Phy computational model with the experimentally 
determined PhlG structure highlights the high similarities between model and template. All 
putative catalytic residues are shown. Their proposed functions in both proteins, which have 
been supported by kinetic data, are highlighted. The comparability of both enzymes is based 
on sequence conservation but also on the structural similarity of their substrates which share 
a common phloroglucinol core (highlighted in green) and are cleaved in the same position.  
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In summary, an insight has been gained into different aspects of carbon-carbon bond 
cleavage by phloretin hydrolase. The enzyme was found to be a metalloprotein in 
which a zinc atom may be of importance for structural integrity. Moreover, it appears 
essential for catalysis, possibly through activation of a catalytic water as proposed 
for the homologous PhlG protein. The similarities and differences in substrate 
specificity between both hydrolases are reflected in the potential to form hydrogen 
bonds with their respective ligands. Future protein engineering experiments may 
exploit these features to widen the Phy substrate scope. This will however require the 
three dimensional structure of the protein, ideally in complex with either substrate, 
reaction intermediate or products. More structural and mechanistic information may 
then even allow for a reversal of the phloretin hydrolase reaction and catalysis of an 
enzymatic Friedel-Crafts acylation.  
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Chapter 6: Purification and crystallisation of the oxidised polyvinyl alcohol 
hydrolase (OPH) from Pseudomonas sp. VM15C 
 
6.1 Introduction 
 
6.1.1 Biopolymer hydrolysis  
 
In addition to the hydrolysis of large aromatic compounds, a number of !-diketone 
hydrolases were shown to cleave carbon-carbon bonds in high molecular weight 
polymer structures. This property makes the enzymes attractive targets for both 
synthetic and degradative biocatalytic applications.    
A variety of polymers have been shown to be degraded by microorganisms or their 
respective isolated enzymes. These include polyesters, such as the bacterial 
polyhydroxyalkanoates, as well as polystyrenes, polyethylenes and polyvinyl 
alcohol. A common feature of enzymes involved in the breakdown of these polymers 
is the presence of a lipase box and a lipoprotein signal sequence in their primary 
amino acid sequence. Polymer breakdown is thus thought to occur on the cell surface 
and using a hydrolytic mechanism centred around the activation of a serine 
nucleophile for attack on the scissile bond (189,190). 
 
6.1.2 Polyvinyl alcohol 
 
Of the listed polymers, polyvinyl alcohol (PVA) has been of particular interest for 
research into bioremediation. The molecule is water soluble and thermostable and it 
is widely used as a fibre coating in the textile industry, as an adhesive or emulsifier 
as well as having a variety of other applications. As such it is released into 
wastewater streams in large quantities and requires efficient methods of breakdown 
(189). The linear backbone is a chain exclusively composed of carbon-carbon single 
bonds, substituted with a hydroxyl group in every second position (see Fig. 6.1). Its 
degradation is catalysed in two subsequent reactions. Stepwise, linear oxidation of 
the hydroxyl moieties leads to formation of !-diketone structures – oxidised 
polyvinyl alcohol (OPVA). This first reaction may be mediated by a dehydrogenase 
or an oxidase but, when quantified, was shown to take place on less than 4 % of the 
total vinyl alcohol units (89,189). As the !-diketone substrate is formed it may be 
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hydrolytically cleaved into a methylketone and a carboxylic acid by the action of a 
hydrolase. In Alcaligenes faecalis, a less common degradation involving formation 
of a !-hydroxyl rather than a diketone, followed by the aldol type cleavage into a 
monoketone and aldehyde, was also observed. OPVA hydrolysis takes places 
spontaneously and in the absence of any enzymes. It is however significantly 
enhanced by the catalysts. 
 
Figure 6.1: Enzymatic degradation of polyvinyl alcohol occurs via formation of a !-diketone 
which may be hydrolysed into a methyl ketone and a carboxylic acid. The latter can be used 
as a carbon source by the whole cell biocatalyst [adapted from (189)].  
 
6.1.3 Oxidised polyvinyl alcohol from Pseudomonas VM15C  
 
The microbial degradation of PVA is slow and generally requires the presence of 
mixed bacterial (predominantly Pseudomonas) cultures. Whereas one strain provides 
the oxidative and hydrolytic enzymes, a second is required for the supply of a 
pyrroloquinoline quinone (PQQ) cofactor essential for dehydrogenase activity 
(89,191,192).  
The isolation of enzymatic catalysts is thus of particular interest for industrial 
applications. In 2000, Shimao and co-workers were able to identify, clone and 
characterise the oxidised polyvinyl alcohol hydrolase from Pseudomonas sp. VM15C 
(OPH) (89). The corresponding gene, pvaB, is encoded upstream of the polyvinyl 
alcohol dehydrogenase gene pvaA and both are thought to constitute an operon. 
When the gene was expressed in a recombinant E. coli host, the sequence translated 
into 379 amino acids assembling into a 40 kDa polypeptide. The translated protein 
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was however predominantly found in the insoluble membrane fraction. This feature 
has since been observed for other OPH enzymes, even after removal of the 
lipoprotein signal sequence (89,193). As a consequence, OPH purification has only 
succeeded from a native hosts to date (194,195).   Using whole cell assays, the 
activity of Pseudomonas VM15C OPH could nonetheless be assayed and the enzyme 
was found to specifically enhance hydrolysis of oxidised polyvinyl alcohol. In 
addition to this native substrate, OPH was found to cleave the !-diketone moiety in 
4,6-nonanedione, giving 2-pentanone and n-butyric acid at an equimolar ratio (see 
Fig. 6.2). This non-native substrate was however turned over at a considerably lower 
rate than OPVA (89). 2,4-pentanedione is not hydrolysed by the enzyme, the closely 
related OPH from Pseudomonas vesicularis however does accept this lower 
molecular weight diketone as a substrate(194). Non-oxidised PVA or monoketones 
were also not accepted as substrates by the Pseudomonas VM15C hydrolase which is 
in agreement with all other characterised OPH homologues (194,195).    
 
6.1.4 Mechanism and structure of OPH 
 
The sequence analysis and inhibition studies of OPH have given a first insight into 
potential reaction mechanisms. A lipase box indicates that the protein contains a 
catalytic serine nucleophile as described above. In accordance with this, all activity is 
inhibited in the presence of phenylmethanesulfonylfluoride (PMSF), a known serine 
hydrolase inihibitor. Metal chelating agents on the other hand did not appear to 
interfere with hydrolysis (89). The lipoprotein signal sequence and cell surface 
assays on related OPH enzymes suggest that catalysis takes place on the cell surface 
where the protein can come into direct contact with its high molecular weight 
substrate (189). 
No three-dimensional structure has been determined for an OPH enzyme to date and 
sequence similarities to structurally characterised proteins are low. The closest 
related homologue of known structure is the fungal polyhydroxybutyrate 
depolymerase (PHBD) from Penicillium funiculosum. OPH and PHBP only share a 
sequence identity of 22 %. Both enzymes are however thought to be serine 
hydrolases and catalyse the fragmentation of high molecular weight polymers. PHBP 
shows a circularly permuted "/!-hydrolase fold and a highly conserved catalytic 
serine-histidine-aspartate triad. Analogous to the lipase family for which this fold 
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was first characterised, both PHBP and OPH have been proposed to catalyse 
hydrolysis by way of a tetrahedral intermediate and, possibly, a transient covalent 
acyl enzyme bond (84,89,196) (see Fig. 6.2). Apart from the similarities described 
above however, OPH is thought to be a highly unique, separately evolved enzyme 
(89).  
 
Figure 6.2: Hydrolysis of the OPH !-diketone substrate 4,6-nonanedione is thought to occur 
after nucleophilic attack by an active site serine residue and the consecutive formation of two 
tetrahedral intermediates [adapted from (84)] (a). The closest OPH homologue for which a 
structure has been determined is the fungal PHBD protein, showing a circularly permuted 
"/! hydrolase fold (b). The two enzymes share a sequence identity of 22 %, with all identical 
residues being centred around the core of significantly longer PHBD sequence.  
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6.1.5 Applications of OPH in biocatalysis 
 
OPH-type enzymes have a considerable potential for industrial applications. They 
are the focus of research into bioremediation and their isolated use would 
significantly enhance the breakdown of soluble polymers in waste water streams 
(189). In addition, if the hydrolytic reaction could be reverted, the enzymes would be 
useful tools in the preparation of !-diketones. The latter are important building 
blocks for synthetic chemistry (84) and their preparation using biocatalysts would 
likely improve reaction specificities, e.g. with respect to acylation, over abiotic 
reactions. 
 
6.1.6 Project aim 
 
Due to the frequently reported problems with the production of correctly folded OPH 
protein, the major goal of this work was to obtain significant amounts of soluble 
enzyme for purification, characterisation and structure determination. Knowledge 
about the kinetic features of C-C bond hydrolysis, as well as the protein’s fold, 
potential active site residues and enzyme-substrate interactions would then allow for 
the proposal of a detailed mechanism of !-diketone cleavage. This could, in the 
future, support protein engineering and experiments aimed at reversing the reaction 
into carbon-carbon bond formation.  
 
6.2 Materials and Methods 
 
6.2.1 Ligation independent cloning of the OPH synthetic gene 
 
For production of the Pseudomonas VM15C OPH protein, a synthetic gene, 
optimised for recombinant expression in E. coli hosts systems, was kindly provided 
by Professor Wolfgang Kroutil from the University of Graz. To attach a 
hexahistidine-tag and allow for metal affinity purification of the translated protein, 
the gene was then inserted into the YSBLIC3C vector using a ligation independent 
cloning (LIC) protocol. LIC optimised primers were designed and used for 
amplification of the oph synthetic gene (103). Their sequences and amplification 
conditions are shown in table 6.1. After T4 polymerase treatment, both gene and 
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digested vector (kindly provided by Dr. Laila Roper) were annealed using the LIC 
optimised cloning procedure.  
 
Variant Forward Primer (5’-3’) Reverse Primer (5’-3’) 
1 OPH 
ccagggaccagcaatgaatcagagcctgggt
gttctgcgtc 
gaggagaaggcgcgttattaatacagaccggta
aacggaccaacatgac 
2 OPH-LSS 
ccagggaccagcaatgggtgcagatcgtacc
gcagcaacaccggcag 
gaggagaaggcgcgttattaatacagaccggta
aacggaccaacatgac  
 
Reaction component Concentration Volume [ul] final concentration 
 
forward primer  
 
20 pmol/µL 
 
1 
 
0.4 µM 
reverse primer 20 pmol/µL 1 0.4 µM 
template DNA  50 ng/uL 1 1 ng/µL 
deoxyribonucleotides (dNTPS) 10 mM 2 0.4 mM 
KOD® hot start DNA 
polymerase buffer 
5x 5 1x 
MgSO4 25 mM 3 1.5 mM 
DMSO 100 %  0.5 1 % (v/v) 
KOD® hot start DNA 
polymerase 
1.0U/ µL 1 0.02 U/ µL 
deionised water - 35.5 - 
 
Cycles Temperature [°C] Time [min:s] Reaction 
 
1 
 
94 
 
2:00 
 
initial denaturation 
25 
94 0:30 denaturation 
45 0:30 annealing 
72 0:30 extension 
1 72 3:00 Final extension 
- 4 ' hold/storage 
 
Table 6.1: The oph gene was amplified from its synthetic template in a PCR reaction using 
LIC specific primers (top). Reaction components (middle) and amplification conditions 
(bottom) are shown and correspond to LIC cloning reactions for both full length protein and 
the truncated OPH-LSS described below.  
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The LIC3C:oph plasmid could eventually be isolated from an E. coli expression host 
transformed by the annealing product. A restriction endonuclease digest confirmed 
the presence and orientation of the gene of interest. Its sequence and completeness 
was verified by sending a small amount of DNA for sequencing with the University 
of York Technology Facility.  
Detailed LIC procedures including the preparation of both vector and insert can also 
be found in chapter 5, section 5.2.  
 
6.2.2 Analysis of OPH gene expression and protein production 
 
After sequencing verified successful insertion of the oph gene into the YSBLIC3C 
vector, three E.coli (DE3) expression strains were transformed by the corresponding 
plasmid DNA: E.coli BL21, BL21 gold and Rosetta. Resulting colonies were picked 
and used for the preparation of 5 mL overnight cultures in LB medium. 10 mL LB 
expression cultures inoculated with this starter culture were grown to an optical 
density (OD) of 0.6, induced with 1 mM IPTG (final concentration). Kanamycin was 
used as the selective antibiotic, at a final concentration of 30 µg/mL for all solid and 
liquid E. coli cultures. The cells were incubated at 18°C for 18 h while shaking at 
180 rpm. After harvesting by centrifugation at 13,000 rpm for 5 min, cells were 
resuspended in 1 mL of 50 mM Tris buffer containing 300 mM NaCl (hereafter 
named resuspension buffer) and disrupted by sonication at 14,000 amplitude microns 
for 3 x 3-4 s with 5 second cooling intervals. The crude cell extracts were 
subsequently centrifuged at 13,000 rpm for 30 min. 10 µL samples were taken from 
disrupted whole cells and the soluble supernatant after their centrifugation, 
representing soluble and total cell fractions respectively. All samples were eventually 
separated and visualised on a 12 % polyacrylamide gel using SDS PAGE 
chromatography. 
 
6.2.3 OPH Ni-affinity purification 
 
For purification of OPH from a recombinant host, an E.coli BL21 (DE3) expression 
strain was transformed by the YSBLIC:oph plasmid. Resulting colonies were picked 
and used for the preparation of starter cultures from which 2 L of LB medium were 
inoculated. The cultures were grown, induced with IPTG, incubated and harvested. 
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Cells were resuspended and disrupted by sonication after which separated, soluble 
fractions loaded could be loaded onto a 5 mL HiTrap™ Chelating HP Nickel affinity 
column. After washing of the column with resuspension buffer, an imidazole 
gradient was applied to allow for elution of the hexahistidine-tagged protein. All 
procedures correspond to those detailed for the BsPAD protein and are also described 
in chapter 4, section 4.2.  
Due to the absence of a chromatography peak or detectable protein bands after SDS 
PAGE chromatography, further purification steps were abandoned at this stage.  
 
6.2.4 Solubility screening 
 
A buffer based solubility screen was carried out after the OPH protein was found to 
be produced exclusively in its insoluble form in all expression strains. For this 
screen, induced cells were grown at 18°C for 18 h and harvested as described above 
for expression testing (section 6.2.2), in 30 aliquots of 10 mL each. Cell pellets were 
then resuspended in 1 mL of buffers, containing the detergents and additives listed in 
Fig. 6.5 (116). Protein solubility was assayed by taking samples of soluble and 
insoluble protein fractions and separating them by SDS PAGE chromatography.   
 
6.2.5 Prediction and removal of the OPH lipoprotein signal sequence 
 
The OPH amino acid sequence was entered into the Oxford Protein Production 
Facility’s Protein Analysis Linker (OPAL) (197) and a lipoprotein signal sequence 
was detected, corresponding to previous reports (89). Consequently, primers for a 
truncated construct lacking the protein’s first 29 N-terminal amino acids were 
designed and are listed in table 6.1. Cloning, isolation and sequencing of the 
shortened protein sequence were performed using the LIC methods described in 
chapter 5, section 5.2. The resulting plasmid and protein were designated 
YSBLIC:oph-LSS and OPH-LSS respectively. Initial gene expression and protein 
production tests in E. coli BL21 (DE3) cells were performed as described for the full 
length construct,with additional samples being taken from a 37 °C incubation test, 1, 
2, 3 and 18 h after induction. The samples were prepared in duplicate and 
resuspended in Tris or phosphate based resuspension buffers, either at a pH of 7.5.  
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6.2.6 Optimisation of OPH-LSS protein solubility 
 
As, despite the lack of its lipoprotein signal sequence, the OPH-LSS protein remained 
insoluble, 1 L of cells transformed by the YSBLIC:oph-LSS plasmids were grown, 
induced and incubated at 16 °C for 18 h. The culture was split into eight aliquots of 
120-140 mL and cells were harvested as described above. The resulting pellets were 
resuspended in either Tris or phosphate based buffer, either of the two buffers 
containing 10 % glycerol, 10 % glycerol and 1 % triton X-100 or 10 % glycerol and 
1% tween 20. After sonication and centrifugation, samples were taken from both 
soluble and resuspended insoluble cell fractions and visualised by SDS PAGE 
chromatography.   
 
6.2.7 Variation of E. coli expression strains to enhance protein solubility 
 
Two E. coli strains optimised to enhance solubility of the translated protein of 
interest were transformed by the YSBLIC:oph-LSS plasmids. Both strains, E. coli 
Lemo21 (DE3) (109,110) and E. coli Arctic Express™ (DE3) (111,112), were 
transformed by the YSBLIC:OPH-LSS plasmid and subsequently grown and induced 
according to the suppliers protocols. Whereas cells were incubated at reduced 
temperatures to induce chaperonin production in the Arctic Express strain, titration 
of rhamnose levels was aimed at regulating expression levels for the gene of interest 
in Lemo cells. As control reactions, both strains were transformed by empty 
YSBLIC3C plasmids, cultured, harvested and analysed under the same conditions as 
their YSBLIC:OPH-LSS expressing counterparts.  
 
6.2.8 Preparation of OPH fusion constructs 
 
Using the In-fusion cloning technique, the oph-LSS gene was fused to four different 
N-terminal protein solubility tags by the University of York’s Technology facility. 
These tags include the glutathione S-transferase (GST), the maltose binding protein 
(MBP), immunoprotein 9 (IM9) and a green fluorescence protein (GFP). Each 
solubility tag contains an additional N-terminal, non-cleavable hexahistidine 
sequence and is linked to the OPH-LSS protein sequence by a HRV3C protease 
cleavage site.  The corresponding vectors are based on the YSBLIC3C system and 
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were thus designated YSBLIC3C:oph:fus, with fus corresponding to either the gst, 
mbp, im9 or gfp genes.  
 
6.2.9 Analysis of YSBLIC3C:oph:fus gene expression and protein production 
 
To assess the effect the four protein tags have on OPH-LSS solubility, E. coli BL21 
(DE3) expression cells were transformed by the corresponding YSBLIC:oph:fus 
plasmids. Resulting colonies were picked and used for the preparation of 5 mL 
overnight cultures from which, in turn, 10 mL LB expression cultures could be 
inoculated, grown and induced as described in section 6.2.2. After shaking 
incubation at 18 °C for 18 h, cells were harvested by centrifugation, resuspended, 
disrupted and their soluble and insoluble fractions analysed by SDS PAGE 
chromatography as detailed above.  
 
6.2.10 Purification of the OPH:GST fusion construct 
 
As the OPH:GST fusion construct showed one of the most pronounced bands in the 
soluble cell fractions visualised by SDS PAGE, it was chosen as the first target for 
large scale protein purification. After transformation of an E.coli BL21 expression 
strain by the corresponding plasmid, resulting colonies were picked, starter cultures 
prepared and used for the inoculation of 2 L of LB medium as described above. After 
induction and incubation, cells were harvested, resuspended, disrupted and the cell 
free extract loaded onto a 5 mL HiTrap™ Chelating HP Nickel affinity 
chromatography column as detailed in section 6.2.3. In contrast to previous 
purification experiments, a chromatography peak could be detected during 
application of the 30-500 mM imidazole gradient. The corresponding peak fractions 
were pooled and mixed with purified HRV3C protease at a ratio of 1:10 (w/w) 
(protease : protein of interest). After incubation at 4 °C for 18 h, the protein/protease 
mix was concentrated to a final volume of 2 mL and loaded onto a 5 mL HiTrap™ 
nickel affinity chromatography column as described above. For elution of the 
cleaved protein, 50 ml of 50 mM Tris buffer (pH 7.5) containing 300 mM NaCl were 
applied to the column, followed by a 0-500 mM imidazole gradient over 100 ml for 
elution of the hexahistidine-tagged GST fusion protein. Protein peak fractions were 
subsequently pooled and concentrated to a total volume of 2 mL before being applied 
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to a Superdex™ S75 gel filtration column. From the latter, protein was eluted in 
resuspension buffer. During all stages of purification, 10 µL samples were taken to 
evaluate protein purity on a 12% SDS PAGE gel. After the final purification step, all 
protein was stored at 4 °C until further use in crystallisation experiments.  
 
6.2.11 Crystallisation of purified OPH:GST protein 
 
After purification, the OPH:GST construct did not appear to have been cleaved by 
the HRV3C protease. Nonetheless, structural experiments were carried out using the 
fused proteins.  
For crystallisation, the purified OPH:GST was concentrated to 3 mg/mL. In three 96 
well trays, the protein was assayed against the PACT, INDEX and CSS 1+2 screens 
using the sitting drop vapour diffusion method. For the latter, two separate pH 
variants were tested using MES Tris buffer at a pH of 5.6 and 8.0 respectively. A 
crystal hit found in the PACT screen’s B4 condition (sodium malonate, imidazole, 
boric acid system, pH 7.0, 25 % PEG 1.5K) was subsequently scaled up using the 
hanging drop vapour diffusion method. Detergent concentrations of this optimisation 
tray were varied between 23 and 28 % PEG, pH values ranged from 6.5 to 7.5.   
   
6.2.12 Crystal testing 
 
Crystals obtained using the INDEX crystallisation screen were fished, flash-cooled 
in liquid nitrogen and tested for diffraction using an in-house X-ray source and a 
MARRESEARCH MAR345 imaging plate detector. A single crystal from the 
INDEX E5 condition was retained and sent to the Diamond Light Source 
synchrotron for further testing. No datasets were collected.  
 
6.2.13 Prediction of protein disorder 
 
To predict stretches of disordered residues in the protein structure, the OPH-LSS 
amino acid sequence was entered into the disorder prediction server Regional Order 
Neural Network (RONN) from the Oxford Protein Production Facility (178).   
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6.3 Results 
 
6.3.1 Ligation independent cloning of the oph and oph-LSS synthetic genes 
 
Using the ligation independent cloning method, the synthetic oph gene could be 
introduced into the YSBLIC3C plasmid. When analysed using the Oxford protein 
production facility Protein Analysis Linker (OPAL) (197), the OPH primary 
sequence was shown to include a lipoprotein signal peptide as suggested previously 
(89). Consequently, a second, truncated construct (OPH-LSS) was designed, lacking 
the protein’s first 29 N-terminal amino acids. It was equally amplified and inserted 
into the YSBLIC3C vector (see above, Fig. 6.3).  
An endonuclease digest on two restriction sites flanking the genes of interest verified 
their insertion and correct orientation within the vector. When the gene sequences 
were determined, translated into the corresponding amino acids and aligned with the 
deposited OPH sequence, no mutations were observed. The signal sequence was 
absent in case of the YSBLIC3C:oph-LSS construct.  
 
Figure 6.3: An endonuclease double digest verified the presence and orientation of the oph 
and oph-LSS genes in the YSBLIC3C vector. The plasmid DNA (blue boxes) can be seen at a 
height of 5.4 kilobases. The inserts (green boxes) are close to the 1.0 kb marker band as 
expected from their molecular weight of 1.1 and 1.0 kb (oph and oph-LSS respectively) (a). 
The lipoprotein signal peptide, as determined by the OPAL server, comprises the first 29 N-
terminal OPH residues and is highlighted in yellow (b).  
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6.3.2 Analysis of OPH (full length) protein production and OPH Ni-affinity 
purification 
 
After three E. coli strains were transformed by the YSBLIC3C:oph plasmid, gene 
expression and protein production were analysed under varying conditions. The 
overproduction of a protein with the correct molecular weight of approximately 
40 kDa could be visualised using SDS PAGE. Irrespective of host strain or 
incubation temperature however, this overproduction was exclusively observed for 
the insoluble fractions of the disrupted cells (see Fig. 6.4). As a protein band appears 
at an equivalent position in uninduced samples or cells transformed by an empty 
YSBLIC3C plasmid, the result remained ambiguous. To determine if low amounts of 
OPH protein may be present in the soluble fraction, the culture volume was scaled up 
and soluble cell fractions loaded onto a Ni-affinity chromatography column. 
Application of a 30-500 mM imidazole gradient to the column did not result in the 
elution of any OPH protein, as shown by the lack of an FPLC absorbance peak or a 
protein band on the subsequently prepared SDS PAGE gel (results not shown). 
 
 
Figure 6.4: Initial expression tests showed the overproduction of a putative OPH full length 
protein with a molecular weight of approximately 40 kDa (yellow box). OPH produced 
exclusively in its insoluble form (ins), soluble fractions (sol) do not differ between induced 
(I) and non-induced  (N) samples. An attempt at purification of the protein from a scaled up 
culture was unsuccessful and no protein signal could be observed (results not shown).  
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6.3.3 Solubility screening 
 
In an attempt to enhance protein solubility and release OPH protein from the 
observed inclusion bodies, harvested cultures were resuspended and cells disrupted 
in buffers supplying a variety of pH values and additives (116). 
 
Figure 6.5: SDS PAGE gels show soluble and insoluble fractions of OPH protein cultures 
resuspended and lysed in one the 30 listed buffers. Significant OPH production (yellow box) 
can only be observed in the insoluble fractions.  
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Despite the clear overexpression of the protein of interest, no improvement in 
solubility could be observed (see Fig. 6.5).   
 
6.3.4 Analysis of OPH-LSS protein production  
 
As solubility problems prevailed with the OPH wild type, protein production and 
solubility were assayed for the construct lacking an N-terminal lipoprotein signal 
sequence. Initial tests using two buffer systems showed successful gene expression 
and translation of the recombinant OPH-LSS protein, albeit exclusively in the form of 
insoluble inclusion bodies (see Fig. 6.6). Results thus resembled those of the full 
length hydrolase.  
 
Figure 6.6: OPH-LSS protein production was analysed under varying conditions with respect 
to incubation time and temperature as well as buffers used for resuspension of harvested 
pellets. SDS PAGE gels of both soluble (a) and insoluble (b) cell fractions are shown, 
including the non-induced control samples (N). The yellow box marks the expected position 
of soluble and insoluble OPH-LSS (dashed and bold lines respectively).  
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6.3.5 Optimisation of OPH-LSS protein solubility 
 
As the protein remained insoluble after removal of the lipoprotein signal sequence, 
attempts were made to solubilise OPH-LSS in buffers containing the detergents 
glycerol, triton X-100 or tween 20. SDS PAGE analysis of soluble cell fractions did 
any noticeable solubilisation of the hydrolase (results not shown).  
 
6.3.6 Variation of E. coli expression strains to enhance OPH-LSS protein solubility 
 
Two alternative cell strains were transformed by the YSBLIC3C:oph plasmid. Both 
are based on the E. coli BL21(DE3) expression system but were modified to enhance 
solubility of recombinantly produced proteins. Whereas the Lemo strain allowed for 
titration of induction levels, a pair of temperature activated chaperonins were co-
expressed in the Arctic express cells (109-112). 
For the latter, production of OPH-LSS protein in addition to at least one of the 
chaperones (Cpn60) was observed. The second chaperone (Cpn10) has a molecular 
weight of 10 kDa and was potentially visible at the bottom of the SDS gel. The 
protein of interest was however still insoluble. Experiments with the Lemo cells did 
not show any noticable production of recombinant OPH-LSS, irrespective of the 
titrated induction levels (see Fig. 6.7). 
 
Figure 6.7: Alternative expression strains were tested for their ability to produce soluble 
OPH-LSS protein. In Lemo cells, induction levels were titrated using L-rhamnose (white bar). 
In Arctic Express (AE) cells, cold-induced chaperones (blue boxes) were co-expressed. Cells 
transformed by an empty YSBLIC3C plasmid served as control reactions.   
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6.3.7 Preparation of OPH fusion constructs and analysis of protein production 
 
Fusion constructs between OPH-LSS and N-terminal GST, GFP, MBP and IM9 
protein tags were prepared in an attempt to support correct folding of the hydrolase 
and make it accessible for purification. The truncated hydrolase gene was cloned into 
the appropriate fusion vectors by the University of York’s Technology facility. Its 
successful insertion was verified by restriction endonuclease digest (results not 
shown).  
When production of the fusion constructs was assayed in an E. coli  BL21 (DE3) 
expression strain, significant overproduction of soluble protein could be observed for 
two out of four constructs, OPH-LSS:GST and OPH-LSS:MBP. Both presented strong 
bands on an SDS PAGE gel, corresponding to the added molecular weight of both 
hydrolase and fusion tag (see Fig. 6.8).  
 
Figure 6.8: Protein production and solubility was assayed for E. coli cells transformed by the 
four fusion construct plasmids. Insoluble (I) and soluble (S) fractions of the lysed cells are 
shown. Yellow boxes mark soluble protein which corresponds in molecular weight to the 
expected fusion construct.   
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6.3.8Purification of the OPH-LSS:GST fusion construct 
 
As the OPH-LSS fusion construct presented the most significant overproduction of 
soluble protein, it was chosen as a first target for purification. Using Ni-affinity 
chromatography, an area with several peaks in absorbance could be separated from 
the soluble cell fraction. Analysis of the peak area using SDS PAGE showed 
dominant bands at the expected molecular weight of the fusion construct (65 kDa, 
see Fig. 6.9).  
 
Figure 6.9: The OPH:GST fusion construct was purified in three steps. After Ni-affinity 
chromatography (top), a protease digest was carried out to separate the hydrolase and from 
its His-tagged fusion protein. SDS PAGE analysis of the second Ni-affinity chromatography 
(centre) however showed protein fractions corresponding predominantly to the fused 
construct. Subsequent size-exclusion chromatography then yielded an OPH:GST protein 
sample with only minor impurities (bottom).  
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Incubation of the pooled protein fractions with HRV3C protease initially appeared to 
allow for separation of the hydrolase from its fusion tag. A sharp absorbance peak 
was observed in the imidazole free buffer fractions of the second Ni-affinity 
purification step, followed by further peaks in the imidazole gradient. SDS PAGE 
analysis however showed the putative hydrolase fractions to correspond to a 65 kDa 
protein – the expected molecular weight of the OPH:GST fusion.  
When the imidazole free peak fractions were pooled, a significant amount of protein 
remained in solution and could be concentrated for a final purification step using size 
exclusion chromatography. The latter resulted in a major peak in absorbance flanked 
by 3 smaller peaks. SDS PAGE analysis showed this peak area to correspond to the 
OPH:GST fusion in addition to minor, lower molecular weight impurities (see Fig. 
6.9). 
 
6.3.9 OPH:GST crystallisation and diffraction testing 
 
To determine the OPH-LSS three-dimensional structure, crystallisation experiments 
were carried using the purified fusion construct. With the hanging drop vapour 
diffusion method and three different screens, various crystal forms were observed 
after an incubation time of several days. The crystals varied in shape, forming 
needles or thin plates, and formed in isolation as well as in larger clusters (see Fig. 
6.10). Hits were predominantly found in the PACT and INDEX screens.  
 
Figure 6.10: When the purified OPH-LSS protein was screened against 3 x 96 conditions, 
crystals of various morphologies were found. Hits were particularly abundant for the INDEX 
and PACT screens.   
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When three of the crystals (from INDEX screen E2 and E5, see above) were tested 
using an in-house X-ray source, no diffraction was observed. A single crystal from 
condition E5 was subjected to synchrotron radiation. Again, no significant diffraction 
could be detected (results not shown).  
 
6.3.10 Prediction of protein disorder 
 
Due to the absence of any perceivable diffraction, the OPH-LSS amino acid sequence 
was analysed for structural disorder. Several amino acid stretches, distributed 
throughout the protein, were predicted to be disordered, with the most prominent 
area being the 23 most N-terminal residues. 
 
Figure 6.11 : Disorder in the OPH-LSS three dimensional structure was predicted using the 
RONN server (178).  Residues with a probability of disorder above 50 % are highlighted 
with stars in the amino acid sequence.   
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6.4 Discussion 
 
The pvaB gene, encoding oxidised polyvinyl alcohol hydrolase from Pseudomonas 
sp. VM15C, has been optimised for expression in E. coli and, once subcloned into 
the pET28a vector, was supplied with an additional hexahistidine sequence for 
purification. However, any attempt to isolate the protein from cell free extracts has 
failed as OPH does not seem to be produced in its soluble form. This is in 
accordance with previous findings, for OPH from Pseudomonas as well as a 
homologue from Sphingopyxis (193). The only soluble protein isolated to this day 
was purified directly from a Pseudomonas strain (194).  
 
The presence of a lipoprotein signal sequence appeared to be the most likely 
explanation for insolubility as it would target the protein to the membrane fraction 
and exclude it from cell free extracts used for protein purification. However, removal 
of the signal sequence does not circumvent this problem. Lyophilised whole cells or 
crude extracts of cells producing OPH without its signal sequence appear to have lost 
their hydrolytic activity. This is in contrast to results obtained using the full length 
protein (Ms Elina Siirola, personal communication). After translation, the signal 
sequence may thus, in addition to its targeting function, contribute to the protein’s 
overall fold. The latter would also explain the lack of success in solubilising the 
protein by the addition of detergents to the resuspension buffer. Also the alteration of 
expression strains may not have an effect on this lack of structural support. The 
E. coli Lemo21 (DE3) strain allows for fine-tuning of T7 RNA polymerase 
expression and thus indirectly controls the Lac promoter in pET28-based YSBLIC3C 
plasmids (109). It is thus particularly well-suited for the overproduction of toxic 
proteins but may not overcome initial folding problems. Growth of the E. coli Arctic 
Express cells at low temperatures induces chaperonins which are subsequently hoped 
to aid in folding of the protein of interest (111,112).  A prerequisite for this type of 
support however is the accessibility of the target peptide to the chaperones.  Early 
aggregation of OPH-LSS may prevent this interaction.  
 
The attachment of protein tags has been shown to allow for solubilisation and 
subsequent purification of previously insoluble targets (118). When a variety of 
protein tags were fused to the OPH-LSS hydrolase, two out four constructs appeared 
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as soluble proteins in the cytosolic fractions of lysed cells. The mechanisms by 
which proteinaceous tags allow for the solubilisation of their targets is not clear and 
might vary between the tags and targets. It has been suggested to be the consequence 
of stabilisation and enhancement of the native folding process. Alternatively, the tag 
may “transport” the target protein to a cellular location which makes it accessible to 
molecular chaperones. Assuming the hydrolase component of the GST:OPH fusion 
is contributing to full length construct’s solubility and is thus itself correctly folded, 
the latter hypothesis would be a likely explanation for the observed production of 
soluble protein. The wild type, full length OPH protein appears in the form of 
inclusion bodies when cells are lysed and their soluble and insoluble fractions are 
visualised by SDS PAGE. Crude extracts of cells producing the protein however are 
active. It is possible that targeting of the protein through the cell plays an important 
role in its stabilisation. It may allow for close contact with chaperones which 
stabilise and/or catalyse the final folding process. It may then catalyse OPVA 
hydrolysis close to or incorporated within the membrane. It could even occur on the 
cell’s surface as suggested previously (190). Removal of the signal sequence may 
thus lead to fast aggregation of the partially folded peptide, during or immediately 
after translation, precluding access to cytosolic chaperones. The fusion of OPH-LSS to 
a protein solubility tag, which is itself highly soluble and stable, could enhance 
relocation and movement of the partially folded hydrolase in the cytosol. Here it 
might fold into a stable tertiary and quarternary structure, stabilised or assisted by 
chaperones.  
If the solubility tag functions predominantly as a transporter, as described above, the 
OPH protein would thus be likely to remain in solution after its cleavage. If GST 
however has an essential stabilising function for the hydrolase, its separation may 
result in immediate precipitation of the hydrolase. If solubility can be retained by the 
hydrolase is unclear to date as attempts to separate both proteins by way of a targeted 
protease digest were unsuccessful. This may be the consequence of a protein fold or 
arrangement in which the 3C cleavage sequence is buried within one of the proteins 
or even“sandwiched” between them. Either case would restrict access of the protease 
to its recognition sequence.  
 
Another stability indicator of the purified fusion construct is its apparent ability to 
crystallise. In the absence of diffraction and, consequently, structural data, it is 
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however unclear if the crystals have formed from the full length fusion protein. The 
crystallisation of targets with large protein tags is rare but has been observed 
previously (198).  Alternatively, spontaneous proteolysis or even remaining 
3C protease activity in the protein sample may have led to cleavage of the fusion and 
crystallisation of individual GST or OPH-LSS protein. The predicted protein disorder 
of the latter would likely impair diffraction properties of the fusion and individual 
hydrolase crystals. The extremely low resolution obtained may be a consequence of 
this feature. In either case, the lack of isolated high resolution spots on the diffraction 
image indicates that the crystals have formed from protein rather than from salt 
contained in the screen solutions.   
 
Figure 6.12: Protein tags have been suggested to enhance solubility of target proteins by 
allowing for interactions with molecular chaperones. For full length OPH, this interaction 
might occur spontaneously as the partially folded protein is channelled through the cytosol 
via the LSS (a). OPH-LSS is likely to form insoluble aggregates after or during its translation, 
leading to formation of inclusion bodies and restricting access to chaperones (b). When fused 
to a highly soluble protein tag, OPH-LSS is pulled into the cytosol where it may come into 
contact with chaperones (c). Once folded correctly it is stable, can be purified and 
concentrated. It remains to be determined if solubility is retained after removal of the protein 
tag (d).  
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In conclusion, an oxidised polyvinyl alcohol hydrolase fusion protein has been 
purified for the first time and could be crystallised. This may create the basis for 
structural and mechanistic investigations into this unusual family of !-diketone 
hydrolases. Future work should include the testing of alternative fusion constructs 
and, if required, their optimisation to allow for cleavage of the hydrolase from its 
protein tag. An extended linker sequence may overcome the apparent problem of 
accessibility to the protease recognition sequence. After purification of the isolated 
OPH-LSS protein, the next priority will have to be the determination of an OPH three-
dimensional structure, substrate range and a potential mechanism of hydrolysis. The 
identification and alteration of catalytic active site residues could alter the reaction 
with respect to efficiency and specificity. Eventually, experiments with an aim to 
revert the reaction could lead to the highly valuable enzymatic synthesis of !-
diketones for synthetic applications.  
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Chapter 7: General conclusions and outlook 
 
The work presented in the previous chapters gives some insight into the diversity of 
enzymatic reactions leading to the cleavage of carbon-carbon bonds. Members of the 
two major protein families involved in this process, the C-C hydrolases and lyases, 
have been analysed with respect to their structure, mechanism and/or substrate 
requirements.  
 
The complex structure of a BsPAD protein with its p-coumaric acid substrate, 
together with kinetic data obtained from an active site mutant library, gave an insight 
into the cofactor independent reactions of carbon-carbon bond lyases. Due to their 
effect on brewing and food fermentation processes, PAD enzymes have already 
(indirectly) been at the centre of biotechnological applications for centuries. More 
detailed understanding of the reactions involved however allows their use in more 
complex applications.  
An example of this is the preparation of natural vanillin from plant derived ferulic 
acid. The process occurs naturally and was shown to be catalysed by a 
hydroxycinnamoyl hydratase lyase. It relies, however, on the substrate to initially 
form a thioester with coenzyme A (feruloylCoA). The latter is then hydrated prior to 
cleavage of the C-C bond (199). The use of a phenolic acid decarboxylase could now 
circumvent this coenzyme dependent reaction step if used in a “one pot” cascade 
reaction with an oxygenase (see Fig. 7.1). Initial experiments with a PAD enzyme 
from Enterobacter and a fungal alkene cleaving enzyme from Trametes hirsuta (200) 
have already shown promising results (Dr. Aashrita Rajagopalan, personal 
communication). If optimised, such processes could create an environmentally 
friendly method of turning plant derived waste products into high value flavour 
compounds.  
In addition to the well characterised decarboxylation, PAD enzymes have been 
shown to catalyse carboxylation reactions and thus have potential applications in 
CO2 fixation and the conversion a waste products into synthetic building blocks (13).  
An enzyme such as BsPAD, which is stable, highly soluble, very reactive and 
amenable to mutations of active site residues is an ideal target for future work in the 
areas described above. Process and/or enzyme engineering could optimise the 
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catalyst even further for large scale applications and maybe even widen it substrate 
scope.  
 
Figure 7.1: BsPAD may be the future target for a cascade reaction with the alkene cleaving 
enzyme from Trametes hirsuta, producing high value vanillin from the renewable resource 
ferulic acid.   
 
In contrast to decarboxylases, the enzyme-catalysed hydrolytic cleavage of carbon-
carbon bonds is less well understood. With the work described in the previous 
chapters, a first insight has been gained into two, structurally and mechanistically, 
very different C-C hydrolases.  
 
Phloretin hydrolase from Eubacterium ramulus (Phy) was shown to resemble a 
previously characterised diacetylphloroglucinol hydrolase (PhlG) in aspects of metal 
dependency and a potential reaction mechanism. Only small differences were found 
regarding the two enzymes’ substrate specificities. With respect to structural features 
and catalytic motifs however, the two hydrolases differ significantly from the well 
characterised, serine dependent, "/! fold carbon-carbon hydrolases. Despite 
successful crystallisation of Phy, the protein’s structure could not be determined to 
date. Efforts to produce crystals of higher diffraction quality and/or an improved 
anomalous signal should thus be central to future work on this hydrolase. Once a 
three-dimensional structure is obtained, Phy may be a fascinating target for further 
protein engineering. The enzyme accepts lower and higher molecular weight 
substrates (MAPG vs. phloretin). This feature that could be exploited for modelling it 
according to ligand requirements as described previously for other biocatalysts (41). 
Ultimately, reverting the Phy reaction into an enzymatic Friedel Crafts acylation 
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would be an unprecedented biocatalytic reaction and allow for the synthesis of high 
value chemical building blocks.  
 
The oxidised polyvinyl alcohol hydrolase analysed as part of this project is a 
similarly exciting target for biocatalytic applications. If its reaction could be 
reverted, OPH would catalyse the formation of !-diketones for downstream synthetic 
applications. A truncated version of the enzyme, lacking its lipoprotein signal 
sequence, has been purified (and possibly crystallised) in the form of a soluble fusion 
construct for the first time. This now creates the basis for fundamental research into 
the OPH structure and function. If the enzyme is active in the presence of its fusion 
tag, an activity screen using a variety !-diketones could give important insights into 
possible substrate requirements. Determination of the enzyme’s structure, ideally in 
complex with one of its substrates or an analogue thereof, would allow for an insight 
into a potential mechanism. Although OPH contains the lipase box motif and is 
likely to make use of a serine nucleophile, it remains to be determined if the catalytic 
mechanism involves formation of a covalent acyl enzyme intermediate. With respect 
to large scale applications, engineering of additional fusion constructs may be 
required. These should be designed to increase protein production levels and, 
potentially, allow cleavage of the hydrolase from its fusion tag. As for Phy (and 
BsPAD), a thorough understanding of the wild type enzyme’s structure and function 
may inspire future protein engineering to improve activity, change selectivity or even 
enable a reversal of the hydrolytic reaction into carbon-carbon bond formation.  
 
In summary, all catalysts described are important targets for biocatalytic 
applications. They could, in time, become a “green” alternative to their abiotic 
counterparts and may be used for both degradative and synthetic reactions. Whereas 
the decarboxylase is already a fascinating target for novel applications, more 
fundamental research is required for the C-C hydrolases described. With the 
appropriate enzyme and process engineering, all proteins may one day be important 
catalysts in large scale industrial applications.   
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LIST OF ABBREVIATIONS 
Amino acids  
Ala Alanine 
Arg Arginine 
Asn Asparagine  
Gln Glutamine 
Glu Glutamate  
His Histidine  
Lys Lysine  
Met Methionine 
Phe Phenylalanine  
SeMet Selenomethionine 
Ser Serine 
Thr Threonine  
Trp  Tryptophan  
Tyr Tyrosine 
PAD Phenolic acid decarboxylase 
Proteins  
AADC Aromatic amino acid decarboxylase  
ABDH Anabaena !–diketone hydrolase 
AMDase "–aryl malonate decarboxylase 
BphD 2-hydroxy-6-keto-6-phenylhexa-2,4-dienoic acid 
hydrolase 
BpPAD Bacillus pumilus phenolic acid decarboxylase 
BsPAD Bacillus subtilis phenolic acid decarboxylase 
DDC L-3,4-dihydroxyphenylalanine decarboxylase 
DHPONH 2,6-dihydroxy-pseudo-oxynicontine hydrolase 
EPAD Enterobacter sp. Px6-4 phenolic acid decarboxylase 
FAH fumarylacetoacetate hydrolase 
Fus Fusion protein (“tag”) 
GFP Green fluorescence protein 
GST Glutathione S-transferase 
HCHL Hydroxycinnamoyl-CoA hydratase lyase 
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ICL Isocitrate lyase 
Im9 Immunity protein 9 
KoPAD Klebsiella oxytoca phenolic acid decarboxylase 
LpPAD Lactobacillus plantarum phenolic acid decarboxylase 
LSS Lipoprotein signal sequence 
MBP maltose binding protein 
MhpC 2-hydroxy-6-keto-nona-1,9-dienoic acid 5,6 hydrolase 
MSAD malonate semialdehyde decarboxylase 
NeuA N-acetylneuraminic acid lyase 
NusA N-utlilization substance A 
OCH oxocamphor hydrolase 
OMPDC orothidine 5’-monophosphate decarboxylase 
OMP outer membrane protease 
OPH Oxidised polyvinyl alcohol hydrolase 
PDC pyruvate decarboxylase 
PhlG Diacetylphloroglucinol hydrolase 
Phy Phloretin hydrolase 
TrxA Thioredoxin A 
VAO Vanillyl-alcohol oxidase 
PHBD Polyhydroxybutyrate depolymerase 
Cofactors  
CoA Coenzyme A 
PLP Pyridoxal phosphate 
PQQ Pyrroloquinoline quinone 
ThDP Thiamine diphosphate 
TPP Thiamine pyrophosphate 
Nucleic acids  
dATP deoxyadenosine triphosphate 
DNA Deoxyribonucleic acid 
dNTP Deoxyribonucleotide 
dTTP deoxythymidine triphosphate 
mRNA Messenger ribonucleic acid 
RNA Ribonucleic acid 
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tRNA Transfer ribonucleic acid 
Methods  
GC Gas chromatography 
HPLC High-performance liquid chromatography 
IMAC Immobilised metal affinity chromatography 
LIC Ligation independent cloning 
NMR Nuclear magnetic resonance 
PCR Polymerase chain reaction 
SDM Site-directed mutagenesis 
SDS PAGE Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis 
SEC Size-exclusion chromatography 
UV Ultraviolet 
UV-VIS Ultraviolet-visible 
Reagents  
DMSO Dimethylsulfoxide 
EDTA Ethylenediaminetetraacetic acid 
IPTG !-D-1-thiogalactopyranoside 
LB Lysogeny broth 
MES 2-(N-morpholino)ethanesulfonic acid 2-(N-
morpholino)ethanesulfonic acid 
Ni-NTA Ni-nitriloacetic acid 
PEG Polyethylene glycol 
PMSF Phenylmethanesulfonylfluoride 
Units  
Å Ångstrom 
bp Basepair 
c Concentration 
h Hour 
kDa Kilodalton 
L Litre  
M Molar 
mg Milligram  
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min Minute 
µg Microgram  
µL Microlitre 
µm Micrometre 
µM Micromolar 
mL Millilitre  
mm Millimetre 
mM Millimolar  
ng Nanogram 
nm Nanometre 
nmoles Nanomoles 
OD Optical density 
rpm Revolutions per minute 
s Second 
v/v Volume/volume 
w/v Weight/volume 
w/w Weight/weight 
Reaction substrates 
and products 
 
2-HAP 2-hydroxyacetophenone  
2,4-DHAP 2,4-dihydroxyacetophenone 
2,6-DHAP 2,6-dihydroxyacetophenone 
4-HAP 4-hydroxyacetophenone 
carbidopa (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methyl-
propanoic acid 
CEHPOBA 4-[(2-carboxyethyl)hydroxyphosphynil]-3-oxobutyric acid 
DAPG Diacetylphloroglucinol 
DHP 2,6-dihydroxypyridine 
DOPA L-3,4-dihydroxyphenylalanine 
dopamine L-3,4-dihydroxyphenylamine 
HODA 2-hydroxy-6-oxo- dienoic acid 
HPD 2-hydroxypenta-2,4-dienoic acid 
HOPDA 2-hydroxy-6-keto-6-phenylhexa-2,4-dienoic acid 
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MAB #-N-methylaminobutyrate 
MAPG Monoacetylphloroglucinol 
MCP Meta-cleavage product 
OHCU 2-Oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline 
OPVA Oxidised polyvinyl alcohol 
PG Phloroglucinol 
PVA polyvinylalcohol 
R-PAC (R)-phenyl acetylcarbinol 
TAPG Triacetylphloroglucinol 
TCA Tricarboxylic acid 
Crystallography  
CSS  Clear strategy screen 
I Intensity  
MAD Multiwavelength anomalous dispersion 
NCS Non-crystallographic symmetry 
RMSD Root-mean-square deviation 
Rmerge Merging R factor 
Rpim precision-indicating merging R factor 
Other  
EC Enzyme commission 
Fig. Figure  
HRV human rhinovirus 
n.d. Not determined 
NP Non-polar 
P Polar 
PDB Protein Data Bank 
pI Isoelectric point 
TM Trademark 
wt Wild type 
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Maria Rodriguez Mata, the imine reductase gene was cloned into the YSBLIC3C 
vector, the recombinant protein purified to high homogeneity and screened against a 
variety of crystallisation conditions.   
After structure determination and mechanistic analysis of two active site point 
mutants by Elisabeth Wells, the results were published in the ChemBioChem Journal 
in 2013: 
 
Maria Rodriguez Mata, Annika Frank, Elizabeth Wells, Friedemann Leipold, 
Nicholas J.Turner, Sam Hart, Johan P. Turkenburg and Gideon Grogan (2013) 
Structure and activity of NADPH- dependent (R)-selective imine reductase Q1EQE0 
from Streptomyces kanamyceticus,ChemBioChem. 
 
A long-term collaboration, throughout the course of this PhD project, involved work 
with Professor Wolfgang Kroutil’s group from the University of Graz. In particular, 
the work on carbon-carbon hydrolases, described in chapters 5 and 6 of this thesis, 
was carried out in close cooperation with Dr. Elina Siirola. This also involved two 
exchange visits between York and Graz. This collaborative work is included in a 
review published in the journal Advanced  Synthesis and Catalysis in 2013: 
 
Elina Siirola, Annika Frank, Gideon Grogan, Wolfgang Kroutil (2013) C-C 
hydrolases for Biocatalysis, Review, Advanced Synthesis & Catalysis, 355(9): 1677-
1691  
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In addition to the work described above, the exchange visits of two Marie Curie 
Early Stage Reasearchers, Dr. Justyna Kulig and Kinga Kedziora, involved projects 
on the structural and mechanistic characterization of alcohol dehydrogenases. Their 
work has been submitted for publication.  
 
 
